CHURCH & DWIGHT CO., INC.
ANNUAL REPOR T 2021
C
H
U
R
C
H
&
D
W
I
G
H
T
C
O
.
,
I
N
C
.
—
A
N
N
U
A
L
R
E
P
O
R
T
2
0
2
1
in millions, except per share data
Net Sales
Gross Profit Margin
Income from Operations
Operating Profit Margin
Net Income
Net Income Per Share – Diluted
Dividends Per Share
Year-end Stock Price
2021
2020
reported
adjusted*
reported
adjusted*
$ 5,190
$ 5,190
$ 4,896
$ 4,896
43.6 %
43.6 %
45.2 %
45.2 %
$ 1,079
$
981
$ 1,030
$ 933
20.8 %
18.9 %
21.0 %
19.0 %
$
828
$ 3.32
$ 1.01
$ 102.50
$
754
$ 3.02
$ 1.01
$ 102.50
$ 786
$ 3.12
$ 0.96
$ 87.23
$ 713
$ 2.83
$ 0.96
$ 87.23
On January 28, 2022, the Company declared a 4.0% increase in
its quarterly dividend from $0.2525 per share to $0.2625 per share.
2021 Key Financial Results
– Worldwide net sales increased 6.0%.
– Organic sales increased 4.3%.
– Gross profit margin decreased 160 basis points to 43.6%.
– Adjusted operating profit margin decreased 10 basis points to 18.9%.
– Net cash from operations increased to a record level of $994 million.
– Adjusted earnings per share increased 6.7%.
NET SALES
(in millions of dollars)
2019
2020
2021
$4,358
$4,896
$5,190
ADJUSTED EARNINGS PER SHARE
(in dollars)
2019
2020
2021
$2.47(1)
$2.83(2)
$3.02(3)
For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended
December 31, 2021.
*
This annual report includes non-GAAP financial measures, including adjusted income from operations, adjusted operating profit margin, adjusted net income, adjusted EPS, organic sales, and
free cash flow, which differ from reported results using Generally Accepted Accounting Principles (GAAP).
(1)
This annual report presents adjusted EPS, namely, earnings per share calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the
Company’s period to period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental
information regarding our year over year earnings per share growth. Adjusted 2019 EPS excludes a $0.02 positive impact from an earn-out reversal from the acquisition of Passport Food
Safety Solutions, Inc., $0.03 negative impact from the loss on the sale of the consumer Brazil business, and $0.02 negative impact from the FLAWLESS acquisition earn-out estimate.
(2) Adjusted 2020 EPS excludes a $0.28 positive FLAWLESS acquisition related earn-out adjustment and a $0.01 gain on the sale of an International Brand.
(3) Adjusted 2021 EPS excludes $0.30 per share positive impact from the FLAWLESS acquisition earn-out estimate.
Corporate
Information
Church & Dwight Co., Inc., founded in 1846, is the leading U.S. producer of sodium
bicarbonate, popularly known as baking soda, a natural product that cleans, deodorizes,
leavens and buffers. The Company’s ARM & HAMMER brand is one of the nation’s most
trusted trademarks for a broad range of consumer and specialty products developed from
the base of sodium bicarbonate and related technologies.
Church & Dwight’s consumer products business is organized into two segments: Consumer
Domestic, which encompasses both household and personal care products, and Consumer
International, which primarily consists of personal care products. The Company has fourteen
key brands representing approximately 80% of its revenues. These “power brands” include
ARM & HAMMER, TROJAN, OXICLEAN, SPINBRUSH, FIRST RESPONSE, NAIR,
ORAJEL, XTRA, VMS (L’IL CRITTERS and VITAFUSION), BATISTE, WATERPIK,
FLAWLESS, ZICAM and THERABREATH. About 43% of the Company’s domestic
consumer products are sold under the ARM & HAMMER brand name and derivative
trademarks, such as ARM & HAMMER liquid and powder laundry detergent,
ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER
baking soda. The remaining 13 power brands have been added to the Company’s portfolio
since 2001 through a series of acquisitions.
The combination of the core ARM & HAMMER brands and the other 13 power brands
make Church & Dwight one of the leading consumer packaged goods companies in the
United States. Church & Dwight’s third business segment is Specialty Products. This business
is a leader in specialty inorganic chemicals, animal nutrition, and specialty cleaners.
Growth Driven by
14 Power Brands
XTRA
#1 Extreme Value
Laundry Detergent
L’IL CRITTERS & VITAFUSION
#1 Gummy Brands for Kids
and Adults
OXICLEAN
#1 Laundry Additive Brand
ARM & HAMMER
More aisles in the grocery store than
any other brand; A&H products are
in 86% of U.S. households
SPINBRUSH
#2 Battery Powered
Toothbrush Brand
FLAWLESS
#1 Women’s Electric Hair
Removal System
FIRST RESPONSE
#2 Branded Pregnancy Kit
WATERPIK
#1 Power Flosser and #1
Replacement Showerhead
ORAJEL
#1 Oral Care Pain Relief Brand
BATISTE
#1 Dry Shampoo
Based on Information Resources, Inc.
(IRI) Total US – MULO for the period
ending 12/26/21.
NAIR
#1 Depilatory Brand
TROJAN
#1 Condom Brand
ZICAM
#1 Adult Cold Shortening
THERABREATH
#2 Alcohol-Free
Mouthwash
| 1 |
MATTHEW T. FARRELL
Chairman, President
and Chief Executive Officer
RICHARD A. DIERKER
Executive Vice President
and Chief Financial Officer
PATRICK D. DE MAYNADIER, ESQ.
Executive Vice President,
General Counsel and Secretary
Dear Fellow Stockholder,
2021 was another volatile year due to inflation, supply
chain disruptions, and record demand for our products.
Shortages of labor and raw materials at our facilities and
those of our suppliers resulted in low fill rates in fulfilling
retailer orders. We acted quickly to the inflationary
pressures, raising prices on our global portfolio. We added
to our supply resiliency and capacity by qualifying new
suppliers and co-manufacturers. We take pride in what
we accomplished.
I am pleased to report another successful year of revenue
and earnings growth in 2021:
– Reported net sales were $5,190 million, a 6% increase.
– Organic sales increased 4.3% driven by 3.6% growth in
our Consumer Domestic business, 5.0% growth in our
Consumer International business, and a 12.0% increase
in our Specialty Products business.
– Gross margin decreased 160 basis points to 43.6%,
primarily due to higher commodities, distribution, and
labor. These were partially offset by our productivity
improvements, leveraging our manufacturing costs with
higher volumes and the impact of higher pricing.
– Adjusted EPS was $3.02 per share, a 6.7% increase.
– We generated $994 million of cash from operating
activities and invested $119 million in capital expenditures
resulting in free cash flow of $875 million.
These results positively impacted the measure that matters
most to our stockholders.
– Total Shareholder Return (TSR) — which reflects the
combination of stock price appreciation and dividends.
We manage Church & Dwight with the perennial goal of
delivering strong TSR to you, our stockholders. In 2021,
we achieved a TSR of 17.9%. Over the past decade, we
delivered an annual TSR of approximately 18.0%, which
was significantly better than the 14.3% TSR of the S&P
500 stock index during the same period. In dollar terms,
if you invested $1,000 on January 1, 2012, in each of
Church & Dwight stock and the S&P 500 stock index,
the Church & Dwight investment was worth $5,230 on
December 31, 2021, whereas the S&P 500 investment
was worth only $3,790. That significant difference in
investment reflects the work of a focused management
team and a disciplined business model.
| 2 | C H U R C H & D W I G H T C O . , I N C . — A N N U A L R E P O R T 202 1
evergreen model
Our long-term mission is to maintain our track record
of delivering outstanding TSR. Our long-term plan for
delivering superior returns is based on what we call our
“Evergreen business model”: 3% annual organic revenue
growth and 8% annual increase in earnings per share.
The 3% annual organic growth is driven by U.S. 2%,
International 6%, and Specialty Products 5%. The 8%
earnings per share growth is driven by 25 basis points of
gross margin expansion and a 25-basis points reduction of
overhead costs resulting in operating margin improvement
of 50 basis points. Achievement of the Evergreen model
influences both our short-term and long-term decision
making and promotes financial literacy inside our
Company. It is an important part of our success.
key drivers of tsr
The following are the key drivers of our success:
(1) A Diversified Product Portfolio
Church & Dwight’s diverse consumer product portfolio,
consisting of both premium (60%) and value (40%) brands,
enables us to succeed in various economic environments. We
believe no other consumer packaged goods (CPG) company
has such a well-balanced portfolio of both premium and
value brands.
(2) Focus on Power Brands
While we sell over 80 brands, 14 of these brands
generate over 80% of our revenues and profits. These
14 brands, which we call our “power brands,” are
ARM & HAMMER, TROJAN, OXICLEAN,
VMS (L’IL CRITTERS and VITAFUSION), XTRA,
FIRST RESPONSE, SPINBRUSH, ORAJEL, NAIR,
BATISTE, WATERPIK, FLAWLESS, ZICAM and
THERABREATH.
Our 14 Power Brands are “Brands Consumers Love”
and, consequently, are market leaders. We connect with
consumers through execution of creative marketing,
innovative new products, and sustained marketing
spending resulting in high market shares for our brands.
(3) High International Growth
Our Evergreen model calls for our Consumer International
business to grow revenues 6% annually. Today, 18% of our
sales are international and growing rapidly. In 2021, we
posted organic growth of 5%, below our Evergreen model
of 6%, but lapping 8.6% growth in 2020. And while we
were below our Evergreen model target, 2021 represented
strong performance in the face of inflation, widespread global
supply disruptions, impacts from COVID-19 and weather-
related events. Our Global Markets Group grew almost
11% and now represents 35% of our international business.
We have fully operational subsidiaries in six countries
(U.K., France, Germany, Canada, Mexico and Australia)
and export to over 130 countries.
(4) Animal Nutrition
We expect our Specialty Products business to grow revenues
5% annually driven by our animal and food production
business. The global population is expected to rise from
7.7 billion today to 9.7 billion in 2050. The demand for
protein will increase with population growth. At the same
time, there is a trend away from the use of antibiotics,
hormones, and chemicals in animal nutrition. Our portfolio
of natural supplements, prebiotics, and custom probiotics
for dairy cows, poultry, cattle, and swine are well-positioned
for this global growth. In 2015, dairy represented 99% of
our animal productivity business, which is cyclical. Our
focus on the non-dairy business (now 24%) has created a
better balance. Considering the population tailwind and
the strength of our products, we have strong confidence
in long-term growth.
(5) Winning Online
Our long-term success requires us to be “digitally savvy.”
One important measure of digital skills is online sales.
In 2015, only 1% of our sales were online. In 2021,
approximately 15% of our global sales were online,
excluding click and collect (i.e., order online, pick up
in store). To analyze consumer and retailer data, we have
created a center of excellence focused on predictive analytics.
Our progress is an illustration of the digital skills we have
developed and the adaptability of our Company. We are
preparing ourselves for a world where 40% of our net
sales are ordered online.
| 3 |
(6) Focus on Gross Margin
Gross margin expansion fuels our organic growth because
it enables us to increase investments in marketing, R&D,
and technology. In 2021, our gross margin decreased 160
basis points to 43.6%, primarily due to COVID-19 related
costs, higher commodities, higher transportation costs, labor
increases, and investments. These were partially offset by our
productivity improvements, leveraging our manufacturing
costs with higher volumes and the impact of higher pricing.
While we took quick action on pricing in 2021, we were
unable to price as quickly as inflation was happening. By
February 2022, we had raised prices on shelf for 80% of
our global portfolio and expect additional pricing actions
in 2022.
(7) Growth through Acquisitions
Church & Dwight has a long history of successfully
acquiring businesses. Over the past 20 years, we acquired
13 of our 14 current Power Brands. To illustrate our long-
term acquisition mindset, we like to say, “14 Power Brands
today, 20 tomorrow.” We possess a competency in targeting,
acquiring, and integrating brands and businesses. In a world
where seven out of 10 acquisitions do not create value, we
have a superior track record in making accretive acquisitions.
We are disciplined in adhering to clear acquisition guidelines.
We quickly integrate acquisitions to leverage our existing
capital base in manufacturing, logistics and purchasing
and other back-office functions. In December 2021, the
Company acquired the THERABREATH brand for
approximately $580 million. THERABREATH is the
#2 brand in the alcohol-free mouthwash category in the
United States and the fastest growing brand in the category.
(8) “BEST IN CLASS” Free Cash Flow Conversion
In 2021, our annual free cash flow (Cash from Operations
minus Capex) was $875 million, with a free cash flow
conversion rate of 116%. This reflects excellent working
capital management by our financial and supply chain teams
and has enabled us to lead the CPG industry by consistently
converting over 100% of net income into free cash flow
(free cash flow conversion). Over the next three years, we
anticipate that we will generate over $2.4 billion in free
cash flow. We expect our financial strength to enable us to
aggressively pursue acquisitions, make capital investments
to continue to support the profitable growth of our existing
businesses, and return cash to our stockholders. We increased
our annual dividend by 4% in the first quarter of 2022. Over
the last five years, we have averaged a 7% dividend growth
rate, well ahead of the peer average. We have paid a quarterly
dividend for 121 consecutive years.
(9) Superior Overhead Management
Maintaining tight controls on our selling, general and
administrative expense (“SG&A”) has been a hallmark of
Church & Dwight. Our adjusted SG&A is 13.6% of sales
and 10.7% excluding amortization. This overhead rate is
one of the lowest in the CPG space. We believe we have the
highest revenue per employee of any major CPG company
($1 million per employee), a measure of productivity that
is often overlooked. Church & Dwighters are committed
to finding ways to grow our revenues, lower our costs and
provide outstanding service to our customers. Because we
are lean, we are a nimble organization enabling us to
communicate easily, make quick decisions, and adapt to
change. Our ability to adapt is evident in our ability to
manage through the pandemic these past 2 years.
(10) Simple Incentive Compensation
At Church & Dwight, we embrace the power of simplicity.
This is evident in our simple incentive compensation plan.
Our bonuses are tied directly to four equally weighted
drivers of TSR: net sales growth, gross margin expansion,
EPS growth, and operating cash flow. Our equity
compensation consists predominantly of stock options
that are valuable only when the value of your investment
rises. And our senior management team is required to
maintain a significant investment in our stock to be
closely aligned with you, our stockholders.
sustainability
Sustainable business practices are important to our
Company, our employees, our retailers, and our consumers.
Church & Dwight has been a friend of the environment
since the early 20th century. In 1907, we began using
recycled paperboard in our packaging. In the 1970’s,
Church & Dwight was the only corporate sponsor of
the first Earth Day and the first to remove phosphates
from laundry detergent. We have planted millions of trees
| 4 | C H U R C H & D W I G H T C O . , I N C . — A N N U A L R E P O R T 202 1
in the Mississippi Valley through our partnership with the
Arbor Day Foundation. Today, 100% of our global electricity
is derived from renewable resources. We are committed
to doing our part for the environment. In 2021, among
other things, we established a new science-based target for
2030 and submitted our application to the Science-Based
Targets Initiative (SBTi). This new target considers the level
of carbon reduction needed to help keep global climate
change safely below the 2-degree threshold, aligned with
the Paris Agreement targets.
culture
Our “secret sauce” is the Church & Dwight culture.
We describe ourselves as blue collar with a high aptitude
and an underdog mentality. Church & Dwighters exhibit
an absence of ego and ‘wear many hats’ because our
responsibilities often extend beyond our job descriptions.
We make decisions based on “What is best for Church
& Dwight”, putting personal goals second.
We emphasize speed in doing our work because speed
of execution determines the winners and the losers in the
consumer products industry. By obsessively focusing on
the consumer experience, our employees discover insights
that lead to new products and brands that consumers love.
Our employees’ willingness to pitch in and help one another
makes teamwork a hallmark of Church & Dwight’s culture.
Church & Dwighters have experience and instincts, but
also a zeal to “get the facts” and make data driven decisions.
Our employees are the backbone of our great Company.
During the past year, our Employee Giving Fund (EGF)
supported our communities by contributing $1.2 million
to 225 charitable organizations through annual grants,
disaster relief, and other monetary support. The EGF is a
great example of how our employees engage in local causes
in which they have a personal interest. Employees purchased
back-to-school supplies to support disadvantaged youth,
donated clothes and non-perishable items for clothing and
food drives and provided supplies for a summer camp and
holiday dinner for families in need.
We strive to create a culture of belonging. We want our
workplace to be a place where people matter and to reflect
the diverse consumer base that we serve. Through our
Diversity & Inclusion Advisory Council, our Company
has made clear our support for racial equality and the
importance of diversity both inside and outside our walls.
The Church & Dwight Philanthropic Foundation (the
“Foundation”) focuses on helping to create equitable and
inclusive opportunities and advancing environmental
preservation, two causes that are important to our Company.
The Foundation is administered by our employees. In
2021, six organizations were chosen and received grants
in aggregate totaling $1 million. At Church & Dwight,
we are focused on creating an inclusive, stronger, more
resilient company while contributing to a better, more
sustainable world.
2022 outlook
We expect to deliver 4%-8% adjusted EPS growth in 2022
through continued focus on the areas that contribute to our
outstanding TSR results. Our 2022 EPS outlook reflects
continued strong business performance and reinvestment to
accelerate growth and other long-term objectives. We expect
reported sales growth to be 5-8% and organic sales growth
of 3-6%. At the end of 2021, our order fill levels remained
low. The high end of our sales and EPS ranges are dependent
on higher fill rates by the second half of 2022. We expect
gross margin contraction, an increase in 2022 marketing
dollars and leverage of our SG&A spend. We expect cash
from operations to be approximately $920 million. We
are also investing for the future as we plan to spend more
than $200 million in 2022 and $300 million in 2023 for
capacity investments for some of our biggest businesses:
laundry, litter, and vitamins.
I would like to thank all employees of Church & Dwight
for the personal sacrifices that they made to deliver excellent
business results in 2021.
MATTHEW T. FARRELL
Chairman, President and
Chief Executive Officer
| 5 |
NON-GAAP MEASURES:
ADJUSTED OPERATING INCOME AND MARGIN:
The following discussion addresses the non-GAAP measures
used in this annual report and reconciliations of these
non-GAAP measures to the most directly comparable GAAP
measures. These non-GAAP financial measures should not
be considered in isolation from or as a substitute for the
comparable GAAP measures. The following non-GAAP
measures may not be the same as similar measures provided
by other companies due to differences in methods of
calculation and items and events being excluded.
ORGANIC SALES GROWTH:
This annual report provides information regarding organic
sales growth, namely net sales growth excluding the effect of
acquisitions, divestitures and foreign exchange rate changes.
Management believes that the presentation of organic sales
growth is useful to investors because it enables them to
assess, on a consistent basis, sales trends related to products
that were marketed by the Company during the entirety
of relevant periods, excluding the impact of acquisitions,
divestitures and excluding foreign exchange rate changes that
are out of the control of, and do not reflect the performance
of, the Company and management.
ADJUSTED SG&A:
This annual report presents information regarding adjusted
selling, general and administrative (SG&A) expenses
excluding items in 2020 relating to the earn-out adjustment
from the FLAWLESS acquisition and the gain on sale of
an international brand and in 2021 relating to the earnout
adjustment from the FLAWLESS acquisition. We believe
that this metric enhances investors’ understanding of the
Company’s year-over-year expenses by excluding certain
significant one-time items.
This annual report provides information regarding adjusted
operating income and margin, which exclude the effect
of items in 2020 relating to the earn-out adjustment from
the FLAWLESS acquisition and the gain on sale of an
international brand and in 2021 relating to the earnout
adjustment from the FLAWLESS acquisition. We believe
that excluding these items from operating income and
margin provides a useful measure of the Company’s ongoing
operating performance and a more effective comparison to
prior periods by excluding significant one-time events.
ADJUSTED EPS:
This annual report also presents adjusted earnings per
share (EPS) calculated in accordance with GAAP, as adjusted
to exclude significant one-time items that are not indicative
of the Company’s period-to-period performance. We believe
that this metric provides investors a useful perspective
of underlying business trends and results and provides
useful supplemental information regarding our year-
over-year earnings per share growth. Adjusted 2020 EPS
excludes items relating to the earn-out adjustments from
the FLAWLESS acquisition and the gain on the sale of
an international brand. Adjusted 2021 EPS excludes
items relating to the earn-out adjustment from the
FLAWLESS acquisition.
FREE CASH FLOW:
Free cash flow is defined as cash from operating activities
less capital expenditures. Management views free cash
flow as an important measure because it is one factor in
determining the amount of cash available for dividends
and discretionary investment.
FREE CASH FLOW AS PERCENTAGE OF
ADJUSTED NET INCOME:
Free cash flow as percentage of adjusted net income is
defined as the ratio of free cash flow to adjusted net income.
Management views this as a measure of how effective the
Company manages its cash flow relating to working capital
and capital expenditures.
| 6 | C H U R C H & D W I G H T C O . , I N C . — A N N U A L R E P O R T 202 1
2021 ORGANIC SALES RECONCILIATION
Reported Sales Growth
Less:
Acquisitions
Add:
FX / Other
Organic Sales Growth
TWELVE MONTHS ENDED 12/31/2021
Total
Company
Worldwide
Consumer
Consumer
Domestic
Consumer
International
Specialty
Products
6.0 %
5.6 %
4.6 %
10.1 %
12.0 %
0.8 %
0.9 %
1.0 %
0.0 %
0.0 %
-0.9 %
4.3 %
-0.9 %
3.8 %
0.0 %
3.6 %
-5.1 %
5.0 %
0.0 %
12.0 %
2021 FREE CASH FLOW AS PERCENTAGE OF ADJUSTED NET INCOME
(Dollars in Millions)
Cash from Operations
Capital Expenditures
Free Cash Flow
Adjusted Net Income
Percentage
$ 993.8
$ (118.8 )
$ 875.0
$ 753.9
116 %
ADJUSTED DILUTED EARNINGS PER SHARE RECONCILIATION
Diluted Earnings Per Share – Reported
Flawless Earn-out Adjustment
Gain on Sale of International Brand
Diluted Earnings Per Share – Adjusted (non-GAAP)
$ 3.32
$ 3.12
6.4 %
$ (0.30 )
$ (0.28 )
$ —
$ 3.02
$ (0.01 )
$ 2.83
—
—
6.7 %
2021
2020 % CHANGE
2021 ADJUSTED SG&A RECONCILIATION
Reported SG&A
Flawless Earn-out Adjustment
Adjusted SG&A
2021
11.7 %
1.9 %
13.6 %
| 7 |
OFFICERS
Barry A. Bruno
Executive Vice President
DIRECTORS
Bradlen S. Cashaw
Chief Operating Officer
and Chief Marketing Officer
Agropur
Patrick D. de Maynadier, Esq.
Executive Vice President,
Director since 2021
James R. Craigie
General Counsel and Secretary
Former Chairman, President
and Chief Executive Officer
Church & Dwight Co., Inc.
Director since 2004
Matthew T. Farrell
Chairman, President and
Chief Executive Officer
Robert K. Shearer
Retired Senior Vice President
and Chief Financial Officer
VF Corporation
Director since 2008
Janet S. Vergis
Former Executive Advisor
Private Equity and Former CEO
OraPharma, Inc.
Director since 2014
Art Winkleblack
Retired Executive Vice President
Richard A. Dierker
Executive Vice President
and Chief Financial Officer
Matthew T. Farrell
Chairman, President
and Chief Executive Officer
Rene M. Hemsey
Executive Vice President,
Global Human Resources
Carlos G. Linares
Executive Vice President,
Global Research and Development
Michael G. Read
Executive Vice President
International
Rick Spann
Executive Vice President,
Global Operations
Paul R. Wood
Executive Vice President,
Sales
Church & Dwight Co., Inc.
and Chief Financial Officer
Director since 2016
Bradley C. Irwin
Lead Director
Retired President
H.J. Heinz Company
Director since 2008
Laurie J. Yoler
General Partner Playground Global
and Chief Executive Officer
Director since 2018
Welch Foods Inc.
Director since 2006
Penry W. Price
Vice President
Marketing Solutions
LinkedIn Corporation
Director since 2011
Susan G. Saideman
Founder and Chief Executive Officer,
Portage Bay Limited LLC and former
Vice President, Amazon, Inc.
Director since 2020
Ravichandra K. Saligram
President and
Chief Executive Officer
Newell Brands
Director since 2006
EMERITUS
DIRECTOR
Dwight C. Minton
Chairman Emeritus
Church & Dwight Co., Inc.
PRINCIPAL
ACCOUNTING
OFFICER
Joseph J. Longo
Vice President, Controller
and Chief Accounting Officer
| 8 | C H U R C H & D W I G H T C O . , I N C . — A N N U A L R E P O R T 202 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(MARK ONE)
È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
OR
‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission file number 1-10585
CHURCH & DWIGHT CO., INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
13-4996950
(I.R.S. Employer
Identification No.)
500 Charles Ewing Boulevard, Ewing, NJ 08628
(Address of principal executive offices)
Registrant’s telephone number, including area code: (609) 806-1200
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, $1 par value
Trading
Symbol(s)
CHD
Name of each exchange
on which registered
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes È No ‘
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ‘ No È
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes È No ‘
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to
submit such files). Yes È No ‘
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer È Accelerated filer ‘ Non-accelerated filer ‘ Smaller reporting company ‘ Emerging growth company ‘
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‘
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its
internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm
that prepared or issued its audit report. È
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ‘ No È
The aggregate market value of the voting and non-voting common equity held by non-affiliates as of June 30, 2021 (the last business day of the
registrant’s most recently completed second fiscal quarter) was approximately $20.2 billion. For purposes of making this calculation only, the
registrant included all directors, executive officers and beneficial owners of more than ten percent of the common stock (the “Common Stock”) of
Church & Dwight Co., Inc. (the “Company”). The aggregate market value is based on the closing price of such stock on the New York Stock
Exchange on June 30, 2021.
As of February 15, 2022, there were 242,691,649 shares of Common Stock outstanding.
Documents Incorporated by Reference
Certain provisions of the registrant’s definitive proxy statement to be filed not later than April 30, 2022 are incorporated by reference in Items 10
through 14 of Part III of this Annual Report on Form 10-K (this “Annual Report”).
CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION
This Annual Report contains forward-looking statements, including, among others, statements relating to net sales
and earnings growth; the impact of the COVID-19 pandemic and the Company’s response; gross margin changes; trade
and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations;
earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and
spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product
launches into new and existing categories; the decline of condom usage; the Company’s hedge programs; the impact of
foreign exchange, tariffs, and commodity price fluctuations; impairments and other charges; the Company’s
investments in joint ventures; the impact of acquisitions and divestitures; capital expenditures; the Company’s effective
tax rate; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; the effect of the credit
environment on the Company’s liquidity and capital resources; the Company’s fixed rate debt; compliance with
covenants under the Company’s debt instruments; the Company’s commercial paper program; the Company’s current
and anticipated future borrowing capacity to meet capital expenditure program costs; and the Company’s share
repurchase programs; payment of dividends; environmental and regulatory matters; the availability and adequacy of
raw materials, including trona reserves and the conversion of such reserves; and the customers and consumer
acceptance of certain ingredients in our products. Other forward-looking statements in this report are generally
identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,”
“project,” “anticipate,” “to be,” “to make” or other comparable terms. These statements represent the intentions, plans,
expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but
may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of
which are outside the Company’s control and could cause actual results to differ materially from such forward-looking
statements. Factors that could cause such differences include a decline in market growth, retailer distribution and
consumer demand (as a result of, among other things, political, economic and marketplace conditions and events),
including those relating to the outbreak of contagious diseases; other impacts of the COVID-19 pandemic and its
impact on the Company’s operations, customers, suppliers, employees, and other constituents, and market volatility and
impact on the economy (including causing recessionary conditions), resulting from global, nationwide or local or
regional outbreaks or increases in infections, new variants, and the risk that the Company will not be able to
successfully execute its response plans with respect to the pandemic or localized outbreaks and the corresponding
uncertainty; the impact of regulatory changes or policies associated with the COVID-19 pandemic, including
continuing or renewed shutdowns of retail and other businesses in various jurisdictions; the impact of continued shifts
in consumer behavior, including accelerating shifts to on-line shopping; unanticipated increases in raw material and
energy prices or other inflationary pressures; delays and increased costs in manufacturing and distribution; increases in
transportation costs; labor shortages; the impact of price increases for our products; the impact of supply chain
disruptions; the impact of inclement weather on raw material and transportation costs; adverse developments affecting
the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending;
growth or declines in various product categories and the impact of customer actions in response to changes in consumer
demand and the economy, including increasing shelf space or online share of private label and retailer-branded
products or other changes in the retail environment; consumer and competitor reaction to, and customer acceptance of,
new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level
acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency
exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; transition to,
and shifting economic policies in the United States; potential changes in export/import and trade laws, regulations and
policies of the United States and other countries, including any increased trade restrictions or tariffs, including the
actual and potential effect of tariffs on Chinese goods imposed by the United States; increased or changing regulation
regarding the Company’s products in the United States and other countries where it or its suppliers operate; market
volatility; issues relating to the Company’s information technology and controls; the impact of natural disasters,
including those related to climate change, on the Company and its customers and suppliers, including third party
information technology service providers; integrations of acquisitions or divestiture of assets; the outcome of
contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the
regulatory environment.
For a description of additional factors that could cause actual results to differ materially from the forward-looking
statements, please see Item 1A, “Risk Factors” in this Annual Report.
The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise, except as required by the United States federal securities laws. You are
advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the
United States Securities and Exchange Commission (the “Commission”).
Unless otherwise specified or the context otherwise requires, all references in this Annual Report on Form 10-K to
“Church & Dwight,” “we,” “us,” “our” and “Company” refer to Church & Dwight Co., Inc. and its consolidated
subsidiaries.
TABLE OF CONTENTS
PART I
Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART II
Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer
Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
RESERVED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Management’s Discussion and Analysis of Financial Condition and Results of Operations . .
Item
1.
1A.
1B.
2.
3.
4.
5.
6.
7.
7A.
Quantitative and Qualitative Disclosures about Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . .
8.
9.
9A.
9B.
9C.
10.
11.
12.
13.
14.
Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in and Disagreements With Accountants on Accounting and Financial
Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections . . . . . . . . . . . . . . . . . . . .
PART III
Directors, Executive Officers and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . . . .
Principal Accounting Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART IV
Page
1
14
32
32
32
32
33
35
36
51
52
96
96
96
96
97
97
97
97
97
15.
Exhibits, Financial Statement Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
98
PART I
ITEM 1. BUSINESS
OVERVIEW OF BUSINESS
We were founded in 1846 and incorporated in Delaware in 1925. We develop, manufacture and market a
broad range of consumer household and personal care products and specialty products focused on animal and
food production, chemicals and cleaners. Our consumer products marketing efforts are focused principally on our
14 “power brands.” These well-recognized brand names include ARM & HAMMER® baking soda, cat litter,
laundry detergent, carpet deodorizer and other baking soda based products; TROJAN® condoms, lubricants and
vibrators; OXICLEAN® stain removers, cleaning solutions, laundry detergents and bleach alternatives;
SPINBRUSH® battery-operated toothbrushes; FIRST RESPONSE® home pregnancy and ovulation test kits;
NAIR® depilatories; ORAJEL® oral analgesic; XTRA® laundry detergent; L’IL CRITTERS® and
VITAFUSION® gummy dietary supplements for children and adults, respectively; BATISTE® dry shampoo;
WATERPIK® water flossers and showerheads, FLAWLESS® products, ZICAM® cold shortening and relief
products and THERABREATH® oral care products.
We sell our consumer products under a variety of brands through a broad distribution platform that includes
supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and
other discount stores, pet and other specialty stores and websites and other e-commerce channels, all of which
sell our products to consumers. We sell our specialty products to industrial customers, livestock producers and
through distributors.
Our Sustainability Strategy and Environmental, Social and Governance (“ESG”) Pillars
We believe that sustainable operations are both financially and operationally beneficial to our business, and
critical to the health of the communities in which we operate, while contributing to a better world. Sustainability
is how we refer to our Environmental, Social and Governance (ESG) efforts as part of our overall success in
delivering growth and profitability while making a meaningful and positive impact. Each year we publish a
Sustainability Report that discloses our business and corporate responsibility commitments by detailing our ESG
performance metrics and targets and other components of our ESG efforts. Our 2020 Sustainability Report is
available on our web site at https://churchdwight.com/pdf/Sustainability/2020-Sustainability-Report.pdf, and our
2021 Sustainability Report will be available in April 2022 (the “2021 Sustainability Report” and together with
the 2020 Sustainability Report, the “Sustainability Reports”). References to our Sustainability Reports are for
informational purposes only and neither the Sustainability Reports nor the other information on our website is
incorporated by reference into this Annual Report on Form 10-K.
Our global sustainability strategy is derived from our heritage and organizational values. The following six
pillars are the core focus of our Environmental and Social efforts. Each is supported through our Governance
practices which are intended to maintain a system of rules and practices that determine how we operate and align
the interests of our stakeholders in support of ethical business practices and financial success.
• Our Brands: Delight consumers with our brands and contribute towards a more sustainable world
•
•
Products: Provide safe and effective products for consumers and the environment
Packaging: Utilize consumer friendly and environmentally responsible packaging
• Employees and Communities: Embrace the principles of diversity, equity and inclusion (“DEI”), good
corporate citizenship and social responsibility within the communities we can impact
1
• Environment: Minimize environmental impact of our global operations, with a focus on increased
renewable energy usage, reduced water consumption, greenhouse gas emissions and solid waste to
landfills
• Responsible Sourcing: Improve our suppliers’ environmental, labor, health & safety and ethical
practices
Environmental. Our operations are subject to federal, state, local and foreign laws, rules and regulations relating
to environmental concerns, including air emissions, wastewater discharges, solid and hazardous waste
management activities, and the safety of our employees. We endeavor to take actions necessary to comply with
such regulations. These steps include periodic environmental and health and safety audits of our facilities. The
audits, conducted by independent firms with expertise in environmental, health and safety compliance, include
site visits at each location, as well as a review of documentary information, to determine compliance with such
federal, state, local and foreign laws, rules and regulations. However, our environmental priorities extend well
beyond our compliance efforts, and include our focus on providing safe and effective products for consumers and
the environment, utilizing consumer friendly and environmentally responsible packaging, achieving greenhouse
gas emission reductions, reducing water usage, recycling waste and solid waste and improving our suppliers’
environmental practices.
Social. Our Social focus areas include our goals of delighting consumers with our brands through our
contributions towards a more sustainable world, improving our suppliers’ labor, health & safety and ethical
practices, and supporting our employees to create a stronger, more resilient company while contributing to a
better world. In their everyday work, employees embody our core values of integrity, quality, commitment, and
innovation, and in doing so, directly contribute to our long-standing character and reputation. Employee safety is
a top priority. We develop and administer company-wide policies to ensure the safety of each team member and
compliance with OSHA standards and have implemented COVID-19 protocols across all locations to ensure both
the safety of our employees and compliance with federal and local requirement and guidelines. We embrace the
diversity of our employees and believe that a diverse workforce reflective of our consumer base fosters
innovation and cultivates an environment filled with unique perspectives and strive to cultivate a culture and
processes that support and enhance our ability to recruit, develop and retain diverse talent at every level. As part
of our enhanced diversity and inclusion initiatives that began in 2020, we intend to publish workplace
demographics of our employees in our 2021 Sustainability Report. We also encourage our employees to become
involved in their communities through our Employee Giving Fund and The Church & Dwight Philanthropic
Foundation (the “Foundation”) which is focused on helping to create DEI opportunities and advancing
environmental preservation. The Foundation is administered by our employees. See pages 11-13 in this Item 1 of
this Annual Report under “Employees and Human Capital” for a discussion of our human capital management.
Governance. Our governance focus includes the processes, rules, resources and systems in support of our
operational, sustainability and ESG efforts, have been described in our 2021 Proxy Statement and will be
described in our Proxy Statement for our upcoming Annual Meeting of Stockholders under the caption
“Sustainability Strategy and ESG Pillars” and in our 2021 Sustainability Report. Our Corporate Issues Council
(the “Council”), comprised of senior executives representing all of our key functional areas, guides the
integration of sustainability with all parts of our business and drives continuous improvement in our
sustainability approach and performance. The Council takes the lead in defining and implementing our
sustainability strategies across the six sustainability and ESG pillars. Our Board of Directors, acting principally
through its Governance, Nominating & Corporate Responsibility Committee, oversees our sustainability efforts,
with that Committee and the Compensation & Human Capital and Audit Committees each focusing on specified
areas of sustainability, including compliance and ethics, human capital and DEI. Our Independent Lead Director
is responsible for ensuring that stockholder requests, recommendations and proposals are evaluated by the
Governance, Nominating & Corporate Responsibility Committee, additional committees within the Board as
appropriate, and then by the Board of Directors, if needed.
2
As described in our Sustainability Reports, our continued progress in key areas of ESG has earned
recognition from various third parties.
We use the standards and guidelines of the Global Reporting Initiative, Sustainability Accounting Standards
Board industry specific standards and the Task Force on Climate-related Financial Disclosures to inform our
sustainability and ESG disclosures included in this Annual Report, our Proxy Statement and our Sustainability
Reports. The “materiality” thresholds in those standards and guidelines may differ from the concept of
“materiality” for purposes of the federal securities laws and disclosures required by the Commission’s rules in
this Annual Report. Moreover, the inclusion of sustainability and ESG disclosures in this Annual Report and in
our other filings with the Commission does not necessarily imply that we consider them to be material for
purposes of the federal securities laws or the Commission’s rules and regulations governing such disclosure.
FINANCIAL INFORMATION ABOUT SEGMENTS AND PRINCIPAL PRODUCTS
As discussed in more detail below, we operate in three principal segments: Consumer Domestic, Consumer
International, and our Specialty Products Division (“SPD”). Refer to Note 17 to the consolidated financial
statements included in this Annual Report and the discussion in “Item 7: Management’s Discussion and Analysis
of Financial Condition and Results of Operations” for information concerning the results of each of our
segments.
All domestic brand “rankings” contained in this Annual Report are based on dollar share rankings from
Information Resources, Inc. (“IRI”) Total US – MULO for the period ending December 26, 2021. Foreign brand
“rankings” are derived from several sources.
Recent Acquisitions
On December 24, 2021, we acquired all of the outstanding equity of Dr. Harold Katz, LLC and HK-IP
International, Inc., the owners of the THERABREATH® brand of oral care products (the “TheraBreath
Acquisition”). We paid $556.0 million, net of cash acquired, at closing and deferred an additional cash payment
of $14.0 million related to certain indemnity obligations provided by the seller. The additional amount, to the
extent not used in satisfaction of such indemnity obligations, is payable in installments between two and four
years from the closing. THERABREATH’s annual net sales for the year ended December 31, 2021 were
approximately $100 million. The acquisition was financed by the proceeds from a $400.0 million three-year term
loan and an underwritten public offering of $400.0 million aggregate principal Senior Notes due on
December 15, 2031 (as defined below under the caption “Liquidity and Capital Resources” in Item 7 of this
Annual Report) completed on December 10, 2021. The THERABREATH business is managed in the Consumer
Domestic and Consumer International segments.
Consumer Domestic
Our founders first marketed sodium bicarbonate, otherwise known as baking soda, in 1846 for use in home
baking. Today, this product has a wide variety of uses in the home, including as a refrigerator and freezer
deodorizer, scratch-free cleaner and deodorizer for kitchen surfaces and cooking appliances, bath additive,
dentifrice, cat litter deodorizer and swimming pool pH stabilizer. We specialize in baking soda-based products,
as well as other products which use the same raw materials or technology or which are sold in the same markets.
Our Consumer Domestic segment includes each of our 14 power brands, as well as other well-known brands and
household and personal care products. We divide the Consumer Domestic segment into household and personal
care product groups.
Household Products
In 2021, household products constituted approximately 53% of our Consumer Domestic sales and
approximately 41% of our consolidated net sales.
3
ARM & HAMMER Baking Soda remains the number one leading brand of baking soda in terms of
consumer recognition of the brand name and reputation for quality and value. The cleaning and deodorizing
properties of baking soda have led to the development of numerous baking soda-based household products. For
example, we market ARM & HAMMER FRIDGE FRESH®, a refrigerator deodorizer equipped with a baking
soda filter to help keep food tasting fresher, and ARM & HAMMER Carpet Deodorizer. Our other primary
household products include laundry detergents marketed under the ARM & HAMMER, OXICLEAN and XTRA
brands, fabric softener sheets marketed under the ARM & HAMMER brand, cat litter under our ARM &
HAMMER brand, and household cleaning products under the CLEAN SHOWER®, SCRUB FREE®, ORANGE
GLO®, OXICLEAN and KABOOM® brands. Our laundry detergents constitute our largest consumer business,
measured by net sales.
Personal Care Products
In 2021, personal care products constituted approximately 47% of our Consumer Domestic sales and
approximately 35% of our consolidated net sales.
Our personal care business was founded on the unique strengths of our ARM & HAMMER trademark and
baking soda technology. We have expanded our personal care business through the acquisition of antiperspirants,
oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and
dietary supplements under a variety of other leading brand names.
ARM & HAMMER Baking Soda, when used as a dentifrice, helps whiten and polish teeth, removes plaque
and leaves the mouth feeling fresh and clean. These properties led to the development of a complete line of
sodium bicarbonate-based dentifrice products that are marketed and sold nationally primarily under the ARM &
HAMMER brand name. Our other personal care products include antiperspirants and deodorants under the
ARRID® and ARM & HAMMER brands, condoms under the TROJAN brand (the number one condom brand in
the U.S.), battery-operated toothbrushes under the SPINBRUSH brand (the number two leading brand of battery-
operated toothbrushes in the U.S. in 2021), water flossers and showerheads under the WATERPIK brand (the
number one water flosser and replacement showerhead brand in the U.S.), home pregnancy and ovulation test
kits under the FIRST RESPONSE brand (the number two selling brand in the U.S.), hair-removal products under
the NAIR brand (the number one depilatory in the U.S.), FLAWLESS and FINISHING TOUCH brands (the
number one women’s electric hair removal system in the U.S.), oral analgesics and oral care products under the
ORAJEL brand (the number one oral care pain relief in the U.S.), children’s gummy dietary supplements under
the L’IL CRITTERS brand and adult gummy dietary supplements under the VITAFUSION brand (both number
one leading brands in their respective categories), ZICAM brand (the number one cold shortening category in the
U.S. ), a growing number of hair products under the BATISTE (the number one dry shampoo in the U.S.),
VIVISCAL (the number one leading supplement for thinning hair), TOPPIK® (the number one leading brand of
cosmetics for thinning hair), THERABREATH (the number two alcohol free mouthwash in the U.S.), and
XFUSION® brands, and nasal saline moisturizers and solutions under the SIMPLY SALINE® brand.
Consumer International
Our Consumer International segment markets a variety of personal care, household and over-the-counter
products in international subsidiary markets, including Australia, Canada, France, Germany, Mexico and the
United Kingdom and in over 130 global export markets around the world, including China and Japan (the
“Global Markets Group” or “GMG”).
Total Consumer International net sales represented approximately 18% of our consolidated net sales in
2021. Net sales of the subsidiary businesses originating in Europe, Canada, Australia and Mexico accounted for
33%, 26%, 8% and 7%, respectively, of our 2021 international net sales in this segment. No other country in
which we operate accounts for more than 20% of our total international net sales and no product line accounts for
more than 20% of total international net sales.
4
Some of our U.S. power brands such as ARM & HAMMER, BATISTE, NAIR, OXICLEAN, TROJAN,
L’IL CRITTERS, SPINBRUSH, WATERPIK, FLAWLESS and VITAFUSION are distributed in many of our
international markets. In addition, we also export unique brands such as STERIMAR®, a natural nasal
decongestant and FEMFRESH®, a feminine hygiene portfolio out of the United Kingdom, to many countries
around the world.
We also market the CURASH® line of babycare products in Australia, and GRAVOL® anti-nauseant and
RUB-A535 topical analgesic in Canada and other international markets. We also sell WATERPIK water flossers
and showerheads in Australia, Canada, Germany, France, the United Kingdom, Mexico and in other international
markets.
Specialty Products Division
Our SPD segment focuses on sales to businesses and participates in three product areas: Animal and Food
Production, Specialty Chemicals and Specialty Cleaners, and accounted for approximately 6% of our
consolidated net sales in 2021.
Animal and Food Production Products
Since the ARM & HAMMER Animal and Food Production business began in 1972, with its launch of
ARM & HAMMER baking soda as a feed additive to help dairy cows produce more milk, we have built a
leading portfolio of nutritional supplements designed to help improve the health and productivity of dairy
cows. Today our portfolio of dairy nutritional supplements includes brands such as MEGALAC® rumen bypass
fat– a supplement made from natural oils – which enables cows to maintain energy levels during the period of
high milk production, resulting in improved milk yields. In addition, we market a line of high-quality protein and
amino acid products, including BIO-CHLOR® and FERMENTEN®, which are designed to help reduce health
issues associated with calving, as well as provide needed protein to ensure proper growth and milk production.
Over the last five years, we have expanded our product offerings to include unique prebiotics and
probiotics. CELMANAX® Refined Functional Carbohydrate is a yeast-based prebiotic that helps ensure a well-
functioning gastrointestinal track in dairy cows, beef cattle, poultry and other livestock. On May 1, 2017, we
acquired the Agro Biosciences, Inc. business and we now market the CERTILLUS® family of probiotics
products in the poultry, dairy, beef and swine industries. On March 8, 2018, we acquired Passport Food Safety
Solutions, Inc., focused on providing pre- and post-harvest food safety solutions for beef, poultry, and swine
primarily for the application to carcasses to reduce food borne pathogens.
Specialty Chemicals
Our specialty chemicals business primarily encompasses the manufacture, marketing and sale of sodium
bicarbonate in a range of grades and granulations for use in industrial markets. In industrial markets, sodium
bicarbonate is used by other manufacturing companies as a leavening agent for commercial baked goods, as an
antacid in pharmaceuticals, as a carbon dioxide release agent in fire extinguishers, as an alkaline agent in
swimming pool chemicals, and as a buffer in kidney dialysis.
We and Occidental Chemical Corporation are equal partners in a joint venture, Armand Products Company,
which manufactures and markets potassium carbonate and potassium bicarbonate for sale in domestic and
international markets. The potassium-based products are used in a wide variety of applications, including
agricultural products, specialty glass and ceramics, and potassium silicates. Armand also manufactures a
potassium carbonate-based animal feed additive for sale by us in the dairy industry, described above under
“Animal and Food Production Products.” Armand’s results are included in our Corporate segment.
5
Specialty Cleaners
We also provide a line of cleaning and deodorizing products for use in commercial and industrial
applications such as office buildings, hotels, restaurants and other facilities.
We and Safety-Kleen Systems, Inc. (“Safety-Kleen”) are equal partners in a joint venture, ARMAKLEEN®,
which has built a specialty cleaning products business based on our technology and Safety-Kleen’s sales and
distribution organization. In North America, this joint venture distributes our proprietary product line of aqueous
cleaners along with our ARMEX® blast media line, which is designed for the removal of a wide variety of
surface coatings. These results are included in our Corporate segment.
COMPETITION
We compete in the household and personal care consumer product categories, which are highly innovative
categories, characterized by a continuous flow of new products and line extensions, and require significant
advertising and promotion. We compete in these categories primarily on the basis of product innovation and
performance, brand recognition, price, value and other consumer benefits. Consumer products, particularly
laundry and dietary supplements, are subject to significant price competition. As a result, we, from time to time,
may need to reduce the prices for some of our products to respond to competitive and customer pressures and to
maintain market share. Product introductions typically involve heavy marketing and trade spending in the year of
launch, and we usually are not able to determine whether the new products and line extensions will be successful
until a period of time has elapsed following the introduction of the new products or the extension of the product
line.
Because of the competitive retail environment, we face pricing pressure from our retail customers and
customers selling through other channels, particularly high-volume retail customers including, internet-based
retailers, who have increasingly sought to obtain pricing concessions or better trade terms that could reduce our
margins. Furthermore, if we are unable to maintain price or trade terms acceptable to our customers, they could
increase product purchases from competitors and reduce purchases from us, which would harm our sales and
profitability.
Our competitors in the Consumer Domestic and Consumer International segments include, among others,
Procter & Gamble Company (“P&G”), The Clorox Company, Colgate-Palmolive Company, S.C. Johnson & Son,
Inc., Nestle Purina PetCare Company and Nestle Health Science, Henkel, Reckitt Benckiser Group plc,
Johnson & Johnson, Ansell Limited, Pfizer Inc., Bayer AG, Alere Inc., NBTY, Inc., Koninklijke Philips N.V.,
Unilever PLC, Sanofi and Pharmavite LLC. Many of these companies have greater financial resources than we
do and have the capacity to outspend us in their attempts to gain market share. In addition, the growing number
of sales channels and business models, such as niche brands, internet-only brands and retailer co-developed and
owned brands, have increased competition in certain product categories, particularly within personal care,
specialty hair care and dietary supplements, from less well capitalized competitors.
Competition within our animal and food production and our specialty chemicals product lines is intense.
The specialty chemicals business operates in a competitive environment influenced by capacity utilization,
customers’ leverage and the impact of raw material and energy costs. Product introductions typically involve
introductory educational costs in the year of launch, and we usually are not able to determine whether new
products and line extensions will be successful until a period of time has elapsed following the introduction of
new products or the extension of the product lines. Our key competitors with respect to our SPD segment are
Cargill Incorporated, Lallemand Inc., Solvay Chemicals, Inc., Genesis Alkali and Natural Soda, Inc. For
additional discussion of the competitive environment in which we conduct our business, see Item 1A, “Risk
Factors.”
6
DISTRIBUTION OF OUR PRODUCTS
Our Consumer Domestic and Consumer International segments products are marketed primarily through a
broad distribution platform that includes supermarkets, mass merchandisers, wholesale clubs, drugstores,
convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and
other e-commerce channels, all of which sell our products to consumers. The Consumer Domestic Segment
employs a sales force based regionally throughout the U.S. and utilizes the services of independent brokers, who
represent our products in the food, mass, pet, dollar, club, and numerous other classes of trade. Our Consumer
International segment conducts business through subsidiaries and global export markets. Our subsidiaries employ
local sales and marketing teams that manage the retailer and trade relationships while export sales and marketing
professionals also manage an extensive distributor network in our global export markets. Our products are stored
in our plants and third-party owned warehouses and are either delivered by independent trucking companies or
picked up by customers at our facilities.
SPD markets sodium bicarbonate and other chemicals to industrial and agricultural customers primarily
throughout the U.S. and Canada. Distribution is accomplished through a dedicated sales force supplemented by
manufacturers’ representatives and independent distributors. Our products in this segment are stored in our plants
and public warehouses and are either delivered by independent trucking companies or picked up by customers at
our facilities.
SEASONALITY
Our business is generally not seasonal, although the Consumer Domestic and Consumer International
segments are affected by sales of SPINBRUSH battery-operated toothbrushes and WATERPIK water flossers
(which typically are higher during the fall, in advance of the holiday season), sales of NAIR depilatories and
waxes (which typically are higher in the spring and summer months), sales of VITAFUSION and L’IL
CRITTERS dietary supplements and ZICAM cold shortening and relief category products (which typically are
slightly higher in the fourth quarter of each year, in advance of the cold and flu season and renewed
commitments to health), and sales of FLAWLESS (which are typically higher in the second half of the year). In
SPD, several of our Animal and Food Production products experience higher demand in warmer weather months
creating higher seasonal demand in the second and third quarters of the year.
RAW MATERIALS AND SOURCES OF SUPPLY
We manufacture sodium bicarbonate for our consumer and specialty products businesses at our plants
located at Green River, Wyoming and Old Fort, Ohio. The primary source of soda ash, a basic raw material used
in the production of sodium bicarbonate, is the mineral trona, which is found in abundance in southwestern
Wyoming near our Green River plant. We have adequate trona reserves under mineral leases to support our
sodium bicarbonate requirements for the foreseeable future.
We are a party to a partnership agreement with Tata Chemicals (Soda Ash) Partners, which mines and
processes trona reserves in Wyoming. We fulfill a substantial amount of our soda ash requirements through the
partnership and related supply and services agreements, enabling us to achieve some of the economies of an
integrated business capable of producing sodium bicarbonate and related products from the basic raw material.
We also have an agreement for the supply of soda ash from another company. The partnership agreement and
other supply agreements between the Tata Chemicals (Soda Ash) Partners and us are terminable upon two years
notice by either of us. We believe that sufficient alternative sources of soda ash supply are available.
We believe that ample sources of raw materials are available for all our other major products. Detergent
chemicals are used in a variety of our products and are available from a number of sources. Bottles, paper
products and clay are available from multiple suppliers, although we choose to source most of these materials
from single sources under long-term supply agreements in order to gain favorable economies of scale. We also
7
use certifiable sustainable palm oil derivatives in a number of products, including primarily in our rumen bypass
fats products. Alternative sources of supply are available in case of the disruption or termination of the supply
agreements.
The cost of raw materials, including surfactants, diesel fuel and oil-based raw and packaging materials used
primarily in our consumer businesses, were higher in 2021 relative to 2020, increasing our core commodity costs.
Increases in the prices of certain raw materials could materially impact our costs and financial results if we are
unable to pass such costs along in the form of price increases to our customers.
We utilize the services of third party contract manufacturers around the world for certain products.
PATENTS AND TRADEMARKS
Our trademarks appear in upper case letters throughout this Annual Report. The majority of our trademarks
are registered with either the U.S. Patent and Trademark Office or with the trademark offices of many foreign
countries. The ARM & HAMMER trademark has been used by us since 1867 and is a valuable asset and
important to the successful operation of our business. Our products are sold under many other valuable
trademarks held by us, including TROJAN, NAIR, ORAJEL, WATERPIK, FIRST RESPONSE, XTRA,
OXICLEAN, SPINBRUSH, BATISTE, SIMPLY SALINE, L’IL CRITTERS, VITAFUSION, FLAWLESS,
ZICAM and THERABREATH. Our portfolio of trademarks represents substantial value in the businesses using
the trademarks.
U.S. patents are currently granted for a term of 20 years from the date the patent application is filed.
Although we actively seek and maintain a number of patents, no single patent is considered significant to the
business as a whole.
CUSTOMERS AND ORDER BACKLOG
In each of the years ended December 31, 2021, 2020 and 2019, net sales to our largest customer, Walmart
Inc. and its affiliates (“Walmart”), were 24%, 23% and 24% respectively, of our consolidated net sales. No other
customer accounted for 10% or more of our consolidated net sales in the three-year period. The time between
receipt of orders and shipment is generally short, and as a result, backlog is not significant.
GOVERNMENT REGULATION
General
Some of our products are subject to regulation by one or more U.S. agencies, including the U.S. Food and
Drug Administration (“FDA”), the Environmental Protection Agency (“EPA”), the Federal Trade Commission
(“FTC”), the Consumer Product Safety Commission (“CPSC”) and foreign agencies.
FDA regulations govern a variety of matters relating to our products, such as product development,
manufacturing, premarket clearance or approval, labeling and distribution. The regulations adopted and standards
imposed by the FDA and similar foreign agencies evolve over time and can require us to make changes in our
manufacturing processes and quality systems to remain in compliance. These agencies periodically inspect
manufacturing and other facilities. If we fail to comply with applicable regulations and standards, we may be
subject to sanctions, including fines and penalties, the recall of products and cessation of manufacturing and/or
distribution.
In addition, we sell products that are subject to regulation under the Federal Insecticide, Fungicide and
Rodenticide Act and the Toxic Substances Control Act, both of which are administered by the EPA.
We are also subject to regulation by the FTC in connection with the content and truthfulness of our labeling,
advertising, promotion, trade practices and other matters. The FTC has instituted numerous enforcement actions
8
against companies for failure to adequately substantiate claims made in advertising or for the use of otherwise
false or misleading advertising claims. These enforcement actions have resulted in consent decrees and the
payment of civil penalties and/or restitution by the companies involved. Such actions can result in substantial
financial penalties and significantly restrict the marketing of our products.
The CPSC has jurisdiction over consumer products, regulates their safety and has authority over recalls. The
CPSC administers the Poison Prevention Packaging Act and has issued regulations requiring special child
resistant packaging for certain products, including pharmaceuticals, dietary supplements, and dietary substances,
containing certain ingredients (e.g., iron).
Our relationship with certain union employees is regulated by various agencies of the countries, states,
provinces and other localities in which we sell our products.
Medical Device Clearance and Approval
To be commercially distributed in the U.S., a medical device must, unless exempt, receive clearance or
approval from the FDA pursuant to the Federal Food, Drug, and Cosmetic Act (“FDCA”). For lower risk class II
devices, we must generally submit a premarket notification requesting clearance for commercial distribution
known as a “510(k)” clearance. Our condoms, lubricants, contact lens solution, wound wash, home pregnancy
test kits and WATERPIK professional dental products are regulated as class II devices. Some other low risk
devices, including SPINBRUSH and other battery powered toothbrushes, and WATERPIK water flossers, are in
class I and are generally exempted from the 510(k) requirements. To obtain 510(k) clearance, a device must be
determined to be substantially equivalent in intended use and in safety and effectiveness to a benchmark device,
or “predicate” that is already legally in commercial distribution. Any modification to a 510(k) cleared device that
could significantly affect its safety or effectiveness, or that would constitute a change in its intended use,
generally requires a new 510(k) clearance. We may determine that a new 510(k) clearance is not required, but if
the FDA disagrees, it may retroactively require a 510(k) clearance and may require us to cease marketing or
recall the modified device until 510(k) clearance is obtained.
OTC Pharmaceutical
We market over-the-counter (“OTC”) pharmaceutical products, such as toothpaste, antiperspirant, and oral
analgesics products, that are also subject to FDA and foreign regulation. Under the U.S. OTC monograph system,
selected OTC pharmaceutical products are generally recognized as safe and effective and do not require the
submission and approval of a new drug application. The FDA OTC monographs include well-known ingredients
and specify requirements for permitted indications, required warnings and precautions, allowable combinations
of ingredients and dosage levels. Pharmaceutical products marketed under the OTC monograph system must
conform to specific quality, formula and labeling requirements. Products not in the monograph system can be
deemed to be unapproved new drugs and can be forced from the market. This is particularly the case for
homeopathic drug products like certain ZICAM products. Both the FDA and the FTC have taken the position that
homeopathic products are unapproved new drugs. Regulatory action against these products is deemed unlikely
unless the products present an unreasonable safety risk. ZICAM homeopathic products are not currently
perceived to pose any such risk.
All facilities where OTC pharmaceutical products are manufactured, tested, packaged, stored or distributed
must comply with cGMP regulations and/or regulations promulgated by competent authorities in the countries
where the facilities are located. All of our pharmaceutical products are manufactured, tested, packaged, stored
and distributed according to cGMP regulations. The FDA performs periodic audits to ensure that our facilities
remain in compliance with all appropriate regulations. The failure of a facility to be in compliance may lead to a
breach of representations made to customers or to regulatory action against us related to the products made in
that facility, such as seizure, injunction or recall. Serious product quality concerns could also result in
governmental actions against us that, among other things, could result in the suspension of production or
9
distribution of our products, product seizures, loss of certain licenses or other governmental penalties, and could
have a material adverse effect on our financial condition or operating results. We are required to report serious
adverse events associated with the use of our OTC pharmaceutical products marketed in the U.S.
We cannot predict whether new legislation regulating our activities will be enacted or what effect any
legislation would have on our business.
Medical Device and OTC Pharmaceutical Postmarket Regulation
After a medical device and/or OTC pharmaceutical is commercialized, numerous regulatory requirements
apply, including:
•
•
•
•
the quality system regulation, which imposes FDA current Good Manufacturing Practice (“cGMP”)
requirements governing the methods used in, and the facilities and controls used for, the design,
manufacture, packaging, servicing, labeling, storage, installation, and distribution of all finished
medical devices and OTC intended for human use;
labeling regulations, including a prohibition on product promotion for unapproved or “off label” uses;
the medical device reporting regulation requiring a manufacturer to report to the FDA if its device may
have caused or contributed to a death or serious injury or malfunctioned in a way that would likely
cause or contribute to a death or serious injury if it were to recur and ongoing post-market surveillance
of the product and like-products to continuously evaluate the benefit/risk over the life of the product;
and
the reports of corrections and removals regulation, which requires a manufacturer to report recalls and
field actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a
violation of the FDCA that may present a risk to health.
Food Products
We market baking soda and animal feed products, such as rumen fermentation enhancers and Dietary
Cation-Anion Difference (“DCAD”) balancers that are also subject to FDA and foreign regulation. The Food
Safety Modernization Act (“FSMA”) regulates food and animal feed products and mandates preventive controls,
including hazard analysis, risk controls, supplier qualifications and controls and increased record keeping. FSMA
grants the FDA the authority to require mandatory recalls for products under certain conditions. The FDA is
currently in the process of establishing rules and guidance to implement the provisions of FSMA. The potential
impact of these rules and applicable guidance cannot be determined now.
Dietary Supplements
The processing, formulation, safety, manufacturing, packaging, labeling, advertising, distribution,
importing, selling, and storing our gummy vitamin dietary supplements are subject to regulation by one or more
federal agencies, including the FDA, the FTC, the CPSC, the EPA, and by various agencies of the states and
localities in which our products are sold. The FDCA governs the composition, safety, labeling, manufacturing
and marketing of dietary supplements.
It is unlawful to market as a dietary supplement any article that is approved as a new drug or is authorized
for investigation as a new drug for which substantial clinical investigations have been instituted and made public,
unless that article was first marketed as a dietary supplement or food. The FDA has authority to effectively void
that restriction through the issuance of a regulation finding the article lawful. To date, the FDA has not exercised
that rulemaking authority for any article.
Dietary ingredients that were not marketed in the U.S. before October 15, 1994 must be the subject of a new
dietary ingredient notification submitted to the FDA at least 75 days before the initial marketing, unless the
10
ingredient has been present in the food supply as an article used for food without being chemically altered. The
notification must provide evidence of a history of use or other evidence establishing that use of the dietary
ingredient is reasonably expected to be safe. The FDA may determine that notification does not provide an
adequate basis to conclude that a new ingredient is reasonably expected to be safe, which could effectively
prevent the marketing of the ingredient. In August of 2016, the FDA issued draft guidance governing notification
of new dietary ingredients. Although the draft guidance was issued for public comment and not for
implementation, it is a strong indication of the FDA’s current thinking on the topics discussed in the guidance,
including the FDA’s approach to enforcement. If the FDA enforces the applicable statutes and regulations in
accord with the draft guidance, that could effectively change the status of dietary ingredients that the industry has
marketed as “old” dietary ingredients to “new” dietary ingredients and may require submission of a new dietary
ingredient notification.
A company that uses a statement of nutritional support in labeling must possess information substantiating
that the statement is truthful and not misleading. If the FDA determines that a particular statement of nutritional
support is an unacceptable drug claim or an unauthorized version of a health claim, or if the FDA determines that
a particular claim is not adequately supported by existing scientific evidence or is otherwise false or misleading,
the claim could not be used and any product bearing the claim could be subject to regulatory action.
The FDA’s cGMP regulations govern the manufacturing, packaging, labeling and holding operations of
dietary supplement manufacturers. As with OTC products, the FDA performs periodic audits to ensure that our
dietary supplement facilities remain in compliance with all appropriate regulations. The failure of a facility to be
in compliance may lead to a breach of representation made to consumers or to regulatory action against us related
to the products made in that facility, seizure, injunction or recall. There is considerable uncertainty with respect
to the FDA’s interpretation and implementation of the cGMP regulations. The failure of a manufacturing facility
to comply with the cGMP regulations may render products manufactured in that facility adulterated and subjects
those products and the manufacturer to a variety of potential FDA enforcement actions. The manufacturer,
packer, or distributor of a dietary supplement marketed in the U.S. whose name appears on the label of the
supplement is required to report serious adverse events associated with the use of that supplement to the FDA.
Additional legislation may be introduced which, if passed, would impose substantial new regulatory
requirements on dietary supplements. The effect of additional domestic or international governmental legislation,
regulations, or administrative orders, if and when promulgated, cannot be determined. New legislation or
regulations may require the reformulation of certain products to meet new standards and require the recall or
discontinuance of certain products not capable of reformulation.
HUMAN CAPITAL
Overview
We take great pride in fostering an enduring culture among our employees that seeks to make meaningful
contributions to society.
Safety and Wellness
Employee safety remains our top priority. We develop and administer company-wide policies to ensure the
safety of each team member and compliance with OSHA standards. In 2020, we implemented COVID-19
protocols across all locations in response to the pandemic, to ensure both the safety of our employees and
compliance with federal and local requirement and guidelines.
Our Employees
As of December 31, 2021, we had approximately 5,100 global employees, an increase of approximately 30
compared to December 31, 2020. The increase is primarily due to increased staffing at our global manufacturing
11
plants. Approximately 87.1% of our workforce is located in the Americas, 9.8% in Europe, Middle East, and
Africa, and 3.1% in the Asia-Pacific region. About 48.6% of our employees are salaried and about 51.4% are
paid hourly wages. During fiscal 2021, our turnover rate was approximately 20.6%. Our revenue per employee in
fiscal 2021 was approximately $1.0 million.
Diversity, Equity and Inclusion
We embrace the diversity of our employees and, our DEI efforts aspire to help us achieve a more diverse
workforce. Also we strive to cultivate a 3culture and processes that support and enhance our ability to recruit,
develop and retain diverse talent at every level.
As a company we remain committed to fair treatment, access, opportunity, and advancement, while at the
same time striving to identify and eliminate barriers that have prevented the full participation of underrepresented
groups.
In 2020, we established a Diversity & Inclusion Council that provides strategic direction, guidance and
advocacy for our DEI initiatives which is led by our Chief Executive Officer and our Director, Diversity &
Inclusion and includes diverse employees at every level from around the world. Our Board of Directors, acting
principally through its Compensation & Human Capital Committee, oversees our DEI efforts.
We are committed to transparency and accountability that will drive continuous progress. As part of our
enhanced diversity and inclusion initiatives that began in 2020, we will publish workplace demographics of our
employees in our 2021 Sustainability Report.
Hiring, Development and Retention
Our talent strategy is focused on attracting the best talent and recognizing and rewarding performance, while
continually developing, engaging and retaining our talented employees.
We invest resources in professional development and growth as a means of improving employee
performance and improving retention. This includes our bi-annual “LEAP” (Leadership Empowerment
Achievement Program), which is aimed at continuous learning, professional training and development
opportunities, targeted leadership development courses for new and existing leaders of different levels of
seniority, tuition reimbursement, and job specific programs for our employees.
Compensation and Benefits
As part of our overall effort to attract, develop and retain talented employees, our compensation programs
are designed to align the compensation of our employees with our Company and their individual performance,
and to provide the proper incentives to attract, retain and motivate employees to achieve superior results.
Moreover, our policies and procedures are designed to ensure compensation is fair for employees of the same
job, at the same level, location and performance. These include utilizing pay grades for appropriate job
groupings, making pay decisions based on relevant factors, such as education, experience, and performance, and
subjecting pay decisions to higher levels of leadership and Human Resources review to ensure those decisions
are fair, equitable and align with our equal employment opportunity policies and objectives.
Employees are eligible for health insurance, prescription drug benefits, dental, vision, hospital indemnity,
accident, critical illness, and disability insurance, life insurance, health savings accounts, flexible spending
accounts, reproductive rights coverage, participation in savings plans, and identity theft insurance, in each case
subject to the terms and conditions of the applicable plans and programs.
12
Communities
We encourage our employees to become involved in their communities, and in 2021, our Employee Giving
Fund supported our communities by providing $1.2 million to 225 deserving community organizations through
annual grants, disaster relief, and other monetary support. Employees purchased back-to-school supplies online
to support disadvantaged youth, donated clothes and non-perishable items for clothing and food drives and
provided supplies for a summer camp and holiday dinner for families in need. The Foundation was established in
2020 with the focus on helping to create equitable and inclusive opportunities and advancing environmental
preservation. The Foundation is administered by our employees. In 2021, six organizations were chosen and
received grants in aggregate totaling $1 million. In the DEI space, the following organizations received grants:
Junior Achievement, The Trevor Project, and Bowie University. In the Sustainability space, the following
organizations received grants: The Recycling Partnership, the Ocean Conservancy, Northeast Wilderness Trust,
and The Xerces Society for Invertebrate Conservation.
PUBLIC INFORMATION
We maintain a website at www.churchdwight.com and on the “Investors-Financial Information-SEC
Filings” page of reports on Form 8-K and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable
after we electronically file these materials with, or furnish them to, the Securities and Exchange Commission (the
“Commission”). Also available on the “Investors-Corporate Governance” page on our website are our Corporate
Governance Guidelines, charters for the Audit, Compensation, & Human Capital and Governance, Nominating &
Corporate Responsibility Committees of our Board of Directors (the “Board”), our Code of Conduct and our
Proxy Statement. We also publish a Sustainability Report that summarizes our business and corporate
responsibility commitments and accomplishments including those related to our environmental, social, and
governance performance. For more information regarding our sustainability strategy and ESG pillars please see
the “Responsibility” page on our website and the discussion under the capital “Our Sustainability Strategy and
Environmental, Social and Governance (“ESG”) Pillars” included above. Each of the foregoing is also available
in print free of charge and may be obtained upon written request to: Church & Dwight Co., Inc., 500 Charles
Ewing Boulevard, Ewing, New Jersey 08628, attention: Secretary. The information presented on our website is
not a part of this Annual Report and the reference to our website is intended to be an inactive textual reference
only.
13
ITEM 1A. RISK FACTORS
The following risks and uncertainties, as well as other factors described elsewhere in this Annual Report or
in our other filings with the Commission, could, individually and collectively, have a material adverse impact on
our business, reputation, financial results, financial condition and/or the trading price of our Common Stock:
Business and Operational Risks
• We face intense competition in our markets.
We face intense competition from consumer products companies, both in the U.S. and in international
markets. Most of our products compete with other widely-advertised promoted and merchandised brands within
each product category and from retailers, including supermarkets, mass merchandisers, wholesale clubs,
drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores and
websites and other e-commerce channels, which are increasingly offering private label and retailer-branded
brands and generic non-branded products in certain categories, which typically are sold at lower prices. In China,
in particular we face strong competition from local manufacturers offering both generic and branded products.
The use of evolving technology to develop more complex pricing models by retailers has led and may continue to
lead to pricing pressures in some categories. In addition, during times of economic uncertainty, consumers may
purchase more “private label” or other lower price brands. These developments have increased competition in
certain product categories in particular, including dietary supplements, diagnostic kits and oral analgesics. In
addition to competition across all our product categories, there continues to be significant product competition in
the gummy dietary supplement category, which has grown from six brands to over 170 in the last nine years.
Shifting consumer behavior, including accelerated shifts to online shopping which has been accelerated by the
COVID-19 pandemic, have also increased competition in e-commerce in many of our categories, from our larger
legacy competitors and newer digitally native brands which have increasingly moved into consumer products and
staples.
Many of our competitors are large companies, including, among others, The Proctor & Gamble Company,
The Clorox Company, Colgate-Palmolive Company, Henkel, Reckitt Benckiser Group plc, Johnson & Johnson,
Nestle Purina PetCare Company and Nestle Health Science, Ansell Limited, Alere Inc., Pfizer Inc., Bayer AG,
S.C. Johnson & Son, Inc., Pharmavite LLC, Koninklijke Philips N.V., Unilever PLC, Sanofi and NBTY, Inc.
Many of these companies have greater financial resources than we do, and, therefore, have the capacity to
outspend us on advertising and promotional activities and introduce competing products more quickly and
respond more effectively to changing business and economic conditions than we can.
Our products generally compete on the basis of performance, brand recognition, price, value or other
benefits to consumers. Significant price competition may require us to reduce the prices for some of our products
or price levels that do not offset manufacturing cost increases, to respond to competitive and customer pressures
and to maintain market share. Increases to our prices, as a result of inflationary pressures or otherwise, could
cause sales of those products to decline. We have recently raised prices on many of our products and expect to
take pricing actions on 80% of our global portfolio of brands by the end of February 2022. Advertising,
promotion, merchandising and packaging also have a significant impact on retail customer decisions regarding
the brands and product lines they sell and on consumer purchasing decisions. A newly introduced consumer
product (whether improved or newly developed) usually encounters intense competition requiring substantial
expenditures for advertising, sales promotion and trade merchandising. If a product gains consumer acceptance,
it normally requires continued advertising, promotional support and product improvements to maintain its
relative market position. If our advertising, marketing and promotional programs are not effective, our sales
growth may decline.
• Loss of any of our principal customers could significantly decrease our sales and profitability.
A limited number of customers account for a large percentage of our net sales and/or net sales of specific
product lines. Walmart is our largest customer, accounting for approximately 24% of net sales in 2021, 23% of
14
net sales in 2020 and 24% of net sales in 2019. Our top three customers accounted for approximately 37% of net
sales in 2021 and 36% of net sales each year in 2020 and 2019. We expect that a significant portion of our net
sales will continue to be derived from a small number of customers and that these percentages may increase if the
growth of mass merchandisers continues. As a result, changes in the strategies of Walmart or any of our other
largest customers, including a reduction in the number of brands they carry or of shelf space they dedicate to
private label products, could materially harm our net sales and profitability. Changes in consumer behavior,
including continued shifting to online shopping instead of physical retail shopping as a result of the COVID-19
pandemic and other trends, could also impact our sales to our largest customers. Some of our retail customers
have been forced to shut down or reduce their hours, which has impacted and may continue to impact their
orders. Some of our retail customers have experienced and may experience in the future declining financial
performance, which could affect their ability to pay amounts due to us on a timely basis or at all. If these impacts
are prolonged, they can further increase the difficulty of planning for operations. Moreover, the use of evolving
technology by our customers to develop more complex pricing models may lead to category pricing pressures.
We could also lose a significant customer due to customer service levels or real or perceived product quality or
appearance issues. As our business is based primarily upon individual sales orders rather than long-term contracts
and most customer agreements include customer termination rights after short notice, many of our customers
could reduce their purchasing levels or cease buying products from us at any time and for any reason.
• Decreases in demand for our products would decrease our sales and profitability.
Factors that can affect demand include competitors’ products, advertising and pricing actions, rates of
unemployment, consumer confidence, health care costs, including increased costs as a result of changes in
federal regulations, significant shifts in government policies, the deterioration of economic or trade relations
between countries or regions, commodity costs, fuel and other energy costs and other economic factors affecting
consumer spending behavior, including gasoline and home heating oil pricing, reduced unemployment benefits in
periods of high unemployment, including the historically high unemployment rates resulting from the COVID-19
pandemic, inflationary pressures, restrictions on travel and access to public spaces, and changes in tax policies,
other effects of governmental shutdowns or a lapse of appropriations or fear of exposure to or actual impacts of a
widespread disease outbreak, such as, COVID-19. In particular, we derive a substantial percentage of our
revenues from sales of laundry detergent, and the continued customer demand for these products are critical to
our future success. Some products have seen decreasing demand in recent years, including condoms, as a result
of demographic and other changes. An increasing number of our products are more durable in nature and,
therefore are more likely to be affected by consumer decisions to control spending.
Changes resulting from the COVID-19 impact may also impact demand for our vitamin and supplement
products. The vitamins and supplements and cold remedy categories have seen increased demand as trends in
health and wellness focus have accelerated. However, demand for these products has typically increased during
winter months when consumers have increased rates of flu and cold infection and increased social distancing and
flu vaccination rates may have a negative impact.
• A continued change in the retail environment and changing consumer preferences could cause our
sales to decline.
Despite increasing shifts to e-commerce, sales of our products remain strongest in the traditional mass
merchandiser, food and drug retail stores, and our products are also sold in club stores and dollar stores channels.
However, alternative retail channels, including e-commerce retailers, hard discounters, subscription services and
buying clubs, have become more prevalent and the volume of consumer products that are sold through such
alternative retail channels is continuing to increase, which may affect customer and consumer preferences,
including in response to the COVID-19 pandemic and market dynamics, including any pricing pressures for
consumer goods as retailers face added costs to build their e-commerce capacity. Further, consumer preferences
continue to evolve due to a number of factors, including fragmentation of the consumer market and changes in
consumer demographics, including the aging of the general population and the emergence of Millennials and
15
Generation Z who have different spending, consumption and purchasing habits; evolving consumer concerns or
perceptions regarding ESG practices of manufacturers, including, packaging materials, such as plastic packaging,
and their environmental impact; greenhouse gas emissions; waste disposal practices; a growing demand for
natural or organic products and ingredients; changing consumer sentiment toward non-local products or sources
among Millennials and other demographic groups; evolving consumer concerns or perceptions regarding the
effects of ingredients or substances present in certain consumer products; and concerns regarding human capital
practices, including DEI.
The movement of consumers to online purchases of consumer products has greatly accelerated as a result of
the COVID-19 pandemic, as store closures, quarantine and gathering restrictions, and social distancing efforts
have reduced physical retail shopping. We and many of our competitors have increased our online sales as a
result, benefiting from scale, brand recognition, and other factors. However, as consumers continue to shift their
behavior, retailers may incur higher e-commerce operating costs and will seek to recover those costs by passing
them onto customers and manufacturers. Additionally, we cannot predict the extent to which our increased
e-commerce demand will continue as pandemic conditions change, including as a result of vaccines, reduced
rates of infection or modified consumer outlook and behaviors.
• We rely on the policies of our key retailer customers.
Larger and increasingly consolidated retailers have increasing influence, and have sought to obtain lower
pricing, special packaging inventory practices, logistics or other changes to the customer-supplier relationship as
a result of this influence. To the extent we provide concessions or better trade terms to those customers, our
profit margins are reduced. Further, if we are unable to effectively respond to the demands of our customers,
these customers could reduce their purchases of our products and increase their purchases of products from
competitors. Reductions in inventory by our customers, including as a result of consolidation in the retail
industry, or these customers managing their working capital requirements, could result in reduced orders for our
products and adversely affect our results of operations and cash flows for financial periods affected by such
reductions.
Protracted unfavorable market conditions, including those caused by the COVID-19 pandemic, have caused
many of our customers to more critically analyze the number of brands they sell, and reduce or discontinue
certain of our product lines, particularly those products that were not number one or two in their category.
In addition, private label and retail-branded products sold by retail trade chains are typically sold at lower
prices than branded products. As consumers look for opportunities to decrease discretionary spending, our
customers have discontinued or reduced distribution of some of our products to encourage those consumers to
purchase the customers’ less expensive and, in some cases, more profitable private label and retail-branded
products (primarily in the dietary supplements, diagnostic kits and oral analgesics categories).
• We have pursued and may continue to pursue strategic acquisitions and divestures.
We may continue to pursue and consummate additional acquisitions or substantial investments in
complementary businesses or products in the future. Those acquisitions may be significantly larger than the ones
completed in the past and may require us to increase our levels of debt, potentially resulting in us being assigned
a lower credit rating. However, we may not be able to identify and successfully negotiate suitable strategic
acquisition at attractive valuations, obtain financing for future acquisitions on satisfactory terms or otherwise
complete future acquisitions. In recent periods, competition from other consumer products companies that are
seeking similar opportunities has been particularly strong, and valuations for potential acquisition assets have
been high, which has placed pressure on our ability to identify, structure and execute transactions. In addition,
acquisitions and investments entail various risks, including the difficulty of entering new markets or product
categories, the challenges of integrating the operations and personnel of the acquired businesses or products, the
potential disruption of our ongoing business and the ongoing business of the acquired company, the need to
16
review and, if necessary, upgrade processes and systems of the acquired company to conform to our own
processes and systems and applicable legal and regulatory requirements, managing an increasingly broad and
complex range of businesses and products, and, generally, our potential inability to obtain the desired financial
and strategic benefits from the acquisition or investment. Any of these risks may divert management and other
resources, require us to incur unanticipated costs or delay the anticipated positive impact on our business and
results of the acquisition. The risks associated with assimilation are increased to the extent we acquire businesses
that have stand-alone operations or businesses that are in new categories that cannot easily be integrated or
operations or sources of supply outside of the U.S. and Canada, for which products are manufactured locally by
third parties.
Acquired companies or operations or newly-created ventures may not be profitable or may not achieve sales
levels and profitability that justify the investments made. In addition, future acquisitions or investments could
result in substantial cash expenditures, the potentially dilutive issuances of new equity by us or the incurrence of
additional debt or business acquisition liabilities.
• Market category declines and changes to our product and geographic mix may impact the
achievement of our sales growth targets, planned pricing and financial results.
A significant percentage of our revenues come from mature markets that are subject to high levels of
competition. During 2021, approximately 82% of our sales were generated in U.S. markets. U.S. markets for
consumer products are considered mature and commonly characterized by high household penetration,
particularly with respect to our most significant product categories, such as laundry detergents, deodorizers,
household cleaning products, toothpastes, dietary supplements, antiperspirants and deodorants. Our ability to
quickly innovate to adapt our products to meet changing consumer demands is essential, especially in light of
e-commerce significantly reducing the barriers for even small competitors to quickly introduce new brands and
products directly to consumers. Even if we are successful in increasing sales within our product categories, a
continuing or accelerating decline in the overall markets for our products could have a negative impact on our
financial results.
The COVID-19 pandemic continues to impact most of our businesses. As certain government restrictions
were reduced or removed, we have experienced increased demand for certain product categories, mainly in the
United States, including ARM & HAMMER® cat litter, VITAFUSION® and L’IL CRITTERS® gummy
vitamins, and BATISTE® dry shampoo, that had been negatively impacted by the temporary and permanent
closures of certain retailers earlier during the pandemic, reduced consumer foot traffic at retailers, and
COVID-19 related precautionary measures. Overall, we have continued to experience increased online sales.
Potential recessionary economic conditions, including after the direct impact of the pandemic has subsided, may
continue to impact consumer demand for certain of our products and put downward pressure on product prices.
• New products and product line extensions may not gain widespread customer acceptance, may be
otherwise discontinued, or cause sales of existing products to decline.
Our future performance and growth depend on our ability to successfully identify, develop and introduce
new products, product line extensions, products in adjacent categories to our current products, and anticipate
changes in consumer preferences. In addition, some of our products have shorter product life spans and depend
heavily on our ability to continuously and timely introduce innovative new products to the marketplace. The
successful development and introduction of new products involves substantial research, development, marketing
and promotional expenditures, which we may be unable to recover if the new products do not gain widespread
market acceptance. New product development and marketing efforts, including efforts to enter markets or
product categories in which we have limited or no prior experience, have inherent risks. These risks include
product development or launch delays, competitor actions, regulatory approval hurdles and the failure of new
products and line extensions to achieve anticipated levels of market acceptance. In addition, if sales generated by
new products could result in a concomitant decline in sales of existing products.
17
Each year, we introduce new products, including launches into new “white space” categories, across the
majority of our marketed brands. However, there is no assurance that our new products will continue to have
widespread acceptance. From time to time, we have discontinued certain products and product lines, which
resulted in returns from customers, asset write-offs and shutdown costs. We may suffer similar adverse
consequences in the future to the extent we discontinue products that do not meet retailer or consumer
expectations or no longer satisfy consumer demand.
• We are subject to cost overruns and delays, regulatory requirements, and miscalculations in capacity
needs with respect to our expansion projects and our manufacturing facilities, as well as disruptions
to our manufacturing facilities and those of our contract manufacturers and other suppliers.
From time to time, we initiate planned and unplanned expansion projects with respect to our facilities and
those of our contract manufacturers and other suppliers which are subject to risks of, and we have from time to
time experienced, delay or cost overruns resulting from numerous factors, including the following: shortages of
equipment, materials or skilled labor; work stoppages; unscheduled delays in the delivery of ordered materials
and equipment; unanticipated cost increases; difficulties in obtaining necessary permits or in meeting permit
conditions; difficulties in meeting regulatory or quality requirements or obtaining regulatory approvals;
availability of suppliers to certify equipment for existing and enhanced regulations; design and engineering
problems; failure or delay of third party service providers; and civil unrest, labor disputes, natural disasters and
pandemics. If we were to experience delays or cost overruns in the future it could result in product allocation and
retailer frustration, the loss of a significant customer or customers and the material decrease of the sales of one or
more of our products. In addition, we could miscalculate our anticipated capacity needs in any of our categories,
such as our laundry detergent, cat litter and dietary supplement categories, including as a result of meeting the
anticipated demand of our customers, or expansion into new product lines or into new markets.
Additionally, the supply of our products depends on the uninterrupted efficient operation of our
manufacturing facilities and those of our contract manufacturers and other suppliers and our ability to meet
customer service levels. The manufacturing of certain of our products is concentrated in one or more of our
plants, contract manufacturers or other suppliers, with limited alternate qualified facilities available. Many of our
manufacturing processes and those of our contract manufacturers and other suppliers are complex and present
difficult technical challenges to obtain the manufacturing yields necessary to operate profitably and may require
complex and specialized equipment which can be expensive to repair or replace with required lead times of up to
a year.
Any event that disrupts or otherwise negatively impacts manufacturing facilities, manufacturing systems or
equipment, or contract manufacturers or other suppliers could result in the delivery of inferior products or our
ability to meet customer requirements or service levels. As the COVID-19 pandemic continues, we could face
challenges and retailer penalties in continuing to operate our facilities and delivery of on time and in full product
shipments as a result of employee absenteeism or sickness, additional governmental or regulatory actions,
closures or other restrictions that limit or close our operating and manufacturing facilities or those of our
suppliers.
• We rely on a limited number of contract manufacturers and suppliers, including sole source contract
manufacturers and suppliers for certain products, and supply chain issues may result in product
shortages or disruptions to the Company’s business.
We rely on a limited number of contract manufacturers and suppliers for certain of our commodities and
raw materials, including sole source suppliers for certain of our raw materials, packaging, product components,
finished products and other necessary supplies. New suppliers must be qualified pursuant to our standards and
may also have to be qualified under governmental and industry standards and any other standards of our
customers, which can require additional investment and time. We could experience material disruptions in
production and other supply chain issues, largely because of shortages in supplier labor which continues to
18
impact the availability of many raw and packaging materials, which continues to result in out-of-stock
conditions. In addition, continued out-of-stock supplies or products due to supply chain issues may cause our
customers to switch to competitors’ products that are more available. Moreover, our relationships with customers
could be adversely affected if new or existing suppliers are unable to meet any standards set by us, government
or industry regulations, or our customers, if we are unable to contract with suppliers at the quantity, quality and
price levels needed for our business, if any of our key suppliers becomes insolvent, ceases or significantly
reduces its operations or experiences financial distress, as a result of the COVID-19 pandemic or otherwise, or if
any environmental, economic or other outside factors impact its operations. We may be unable to qualify any
needed new contract manufacturers or suppliers or maintain supplier arrangements and relationships based on a
variety of factors; we may be unable to contract with suppliers at the quantity, quality and price levels needed for
our business; certain of our suppliers may not meet the standards of our customers or licensors; or certain of our
key contract manufacturers or suppliers may become insolvent or experience other financial distress or face
closure or suspension of operations. If any of these events occurs and we have failed to identify and qualify an
alternative vendor, then we may be unable to meet our contractual obligations and customer expectations, which
could damage our reputation and result in lost customers and sales, or the incurrence of fines or higher than
expected expenses. Further, the COVID-19 pandemic has caused worldwide increases in demand for some
products and reduced demand for other products, which has caused strain on our supply chain network and its
ability to meet such demand.
• Volatility and increases in the price of raw and packaging materials or energy costs could erode our
profit margins.
The principal raw materials and packaging used by us and certain of our suppliers and contract
manufacturers include surfactants (cleaning agents), paper products and resin-based molded components.
Volatility and increases in the price of raw materials, disruptions in production or transportation, or increases in
the costs of energy, labor, shipping and other necessary services, could significantly affect our profit margins if
we are unable to pass along any higher costs in the form of price increases or otherwise achieve cost efficiencies,
such as in manufacturing and distribution. Significant inflation of material, component and co-packer costs
impacted our gross margin in 2021. There is no assurance that we will be able to fully offset any price increases,
through cost reduction programs or price increases of our products or enter locked-in price arrangements or
hedge agreements, especially given the competitive environment. Sustained price increases may lead to declines
in volume as competitors may not adjust their prices or customers may decide not to pay the higher prices, which
could lead to sales declines and loss of market share. While we seek to project tradeoffs between price increases
and volume, our projections may not accurately predict the volume impact of price increases. In addition,
volatility in certain commodity markets could significantly affect our production cost.
From time to time, we use hedge agreements to mitigate the volatility of commodities and diesel fuel prices.
The hedge agreements are designed to add stability to product costs, enabling us to make pricing decisions and
lessen the economic impact of abrupt changes in prices over the term of the contract. However, in periods of
declining fuel or other commodity prices, the hedge agreements can have the effect of locking us in at above-
market prices.
• Reduced availability of transportation or disruptions in our transportation network could adversely
affect us.
We distribute our products and receive raw materials and packaging components primarily by truck, rail and
ship and through various ports of entry. Reduced availability of trucking, rail or shipping capacity due to adverse
weather conditions, natural disasters, including climatic events (including any potential effect of climate change),
allocation of assets to other industries or geographies or otherwise, work stoppages, closure of operations due to
government restrictions or sick employees or other impacts of pandemics, strikes or shutdowns of ports of entry
or such transportation sources, could lead to inflationary cost pressures, cause us to incur unanticipated expenses
19
and impair our ability to distribute our products or receive our raw materials or packaging components in a
timely manner, which could disrupt our operations, strain our customer relationships and competitive position.
• Damage to the reputation of one or more of our leading brands could adversely affect us.
Our financial success is directly dependent on the reputation and success of our brands, particularly the
ARM & HAMMER, BATISTE, FIRST RESPONSE, NAIR, ORAJEL, OXICLEAN, TROJAN, L’IL CRITTERS
and VITAFUSION, SPINBRUSH, WATERPIK, XTRA, FLAWLESS, ZICAM and THERABREATH brands.
The effectiveness of these brands could suffer if our marketing plans or product initiatives do not have the
desired impact on a brand’s image or its ability to attract consumers. Our brands could suffer damage to their
reputations due to real or perceived, sustainability, quality or safety issues, including as a result of, among other
things, significant product recalls, product-related litigation, defects or impurities in our products, product
misuse, changing consumer perceptions of certain ingredients or environmental impacts (including packaging,
energy and water use and waste management), or allegations of product tampering. In addition, as our sales on
various e-commerce platforms grow, we may be unable to prevent sales of counterfeit, pirated, or stolen goods,
unlawful or unethical sales, unauthorized resellers online, or sales in violation of our policies.
Additionally, claims made in our marketing campaigns may become subject to litigation alleging false
advertising and could cause us to alter our marketing plans and may affect sales or result in the imposition of
significant damages against us.
Widespread use of social media and networking sites by consumers has greatly increased the accessibility
and speed of dissemination of negative information. Negative online consumer reviews or inaccurate posting or
comments about us or our brands in the media or on any social networking website, whether accurate or
inaccurate, or the disclosure of non-public sensitive information through social media, could generate adverse
publicity that could damage the reputation of our brands. In addition, given the association of our individual
products with us, an issue with one of our products could negatively affect the reputation of our other products,
or us as a whole.
• We are subject to risks related to our expansion and international operations that could adversely
affect our results of operations.
Our ability to continue to grow our sales and profits is dependent on expanding in the locations in which we
already do business and entering into new geographic locations, both of which require significant resources and
investments which would affect our risk profile. Further, our international operations subject us to risks
customarily associated with foreign operations, including:
•
currency fluctuations;
• widespread health emergencies, such as COVID-19 or other pandemics or epidemics;
•
•
•
•
•
•
•
import and export license and taxation requirements and restrictions;
trade restrictions, including local investment or exchange control regulations;
changes in tariffs and taxes;
the effect of foreign income taxes, value-added taxes and withholding taxes, including the inability to
recover amounts owed to us by foreign governments, and the determination of the U.S. Internal
Revenue Service (the “I.R.S.”) regarding the applicability of certain regulations, including the Foreign
Account Tax Compliance Act, to our international transactions;
the possibility of expropriation, confiscatory taxation or price controls;
restrictions on or the costs related to repatriating foreign profits back to the U.S.;
political or economic instability, and civil unrest;
20
•
•
•
•
•
•
disruptions in the global transportation network, such as work stoppages, strikes or shutdowns of ports
of entry or such other transportation sources, or other labor unrest;
compliance with laws and regulations concerning ethical business practices, including without
limitation, the U.S. Foreign Corrupt Practices Act and United Kingdom Bribery Act;
the impact of the United Kingdom’s exit from the European Union;
difficulty in enforcing contractual and intellectual property rights;
regulatory and quality system requirements for certain products; and
difficulties in staffing and managing international operations.
The COVID-19 pandemic has had and may continue to have a negative impact on regional and global
economies, with reduced international travel, restrictions and social distancing measures, and recessionary
conditions in many countries. Major developments in trade relations, including the imposition of new or
increased tariffs by the U.S. and/or other countries, and any emerging nationalist trends in specific countries
could alter the trade environment and consumer purchasing. All the foregoing risks could have a significant
impact on our ability to commercialize our products on a competitive basis in international markets.
In addition, changes as result of the United Kingdom’s decision and subsequent negotiations to exit the EU
could subject us to heightened risks in that region, including disruptions to trade and free movement of goods,
services and people to and from the United Kingdom, increased foreign exchange volatility with respect to the
British pound and additional legal and economic uncertainty. Additional costs have been incurred in 2020 and
2021 because of measures implemented to address or mitigate risks. Moreover, in all foreign jurisdictions in
which we operate, we are subject to laws and regulations that govern foreign investment, foreign trade and
currency exchange transactions. The recent imposition of tariffs on products imported from certain countries has
introduced greater uncertainty with respect to trade policies and government regulations affecting trade between
the U.S. and other countries. Major developments in trade relations, including the imposition of new or increased
tariffs by the U.S. and/or other countries, and any emerging nationalist trends in specific countries could alter the
trade environment and consumer purchasing behavior which, in turn, could have a material effect on our balance
sheet and results of operations. All the foregoing risks could have a significant impact on our ability to
commercialize our products on a competitive basis in international markets and may have a material adverse
effect on our results of operations and cash flows or financial position.
• Failure to effectively utilize or successfully assert intellectual property rights, and the loss or
expiration of such rights, could materially adversely affect our competitiveness. Infringement by us of
third-party intellectual property rights could result in costly litigation and/or the modification or
discontinuance of our products.
The market for our products depends to a significant extent upon the value associated with our trademarks
and brand names. We own the material trademarks and brand names used in connection with the marketing and
distribution of our major products both in the U.S. and in other countries. While we hold several valuable patents
on our products, they may not serve as an effective barrier to entry for new competitors. Accordingly, we rely on
trademark, trade secret, patent and copyright laws to protect our intellectual property rights. Although most of
our material intellectual property is registered in the U.S. and in certain foreign countries in which we operate,
we cannot be sure that our intellectual property rights will be sufficient or effectively utilized or, if necessary,
successfully asserted. There is a risk that we will not be able to obtain and perfect our own intellectual property
rights, or, where appropriate, license from others intellectual property rights necessary to support new product
introductions. We cannot be sure that these rights, if obtained, will not be invalidated, circumvented or
challenged in the future, and we could incur significant costs in connection with legal actions relating to such
rights. In addition, even if such rights are obtained in the U.S., the laws of some of the other countries in which
our products are or may be sold do not protect intellectual property rights to the same extent as the laws of the
21
U.S. If other parties infringe our intellectual property rights, they may dilute the value of our brands in the
marketplace, which could diminish the value that consumers associate with our brands and harm our sales. Our
failure to perfect or successfully assert intellectual property rights could make us less competitive and could have
a material adverse effect on our business, operating results and financial condition.
In addition, if our products are found to infringe intellectual property rights of others, the owners of those
rights could bring legal actions against us claiming substantial damages for past infringement and seeking to
enjoin manufacturing and marketing of the affected products. If these legal actions are successful, in addition to
any potential liability for damages from past infringement, we could be required to obtain a license in order to
continue to manufacture or market the affected products, potentially adding significant costs. We might not
prevail in any action brought against us or we may be unsuccessful in securing any license for continued use and
therefore have to discontinue the marketing and sale of a product.
•
Impairment of our goodwill and other long-lived intangible and tangible assets may result in a
reduction in net income.
We have a material amount of goodwill, trademarks and other intangible assets, as well as other long-lived
tangible assets, which are periodically evaluated for impairment in accordance with current accounting standards.
Declines in our profitability and/or estimated cash flows related to specific intangible assets, as well as potential
changes in market valuations for similar assets and market discount rates, has resulted in impairment charges
from time to time, and may result in future impairment charges.
Regulatory and Litigation Risks
• We may be subject to product liability claims, withdrawals or recalls or other legal proceedings and
from time to time we are involved in litigation, arbitration or regulatory matters where the outcome is
uncertain and which could entail significant expense.
From time to time, we are subject to product liability or other product-related claims. We may be required to
pay for losses or injuries actually or purportedly caused by our products, including losses or injuries caused by
raw materials or other components provided by third party suppliers that are included in our products. Claims
could be based on allegations that, among other things, our products contain contaminants, are improperly tested,
labeled or designed, or provide inadequate instructions regarding their use or inadequate warnings of potential
dangers related to their use. Whether or not successful, product liability claims could result in negative publicity
that could harm our sales and operating results and the reputation of our brands. In addition, if one of our
products is found to be defective or non-compliant with applicable rules or regulations, we could be required to
withdraw or recall it, which could result in adverse publicity and significant expenses. Although we maintain
product liability and product recall insurance coverage, potential product liability or other product-related
damages claims and/or withdrawal and recall costs may exceed the amount of insurance coverage or may be
excluded under the terms of the policy.
• Litigation, arbitration or regulatory matters where the outcome is uncertain could entail significant
expense.
From time to time, we are the subject of, or party to, various pending or threatened legal actions (including
class actions), government investigations and proceedings, including, without limitation, those relating to,
commercial transactions, product liability, consumer, employment, antitrust, environmental, health, safety and
compliance-related matters. Such proceedings are subject to many uncertainties and the outcome of certain
pending or threatened legal actions, investigations and proceedings may not be reasonably predictable and any
related damages, injunctions and/or settlements may not be estimable.
22
• Environmental matters create potential liability risks.
We must comply with various environmental laws and regulations in the jurisdictions in which we operate,
including those relating to the handling and disposal of solid and hazardous wastes and the remediation of
contamination associated with the use and disposal of hazardous substances. A release of such substances due to
accident or an intentional act could result in substantial liability to governmental authorities or to third parties.
We have incurred, and will continue to incur, capital and operating expenditures and other costs in complying
with environmental laws and regulations.
• We are subject to increasing focus and sensitivity by governmental, non-governmental organizations,
customers, consumers and investors to ESG issues, including those related to climate change.
As climate change, land use, water use, deforestation, recyclability or recoverability of packaging, plastic
waste, ingredients and other ESG concerns become more prevalent, federal, state and local governments,
non-governmental organizations and our customers, consumers and investors are increasingly concerned about
these issues. Their requirements and preferences could negatively impact the Company’s ability to obtain raw
materials or could increase its acquisition and compliance costs or cause the company to contribute funds to
recycling and other waste management infrastructure, thus making our products more costly, less competitive
than other competitive products or reduce consumer demand. This increased focus on ESG may result in new
laws, regulations and requirements that could cause disruptions in or increased costs associated with
manufacturing our products. This could cause us to incur additional costs or to make changes to our operations to
comply with any of the foregoing. We could also lose revenue if our consumers change brands or our customers
move business from us because we have not complied with their ESG requirements and ESG-conscious investors
may choose not to invest in our Common Stock if we do not comply with their business expectations.
We have recognized that our customers and consumers are increasingly demanding transparency regarding
our efforts to mitigate our impacts on climate change. For example, during 2021, some of our major customers
requested we respond to various questionnaires, including the Climate Disclosure Project (“CDP”) Climate
Change and Forests Questionnaires and use our responses and CDP grades to evaluate us. Efforts to meet these
standards could impact our costs, and failure to meet our customers’ expectations could impact our sales.
Certain of our business activities and the production of some of the materials used in our products and
certain of our business activities, including petroleum based, agricultural and forest materials, and the growing
global demand for livestock products which is a focus of our Animal and Food Production business, contribute to
deforestation and climate change and reduction in biodiversity, and can adversely impact water quality and
availability, people and communities. Climate change is, in turn, a threat to each of those activities. While we
strive to minimize the environmental impact of our global operations, a potential loss in business could result
from reduced demand for our products and loss of customers if we do not meet their expectations related to our
efforts towards sustainability and fighting climate change.
• Current and future laws and regulations in the countries in which we and our suppliers operate could
expose us to increased costs and other adverse consequences.
The development, manufacturing, processing, formulation (including stability), packaging, labeling,
marketing, distribution and sale of our products are subject to regulation by federal agencies, including the FDA,
the FTC, the EPA and the CPSC and foreign regulators and agencies. In addition, our and our suppliers’
operations are subject to the oversight of the Occupational Safety and Health Administration and the National
Labor Relations Board. Our activities are also regulated by various agencies of the states, localities and foreign
countries in which our products and their constituent materials and components are manufactured and sold.
In particular, the FDA and foreign counterparts regulate the formulation, safety, development,
manufacturing, packaging, labeling and distribution of condoms, home pregnancy and ovulation test kits, vaginal
lubricants, electric and battery powered medical devices, over-the-counter pharmaceuticals and dietary
supplements, including vitamins, minerals, and homeopathic products. The FDA or a similar foreign agency also
23
exercises oversight over cosmetic products such as depilatories. In addition, under a memorandum of
understanding between the FDA and the FTC, the FTC has jurisdiction with regard to the promotion and
advertising of these products, and the FTC regulates the promotion and advertising of our other products as well.
As part of its regulatory authority, the FDA may periodically conduct inspections of the physical facilities,
machinery, processes and procedures that we and our suppliers use to manufacture regulated products and may
identify compliance issues that would require us and our suppliers to make certain changes in our manufacturing
facilities and processes. The failure of a facility to be in compliance may lead to regulatory action against the
products made in that facility, including seizure, injunction or recall, as well as to possible action against the
owner of the facility/manufacturer. We may be required to make additional expenditures to address these issues
or possibly stop selling certain products until the compliance issue has been remediated.
Likewise, any future determination by the FDA or a similar foreign agency, or by us in reviewing our
compliance with applicable rules and regulations, that our products or quality systems do not comply with
applicable regulations could result in future compliance activities, including product withdrawals or recalls,
import detentions, injunctions preventing the shipment of products, or other enforcement actions. For example,
the FDA may determine that a particular claim that we use to support the marketing of a product is not
substantiated, may not accept the evidence of safety for a new product that we may wish to market, may
challenge the safety or effectiveness of existing products based on, among other things, changes in formulations,
inadequate stability or “shelf-life,” consumer complaints, or improper labeling, and may determine that our
dietary supplement business manufacturing, packaging, labeling and holding operations do not comply with
cGMPs. Similarly, we may identify these or other issues in internal compliance reviews of our operations and the
operations and products of vendors and acquired companies. These other issues may include the identification of
contaminants or non-compliant levels of particular ingredients. Any of the foregoing could subject us to adverse
publicity, force us to incur unanticipated costs and have a material adverse effect on our business, financial
condition, results of operations and cash flows. Additionally, delays in the acceptance, review and approval of
products by the FDA, or other required governmental approvals, may result from government shutdowns due to
the failure by Congress to enact regular appropriations.
In 2019, our VITAFUSION brand launched CBD Full Spectrum Hemp Extract gummies, a new product line
made with full spectrum hemp extract containing cannabidiol (“CBD”). Hemp was exempted from federal
regulation as a controlled substance under the Agriculture Improvement Act of 2018 (the “2018 Farm Bill”). The
2018 Farm Bill did not eliminate or affect regulation of hemp and its derivatives by the FDA, FTC, or state
governments. We believe that our new product line complies with applicable FDA requirements, although the
FDA takes the position that CBD products cannot be marketed as dietary supplements and that CBD cannot be
added to food. To date, the FDA’s enforcement activity has focused primarily on CBD products that bear express
or implied claims suggesting that the products are intended to treat, cure, prevent, or mitigate a disease. The FTC
has similarly focused on disease claims. Our products do not bear disease claims.
The FDA has not confirmed whether it will engage in rulemaking to permit the marketing of CBD products
as dietary supplements. In the interim, there has been discussion of legislative changes. For example, S 1698 was
introduced in May 2021. S 1698 would amend the FDC Act to include hemp-derived CBD in the definition of a
dietary supplement. Although state laws have been evolving in the wake of the 2018 Farm Bill, we do not intend
to sell our products in states that continue to prohibit sales of certain hemp-based CBD products. In 2021, our
Nair brand is launching one depilatory cosmetic product that contains broad spectrum hemp extract. FDA’s
position that CBD products cannot be marketed as dietary supplements and that CBD cannot be added to food
does not extend to cosmetic products. We do not intend to sell our Nair product in states that continue to prohibit
sales of certain hemp-based CBD products. The FDA and certain states and local governments may enact
regulations or change their enforcement priorities in a manner that further limits the marketing and use of CBD
products. We do not know what the impact of such regulatory activities would be on our products, and what
costs, requirements, and possible prohibitions may be associated with such regulatory activities. Our failure to
comply with applicable regulatory requirements or FDA’s or any other state’s disagreeing with our interpretation
of applicable FDA or state requirements could result in, among other things, administrative, civil, or criminal
24
penalties or fines; product seizure, mandatory or voluntary product recalls; warning or untitled letters; cease and
desist orders against operations that are not in compliance; closure of facilities or operations; the loss, revocation,
or modification of any existing licenses, permits, registrations, or approvals; or the failure to obtain additional
licenses, permits, registrations, or approvals in new jurisdictions where we intend to do business. These laws and
regulations may change in the future and we may incur material costs in our efforts to comply with current or
future laws and regulations or in any product recalls.
We are subject to regulations regarding the transportation, storage or use of certain chemicals to protect the
environment, as well as the Commission’s rules with respect to “conflict minerals.” The new administration and
Congress in the United States may seek to pass more stringent regulations in these areas, or more aggressively
enforce existing regulations. Recent trade policies, tariffs and government regulations affecting trade between the
U.S. and other countries, have introduced greater uncertainty and volatility. In addition, any additional or
renewed significant governmental actions pertaining to the COVID-19 pandemic, including lockdowns,
quarantines or other restrictions on the ability of our employees to travel or perform necessary business functions
or our ability to develop, manufacture, distribute, market or sell our products, or the ability of our suppliers,
customers or third-party partners to effectively run their operations, may negatively impact our ability to
manufacture, distribute, market and sell our products. We are not able to predict the nature of these changes or of
such future laws, regulations, repeals or interpretations or to predict the effect additional or shifting governmental
regulation, when and if it occurs, would have on our business in the future. Such developments could require
reformulation of certain products to meet new standards, recalls or discontinuance of certain products not able to
be reformulated, additional record-keeping requirements, increased documentation of the properties of certain
products, additional or different labeling, additional scientific substantiation, expanded adverse event reporting or
other new requirements.
There is also an increased risk of fraud or corruption in certain foreign jurisdictions and related difficulties
in maintaining effective internal controls. Additionally, we could be subject to future inquiries or investigations
by governmental and other regulatory bodies, which may be delayed or disrupted due to any government
furlough. We could also be adversely affected by violations, or allegations of violations, of the Foreign Corrupt
Practices Act and similar international anti-bribery laws. The Foreign Corrupt Practices Act and similar
international anti-bribery laws generally prohibit companies and their intermediaries from making improper
payments to government officials or other third parties for the purpose of obtaining or retaining business.
• We are subject to increasingly stringent privacy and security regulation.
We collect, use and store personal data of our employees, customers and other third parties in the ordinary
course of business, and we are required to comply with increasingly complex and changing data privacy and
security laws and regulations, that apply to the collection, storage, use, transmission and protection of personal
information and other consumer and employee data, including particularly the transfer of personal data between
or among countries. Recent high-profile security breaches of the information systems of a number of government
agencies and U.S. companies may result in increased regulations and new security laws. The new administration
and Congress in the United States may seek to pass more stringent regulations in these areas, or more
aggressively enforce existing regulations.
Numerous local, municipal, state, federal and international law and regulations address privacy and security
including the California Online Privacy Protection Act, the Personal information Protection and Electronic
Documents Act, the Controlling the Assault of Non-Solicited Pornography and Marketing (CAN-SPAM) Act, the
Telephone Consumer Protection Act of 1991, the Health Insurance Portability and Accountability Act of 1996
(HIPAA), Section 5(c) of the Federal Trade Commission Act, and, effective as of January 1, 2020 the California
Consumer Privacy Act (CCPA). These privacy and security laws and regulations change frequently, and new
legislation continues to be introduced such as the Virginia Consumer Data Protection Act and the Colorado
Privacy Act which will become effective in 2023. In particular, the CCPA requires new disclosures to California
consumers, gives California consumers new rights with respect to their data, and permits California consumers
to opt-out of certain sales of personal information. The CCPA provides for fines of up to $7,500 per violation.
25
In Europe, the European Union (“EU”) has adopted strict data privacy regulations. Following the passage of
the EU’s General Data Protection Regulation ((EU) 2016/679) (“GDPR”) and the Regulation on Privacy and
Electronic Communications (the “ePrivacy Regulation”), data privacy and security compliance in the EU are
increasingly complex and challenging. The GDPR in particular has broad extraterritorial effect and imposes a
strict data protection compliance regime with significant penalties for non-compliance (up to 4% of worldwide
annual turnover or €20 million, whichever is higher). It is also important to note that many countries are
following the EU in producing a broad omnibus law in relation to privacy protection. For instance, Brazil has just
published a GDPR-like law. In general, the GDPR and ePrivacy Regulation, CCPA, and other local privacy laws,
could also require adaptation of our technologies or practices, increased costs and changes to operations to satisfy
local privacy requirements and standards.
We may also face audits or investigations by one or more domestic or foreign government agencies relating
to our compliance with these regulations. An adverse outcome under any such investigation or audit could
subject us to fines, penalties or orders to cease, delay or modify collection, use or transfers of personal data. We
could also face rights requests, complaints, claims, or litigation from those persons whose data we collect, use
and store as well as government investigations and fines. Any of these events or other circumstances related to
our collection, use and transfer of personal data could also lead to negative media attention, damage to our
reputation in the market or otherwise adversely affect our business.
• Changes in tax laws and regulations or in our operations may impact our effective tax rate and may
adversely affect our business, financial condition and operating results.
Our future effective tax rate could be affected by changes in tax laws and regulations or their interpretation,
changes in the mix of earnings in countries with differing statutory tax rates, or changes in the valuation of
deferred tax assets and liabilities. In addition, we evaluate our deferred income tax assets and record a valuation
allowance if it is “more likely than not” that all or a portion of the deferred tax asset will not be realized. If the
actual amount of our future taxable income is less than the amount we are currently projecting with respect to
specific tax jurisdictions, or if there is a change in the time period within which the deferred tax asset becomes
deductible, we could be required to record a valuation allowance against our deferred tax assets. The recording of
a valuation allowance would result in an increase in our effective tax rate and would have an adverse effect on
our operating results. In addition, changes in statutory tax rates may change our deferred tax assets or liability
balances, which would also impact our effective tax rate. The Biden administration has introduced greater
uncertainty with respect to tax policies in the United States and major developments in tax policy could impact
our business.
• Resolutions of tax disputes may adversely affect our earnings and cash flow.
Significant judgment is required in determining our effective tax rate and in evaluating our tax positions.
We provide for uncertain tax positions with respect to tax positions that do not meet the recognition thresholds or
measurement standards mandated by applicable accounting guidance. Fluctuations in federal, state, local and
foreign taxes or changes to uncertain tax positions, including related interest and penalties, may impact our
effective tax rate and our financial results. We are regularly under audit by tax authorities, and although we
believe our tax estimates are reasonable, the final outcome of tax audits and related litigation could be materially
different than that reflected in our historical income tax provisions and accruals. In addition, when particular tax
matters arise, a number of years may elapse before such matters are audited and finally resolved. Favorable
resolution of such matters could be recognized as a reduction to our effective tax rate in the year of resolution.
Unfavorable resolution of any tax matter could increase the effective tax rate. Any resolution of a tax issue may
require the use of cash in the year of resolution.
• Our amended and restated bylaws include an exclusive forum provision.
Our amended and restated bylaws include an “exclusive forum provision, which may limit the ability of our
stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our
26
directors or officers, which may discourage such lawsuits against us and our directors and officers. If a court
outside of Delaware were to find this exclusive forum provision inapplicable to, or unenforceable in respect of,
one or more of the specified types of actions or proceedings described above, we could incur additional costs
associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial
condition or results of operations or cash flows.
Financial Risks
• We have substantial indebtedness and we may incur substantially more debt in the future.
As of December 31, 2021, we had approximately $2,563 million of total consolidated indebtedness, net of
debt issuance costs. This amount of indebtedness could have important consequences, including:
• making it more difficult for us to satisfy our obligations;
•
•
•
•
•
limiting our ability to fund potential acquisitions;
requiring us to dedicate a portion of our cash flow from operations to payments on our indebtedness,
which would reduce the availability of cash flow to fund capital expenditures and other general
corporate purposes;
limiting our flexibility in reacting to general adverse economic conditions or changes in our business
and the industry in which we operate;
limiting our ability to repurchase our Common Stock; and
placing us at a competitive disadvantage compared to our competitors that have less debt.
Additionally, our credit facility is subject to certain financial and other customary covenants. In the event of
a breach of those covenants, our lenders under the credit facility may be entitled to accelerate the related debt
(and any lenders in respect of any other debt to which a cross-default provision applies may be entitled to
accelerate such other debt), and we could be required to seek amendments or waivers under the debt instruments
or to refinance the debt. We may incur substantial additional indebtedness in the future to fund acquisitions, to
repurchase shares or to fund other activities for general business purposes. If additional new debt is added to the
current debt levels, the related risks that we now face could intensify. A substantial increase in our indebtedness
could also have a negative impact on our credit ratings. In this regard, a deterioration in our credit ratings could
adversely affect the interest rate available to us in future financings, as well as our liquidity, competitive position
and access to capital markets. Any decision regarding future borrowings will be based on the facts and
circumstances existing at the time, including market conditions and impact to our credit ratings.
LIBOR, the interest rate benchmark used as a reference rate on our variable rate debt, including our
revolving credit facility, term loan, and interest rate swaps was expected to be fully phased out by the end of
2021, when private-sector banks are no longer required to report the information used to set the rate. However, in
late 2020, ICE Benchmark Administration (“IBA”), the organization responsible for administering LIBOR,
announced its intention to extend the publication of certain USD LIBOR tenors until June 30, 2023. The
Alternative Reference Rates Committee (“ARRC”), a group convened for the purpose of ensuring a successful
transition away from USD LIBOR, has identified the Secured Overnight Financing Rate (“SOFR”) as its
preferred alternative rate. Given the inherent differences between LIBOR and SOFR or any other alternative
benchmark rate that may be established, there are additional uncertainties regarding a transition from LIBOR,
including but not limited to the need to amend all contracts with LIBOR as the reference rate and how this will
impact our cost of variable rate debt and certain derivative financial instruments. We will also need to consider
new contracts and if they should reference an alternative benchmark rate or include suggested fallback language,
as published by the ARRC from time to time.
27
• Our business is exposed to domestic and foreign currency fluctuations.
We are exposed to foreign currency exchange rate risk (both transaction and translation) with respect to our
sales, profits, assets and liabilities denominated in currencies other than the U.S. Dollar. Outside of the U.S.,
sales and costs are denominated in a variety of currencies, including the Canadian Dollar, Euro, Pound, Mexican
Peso and Australian Dollar, among others. A weakening of the currencies in which sales are generated relative to
the currencies in which costs are denominated would decrease operating profits and cash flow. Changes in
currency exchange rates may also affect the relative prices at which we purchase materials and services in
foreign markets. Although we, from time to time, enter into forward exchange contracts to reduce the impact of
foreign exchange rate fluctuations related to anticipated but not yet committed sales or purchases denominated in
the U.S. Dollar, Canadian Dollar, Pound, Euro, Mexican Peso and Australian Dollar, foreign currency
fluctuations could have a material adverse effect on our business, financial condition and results of operations.
General Risks
• We must successfully manage the demand, supply, and operational challenges associated with the
actual or perceived effects of the COVID-19 pandemic.
Our business and financial results have been, and may continue to be, negatively impacted by the fear of
exposure to or actual effects of the COVID-19 pandemic, such as, but not limited to:
•
•
•
•
•
•
•
•
•
•
negative impact on the global and U.S. domestic economy, significant unemployment, and market
volatility;
reduced travel or recommendations or mandates from governmental authorities to avoid various sized
gatherings, close facilities, suspend operations, or reduce hours, or to self-quarantine:
the impact of the laws or regulations, employee-quarantines or similar other restrictions on our
business operations or those of our customers;
significant increases in or reductions in demand or significant volatility in demand for one or more of
our products, resulting in pressure on our operations and supply chain networks and the ability to meet
such demand;
inability to meet our retailer orders and customers’ needs due to disruptions in our manufacturing and
distribution network, supply chain, or capacity constraints or those of our finished goods, raw
materials, or transportation suppliers;
continued shifts in consumer demand, including accelerated shifts to online shopping and increased
competition in e-commerce in many of our categories from our larger legacy competitors and newer
digitally native brands which have increasingly moved into consumer products and staples;
pricing pressures on our products as retailers face added costs to build their e-commerce capacity;
retailer fines related to our underperformance with respect to on time and in full shipments due to
restrictions on our ability to produce and deliver products as a result of employee absenteeism or
sickness, a tight trucking market or reduced shipping capacity, additional governmental or regulatory
actions, closures or other restrictions that limit or close our operating and manufacturing facilities or
those of our suppliers;
closures or reduced hours by our customers; and
the impact of ongoing government orders and the need to protect our workforce.
Despite our efforts to manage and remedy these impacts, their ultimate impact also depends on factors
beyond our knowledge or control, including the duration and severity of any such outbreak as well as third-party
or governmental actions taken to contain its spread and mitigate its public health effects. While the vast majority
of our products are consumer staples that generally are less vulnerable to decreases in discretionary spending
28
than other products, some of our products, particularly WATERPIK and some other personal care brands, are
more discretionary in nature and, are more likely to be affected by consumer decisions to control spending and
the impact and duration of recessionary economic conditions.
The impact of COVID-19, including the impact of restrictions imposed to combat its spread, could result in
additional businesses being shut down, additional work restrictions and supply chains being interrupted, slowed,
or rendered inoperable, in particular as new COVID-19 variants such as the Delta and Omicron and other new
variants spread. As a result, it may be even more challenging to obtain and process raw materials to support our
business needs, and more individuals could become ill, quarantined or otherwise unable to work and/or travel due
to health reasons or governmental restrictions. Also, governments may impose other laws, regulations or taxes
which could adversely impact our business, financial condition or results of operations. Further, as some of our
customers’ businesses are similarly affected, they might delay or reduce purchases from us, which could
adversely affect our results of our business, financial condition or results of operations. The potential effects of
COVID-19 also could impact many of the other risk factors described herein, but given the evolving health,
economic, social and governmental environments, such potential impact remains uncertain. While we expect the
impacts of COVID-19 to continue to have an effect on our business, financial condition and results of operations
and cash flows, we are unable to predict the extent or nature of these impacts at this time.
• Our operating results have been, and could be in the future, adversely affected by natural disasters,
public health crises, political crises, or other catastrophic events, or unfavorable worldwide, regional
and local economic and financial market conditions.
Our operations, as well as the operations of our third-party manufacturers, suppliers and customers, may be
subject to disruption from a variety of causes, including a protracted economic downturn, material shortages,
financial difficulties, work stoppages, cyberattacks, and other disruptions in information technology systems,
demonstrations, political instability or uncertainty in the U.S. or abroad, rising geopolitical tensions and
hostilities (for example between Russia and Ukraine and China and Taiwan), disease outbreaks or pandemics (for
example, an outbreak of a virus such as COVID-19), acts of war, terrorism, fire, earthquakes, flooding or other
natural disasters, disruptions in logistics, loss or impairment of key manufacturing sites, supplier capacity
constraints, raw material and product quality or safety issues, industrial accidents or other occupational health
and safety issues. If a major disruption were to occur, it could result in harm to people or the natural
environment, delays in shipments of products to customers or suspension of operations.
The global economy and the economies in regions in which we conduct business have experienced
substantial economic downturns as a result of the COVID-19 pandemic. We are currently experiencing reduced
demand for certain of our consumer products and may in the future be adversely affected in a material way by
lower consumer demand as a result of recessionary economic conditions, including after the direct impact of the
COVID-19 pandemic has subsided. In addition, ongoing political uncertainty in many countries, including the
ongoing political transition in Hong Kong, and the exit of the United Kingdom from the European Union have
created additional economic uncertainty and volatility in the financial markets.
• We rely significantly on information technology. Any inadequacy, interruption, theft or loss of data,
malicious attack, integration failure, failure to maintain the security, confidentiality or privacy of
sensitive data residing on our systems or other security failure of that technology could harm our
ability to effectively operate our business and damage the reputation of our brands.
We rely extensively on information technology systems, some of which are managed by third-party service
providers, to conduct our business. These systems include, but are not limited to, programs and processes relating
to internal communications and communications with other parties, ordering and managing materials from
suppliers, converting materials to finished products, shipping product to customers, billing customers and
receiving and applying payment, processing transactions, summarizing and reporting results of operations,
29
complying with regulatory, legal or tax requirements, collecting and storing customer, consumer, employee,
investor, and other stakeholder information and personal data, and other processes necessary to manage our
business. We sell certain of our products directly to consumers online and through websites, mobile apps and
connected devices, and we offer promotions, rebates, customer loyalty and other programs through which it may
receive personal information, and we or our vendors could experience cyber-attacks, privacy breaches, data
breaches or other incidents that may result in unauthorized access, disclosure and misuse of consumer, customer,
employee, vendor or Company information.
Increased information technology security threats and more sophisticated computer crime, including
ransomware, denial of service and phishing attacks and advanced persistent threats, pose a potential risk to the
security of our information technology systems, networks, and services, and those of our customers and other
business partners, as well as the confidentiality, availability, and integrity of our data, and the data of our
customers and other business partners. As a result, our information technology systems, networks or service
providers could be damaged or cease to function properly or we could suffer a loss or disclosure of business,
personal or stakeholder information, due to any number of causes, including catastrophic events, power outages
and security breaches. Although we have business continuity plans in place and have implemented a breach
response plan to address service interruptions, if these plans do not provide effective alternative processes on a
timely basis, we may suffer interruptions in our ability to manage or conduct our operations which may adversely
affect our business. In addition, if our service providers, suppliers or customers experience a breach or
unauthorized disclosure or system failure, their businesses could be disrupted or otherwise negatively affected,
which may result in a disruption in our supply chain or reduced customer orders or other business operations.
Moreover, any costs related to a breach may exceed the amount of insurance coverage or be excluded under the
terms of our cybersecurity policy. Recently, there have been high profile security breaches of the information
systems of a number of government agencies and U.S. companies, resulting in significant disruptions.
Our information technology systems and, our third-party providers’ systems, have been, and will likely
continue to be, subject to advanced computer viruses or other malicious codes, ransomware, unauthorized access
attempts, denial of service attacks, phishing, social engineering, hacking and other cyberattacks. Such attacks
may originate from nation states or attempts by outside parties, hackers, criminal organizations or other threat
actors. In addition, insider actors-malicious or otherwise-could cause technical disruptions and/or confidential
data leakage. To date, we have seen no material impact on our business or operations from these attacks;
however, we cannot guarantee that our security efforts will prevent attacks and resulting breaches or breakdowns
of our, or our third-party service providers’ databases or systems. In addition, although we have policies and
procedures in place governing the secure storage of personal information collected by us or our third-party
service providers, data breaches due to human error or intentional or unintentional conduct may occur in the
future.
We continuously perform enterprise-wide upgrades to our systems and will continue to monitor and upgrade
systems as appropriate, legacy systems may be vulnerable to increased risk. Additionally, if a new system does
not function properly, it could affect our ability to order supplies, process and deliver customer orders and
process and receive payments for our products. This could adversely impact our results of operations and cash
flows. Upgraded or new technology may not function as designed and any such upgrades may not go as planned.
Moreover, because the techniques, tools and tactics used in cyberattacks frequently change and may be difficult
to detect for periods of time, we may face difficulties in anticipating and implementing adequate preventative
measures or fully mitigating harms after such an attack. As such, we may need to expend additional resources
and incur additional costs in the future to continue to protect against or address problems caused by any business
interruptions or data security breaches.
• We may not be able to attract, retain and develop key personnel.
The labor market in the United States is very competitive. Our future performance depends in significant
part upon the continued service of our executive officers and other key personnel, including at our plants.
30
Competition for qualified plant personnel has been intense. The loss of the services of one or more executive
officers or other key employees, including as a result of illness to themselves or their families due to the
COVID-19 pandemic or otherwise, could have a material adverse effect on our business, prospects, financial
condition and results of operations. This effect could be exacerbated if any officers or other key personnel left as
a group or at the same time. Our success also depends, in part, on our continuing ability to attract, retain and
develop highly qualified and diverse personnel. Competition for such personnel is intense, and there can be no
assurance that we can retain our key employees or attract, assimilate and retain other highly qualified personnel
in the future. Factors that may affect our ability to attract and retain sufficient numbers of key employees include
employee morale, our reputation, competition from other employers and the availability of qualified personnel in
a tightening labor market. We have experienced increased levels of personnel turnover in recent years, increasing
from an employee turnover rate of 14.9% in 2020 to an employee turnover rate of 20.6% in 2021. We may
continue to experience increased personnel turnover in the future compared to prior years, either as a result of our
business operations, or as a result of the COVID-19 pandemic or other broad-based economic or cultural factors.
• Our continued growth and expansion, reliance on third-party service providers and implementation
of new accounting standards could adversely affect our internal control over financial reporting.
Our management is responsible for establishing and maintaining adequate internal control over financial
reporting. Internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting for external purposes in accordance with generally accepted
accounting principles in the U.S. Because of its inherent limitations, internal control over financial reporting
cannot provide absolute assurance that a misstatement of our financial statements would be prevented or
detected. Our continuing growth and expansion in domestic and globally dispersed markets, such as our
acquisition of WATERPIK, FLAWLESS, PASSPORT, ZICAM, THERABREATH and others, may place
significant additional pressure on our system of internal control over financial reporting and require us to update
our internal control over financial reporting to integrate such acquisitions. Moreover, we engage the services of
third parties to assist with business operations and financial reporting processes, which injects additional
monitoring obligations and risk into the system of internal control. When we are required to comply with new or
revised accounting standards, we must make any appropriate changes to our internal control over financial
reporting to fully implement the standards, which may require significant effort and judgment. Any failure to
maintain an effective system of internal control over financial reporting could limit our ability to report our
results of operations accurately and on a timely basis, or to detect and prevent fraud and could expose us to
regulatory enforcement action and stockholder claims.
• Our business could be negatively impacted as a result of stockholder activism, an unsolicited takeover
proposal or a proxy contest or short sellers.
In recent years, proxy contests, unsolicited takeovers and other forms of stockholder activism have been
directed against numerous companies in our industry, including us. If such a campaign or proposal were to be
made against us, we would likely incur significant costs. Stockholder activists may also seek to involve
themselves in the governance, strategic direction and operations of our business through stockholder proposals or
otherwise disrupting our business and diverting the attention of our management and employees, and any
perceived uncertainties as to our future direction resulting from such a situation could result in the loss of
potential business opportunities, the perception that we need a change in the direction of our business, or the
perception that we are unstable or lack continuity, which may be exploited by our competitors, cause concern to
our current or potential customers, and may make it more difficult for us to attract and retain qualified personnel
and business partners. Actions of activist stockholders may cause significant fluctuations in our stock price based
on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying
fundamentals and prospects of our business. We may also be the target of short sellers who engage in negative
publicity campaigns that may use selective information that may be presented out of context or that may
misrepresent facts and circumstances.
31
ITEM 1B. UNRESOLVED STAFF COMMENTS
Not applicable.
ITEM 2. PROPERTIES
We lease a corporate office building in Ewing, New Jersey for our global corporate headquarters. The lease
expires in 2033 and includes two 10-year extension terms at our option. In addition, we own an office building in
Fort Collins, Colorado and an office building in Princeton, New Jersey that is occupied by our research and
development department.
We own or lease manufacturing facilities, warehouses and other offices in 15 different U.S. states and 11
different countries outside of the U.S. Many of our domestic and international sites manufacture and distribute
products for multiple segments of our business. We believe that our operating and administrative facilities are
adequate and suitable for the conduct of our business. We also believe that our production facilities are suitable
for current manufacturing requirements for our consumer and specialty products businesses.
ITEM 3. LEGAL PROCEEDINGS
We, in the ordinary course of our business are the subject of, or party to, various pending or threatened legal
actions, government investigations and proceedings from time to time, including, without limitation, those
relating to commercial transactions, product liability, purported consumer class actions, employment matters,
antitrust, environmental, health, safety and other compliance related matters. Such proceedings are subject to
many uncertainties and the outcome of certain pending or threatened legal actions may not be reasonably
predictable and any related damages may not be estimable. Certain legal actions could result in an adverse
outcome for us, and any such adverse outcome could have a material adverse effect on our business, financial
condition, results of operations, and cash flows. There are no relevant matters to disclose under this Item for this
period.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
32
PART II
ITEM 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our shares of common stock are traded on the New York Stock Exchange with the stock ticker symbol
“CHD”.
Approximate number of record holders of our Common Stock as of December 31, 2021: 1,700.
The following graph compares the yearly change in the cumulative total stockholder return on our Common
Stock for the past five fiscal years with the cumulative total return of the S&P 500 Index and the S&P 500
Household Products Index described more fully below. The returns are indexed to a value of $100 at
December 31, 2016. Dividend reinvestment has been assumed.
Comparison of Cumulative Five-Year Total Return among Company, S&P 500 Index and the S&P 500
Household Products Index(1)
(1) S&P 500 Household Products Index consists of the Church & Dwight Co., Inc., Clorox Company, Colgate-
Palmolive Company, Kimberly-Clark Corporation and P&G.
COMPARISON OF CUMULATIVE FIVE-YEAR TOTAL RETURN
Five-Year
Average
Annual
Return
Church & Dwight Co., Inc.
S&P 500 Index
S&P 500 Household Products Index
20.0%
18.5%
14.8%
Dollars
300.00
250.00
200.00
150.00
100.00
50.00
0.00
2016
2017
2018
2019
2020
2021
Company / Index
2016
2017
2018
2019
2020
2021
Church & Dwight Co., Inc. . . . . . . . . . . . . . . . . . . . . . .
S&P 500 Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S&P 500 Household Products Index . . . . . . . . . . . . . . .
100.00
100.00
100.00
115.32
121.82
113.85
153.64
116.47
113.86
166.49
153.14
149.72
208.90
181.30
173.32
248.34
233.29
199.74
Share Repurchase Authorization
On November 1, 2017, the Board authorized a share repurchase program, under which we may repurchase
up to $500.0 million in shares of Common Stock (the “2017 Share Repurchase Program”). On October 28, 2021,
the Board authorized a new share repurchase program, under which we may repurchase up to $1.0 billion in
shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not
have an expiration and replaced the 2017 Share Repurchase Program. All remaining dollars authorized for
repurchase under the 2017 Share Repurchase Plan have been cancelled. The 2021 Share Repurchase Program did
33
not modify our evergreen share repurchase program, authorized by the Board on January 29, 2014, under which
we may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances
of Common Stock under our incentive plans.
In December 2020, we entered into an Accelerated Share Repurchase (“ASR”) contract with a commercial
bank to purchase our Common Stock. We paid $300.0 million to the bank, inclusive of fees, and received an
initial delivery of shares equal to $270.0 million, or 3.1 million shares. We used cash on hand and short-term
borrowings to fund the initial purchase price. Upon the completion of the ASR, which ended in February 2021,
the bank delivered to us an additional 0.4 million shares. The final shares delivered to the us were determined by
the average price per share paid by the bank during the purchase period. All 3.5 million shares were purchased
under our evergreen program.
In August 2021, we executed an agreement to purchase up to $200.0 million of our Common Stock through
October 31, 2021. We purchased 1.6 million shares for approximately $130.0 million through October, inclusive
of fees, all of which was purchased under the 2017 Share Repurchase Program.
In December 2021, we executed open market purchases of 1.8 million shares for $170.3 million, inclusive
of fees, of which $100.0 million was purchased under the evergreen share repurchase program and $70.3 million
was purchased under the 2021 Share Repurchase Program. In December 2021, we also entered into an
ASR contract with a commercial bank to purchase Common Stock. We paid $200.0 million to the bank, inclusive
of fees, and received an initial delivery of shares equal to $180.0 million, or 1.8 million shares. We used cash on
hand and short-term borrowings to fund the initial purchase price. Upon the completion of the ASR, which ended
in February 2022, the bank delivered an additional 0.2 million shares to us. The final shares delivered to us were
determined by the average price per share paid by the bank during the purchase period. All 2.0 million shares
were purchased under the 2021 Share Repurchase Program.
As a result of our recent stock repurchases, there remains $729.7 million of share repurchase availability
under the 2021 Share Repurchase Program as of December 31, 2021.
Period
Total Number
of Shares
Purchased(1)
Average Price
Paid per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Approximate Dollar
Value of Shares that
May Yet Be Purchased
Under All
Programs
10/1/2021 to 10/31/2021 . . . . . . . . . . . . . . .
11/1/2021 to 11/30/2021 . . . . . . . . . . . . . . .
12/1/2021 to 12/31/2021 . . . . . . . . . . . . . . .
907,937
374
3,662,770
Total
. . . . . . . . . . . . . . . . . . . . . . . . . .
4,571,081
$82.40
91.10
95.63
$93.00
907,937
—
3,662,770
4,570,707
$1,000,000,000
$1,000,000,000
$ 729,727,297
(1)
Includes shares of Common Stock withheld by us to satisfy tax withholding obligations in connection with
the vesting of restricted stock.
34
ITEM 6. RESERVED
35
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in
conjunction with our consolidated financial statements.
OVERVIEW
Our Business
We develop, manufacture and market a broad range of consumer household, personal care and specialty
products focused on animal and food production, chemicals and cleaners. We focus our consumer products
marketing efforts principally on our 14 “power brands.” These well-recognized brand names include ARM &
HAMMER®, used in multiple product categories such as baking soda, cat litter, carpet deodorization and laundry
detergent; TROJAN® condoms, lubricants and vibrators; OXICLEAN® stain removers, cleaning solutions,
laundry detergent and bleach alternatives; SPINBRUSH® battery-operated and manual toothbrushes; FIRST
RESPONSE® home pregnancy and ovulation test kits; NAIR® depilatories; ORAJEL® oral analgesic; XTRA®
laundry detergent; L’IL CRITTERS® and VITAFUSION® gummy dietary supplements; BATISTE® dry
shampoos; WATERPIK® water flossers and replacement showerheads; FLAWLESS® products; ZICAM® cold
shortening and relief products and THERABREATH® oral care products.
We sell our consumer products under a variety of brands through a broad distribution platform that includes
supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar, pet and
other specialty stores and websites and other e-commerce channels, all of which sell the products to consumers.
We sell our specialty products to industrial customers, livestock producers and through distributors.
We operate our business in three segments: Consumer Domestic, Consumer International and the Specialty
Products Division (“SPD”). The segments are based on differences in the nature of products and organizational
and ownership structures. In 2021, the Consumer Domestic, Consumer International and SPD segments
represented approximately 76%, 18% and 6%, respectively, of our consolidated net sales.
COVID-19 Pandemic and Other Recent Developments
The COVID-19 pandemic continues to impact most of our businesses. As certain government restrictions
were reduced or removed, we have experienced increased demand for certain product categories, mainly in the
United States, including ARM & HAMMER cat litter, VITAFUSION and L’IL CRITTERS gummy vitamins,
and BATISTE dry shampoo, that had been negatively impacted by the temporary and permanent closures of
certain retailers, reduced consumer foot traffic at retailers, and COVID-19 related precautionary measures.
Overall, we have continued to experience increased online sales.
We continue to experience challenges to meet customer demand, largely because of broad-based shortages
in suppliers’ labor which impact the availability of many critical components in our supply chain and
distribution. Additionally, we and our suppliers are experiencing significant broad-based inflation of
manufacturing and distribution costs as well as transportation challenges. We expect shortages to continue at
least through the first half of 2022 and input cost inflation to continue at least throughout 2022.
To attempt to offset some of these cost pressures, we have recently enacted and continue to evaluate price
increases. In addition, to address challenges meeting customer demand, we have taken steps to increase our
short-term manufacturing capacity for many of our products (including laundry detergent, baking soda, cleaners
and vitamins) as well as our raw material and packaging capacity, and continue to work closely with our
36
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
suppliers, contract manufacturers and retail partners to increase capacity and ensure sustained supply to keep
pace with increased demand. We have also made investments in the expansion of long-term, in-house and third-
party manufacturing capacity and are working to enlist additional suppliers that meet our quality specifications.
While we expect supply availability issues to start improving in the second half of 2022 for most of our brands,
there is no assurance that these challenges will abate in the foreseeable future or that our customers will accept
all or a portion of any price increases, or that the other measures we have or may implement will mitigate the
impact of supply disruptions or rising costs.
Looking forward, the extent that COVID-19 and other recent developments’ have on our operational and
financial performance will depend on future developments, including the duration, spread and intensity of the
pandemic, the spread and severity of new variants such as Omicron, the impact of vaccines, and our continued
ability to manufacture and distribute our products, as well as any future government actions affecting employers,
consumers and the economy generally, all of which are uncertain and difficult to predict considering the rapidly
evolving landscape. Our priorities during the COVID-19 pandemic continue to be protecting the health and
safety of our employees; maximizing the availability of products that help consumers with their health, hygiene
and cleaning needs; and using our employees’ talents and our resources to help society meet and overcome the
current challenges.
We are monitoring the impact of both inflation and the COVID-19 pandemic, including the effect of
corresponding government actions on consumer demand, and how these factors will potentially influence future
cash flows for the short and long term. While we expect that many of these effects will not be permanent, it is
impossible to predict their duration.
2021 Financial Highlights
Key 2021 financial results include:
•
2021 net sales grew 6.0% over 2020, with gains in all three of our segments. The gains are primarily
due to favorable pricing/product mix in the Consumer Domestic and SPD segments, partially offset by
unfavorable pricing/product mix in Consumer International, as well as favorable volumes in the
Consumer International and SPD segments, partially offset by slightly decreased sales volumes in the
Consumer Domestic segment. Changes in foreign exchange rates and acquisitions also contributed to
2021 sales growth.
• Gross margin decreased 160 basis points to 43.6% in 2021 from 45.2% in 2020, primarily due to higher
manufacturing costs including labor, raw materials and components, as well as higher transportation
costs, and higher tariffs, partially offset by favorable volumes/price/product mix, the impact of
productivity programs, and business acquisition benefits.
• Operating margin decreased 20 basis points to 20.8% in 2021 from 21.0% in 2020, reflecting a lower
gross margin percentage, partially offset by lower marketing costs and selling general and
administrative costs as a percentage of sales (including the higher favorable impact of the Flawless
business acquisition liability adjustments.)
• We reported diluted net earnings per share in 2021 of $3.32, an increase of approximately 6.4% from
2020 diluted net earnings per share of $3.12.
• Cash provided by operations was $993.8 in 2021, a $3.5 increase from the prior year, as higher cash
earnings (net income adjusted for non-cash items) were partially offset by higher working capital.
• We returned $747.5 in 2021 to our stockholders through dividends and share repurchases.
37
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Strategic Goals, Challenges and Initiatives
Our ability to generate sales depends on consumer demand for our products and retail customers’ decisions
to carry our products, which are, in part, affected by general economic conditions in our markets. While a vast
majority of our products are consumer staples and less vulnerable to decreases in discretionary spending than
other products, an increasing number of our products, particularly those from our recent acquisitions, are more
likely to be affected by consumer decisions to control spending. Some customers have responded to economic
conditions by increasing their private label offerings (primarily in the dietary supplements, diagnostic kits and
oral analgesics categories), launching their own brands, and consolidating the product selections they offer to the
top few leading brands in each category. In addition, an increasing portion of our product categories are being
sold by club stores, dollar stores, mass merchandisers and internet-based retailers. These factors have placed
downward pressure on our sales and gross margins.
We intend to continue to aggressively pursue several key strategic initiatives: maintain competitive
marketing and trade spending, tightly control our cost structure, continue to develop and launch new and
differentiated products, and pursue strategic acquisitions. We also intend to continue to grow our product sales
globally and maintain an offering of premium and value brand products to appeal to a wide range of consumers.
We derive a substantial percentage of our revenues from sales of liquid laundry detergent. As a result, any
delays or reduction of sales of these products, in the event that our product category diversification efforts
discussed below are not successful, could have a material adverse effect on our business, financial condition and
operating results and cash flows. Condom usage has declined over the last decade. However, after a large decline
in condom sales during 2020 due to social distancing, the condom category began to recover in 2021 with fewer
social restrictions leading to an increase in sexual activity. However, there is no assurance the category will not
decline in the future and that we will be able to offset any such decline.
We are continuously focused on strengthening our key brands through the launch of innovative new
products, which span various product categories, including premium and value household products supported by
increased marketing and trade spending. There can be no assurance that these measures will be successful.
In the domestic business, six out of 13 “power brands” met or exceeded category growth for the full year
2021. With the acquisition of THERABREATH, we now have 14 “power brands”. Our global product portfolio
consists of both premium (60% of total worldwide consumer revenue in 2021) and value (40% of total worldwide
consumer revenue in 2021) brands, which we believe enables us to succeed in a range of economic environments.
We intend to continue to develop a portfolio of appealing new products to build loyalty among cost-conscious
consumers.
Over the past two decades, we have diversified from an almost exclusively U.S. business to a global
company with approximately 18% of sales derived from countries outside of the United States in 2021. We have
subsidiary operations in seven countries (Canada, Mexico, U.K., France, Germany, China and Australia) and sell
into over 130 other countries. In 2021, we benefited from our expanded global footprint and expect to continue to
focus on selectively expanding our global business. If we are unable to expand our business internationally at the
rate that we expect, we may not realize our anticipated growth targets.
Although we believe ongoing international expansion represents a significant opportunity to grow our
business, our increasing activity in global markets exposes us to additional complexity and uncertainty. Sales
generated outside of the U.S. are exposed to foreign currency exchange rate fluctuations as well as political
uncertainty which could impact future operating results. Moreover, the current domestic and international
political environment, including existing and potential changes to U.S. policies related to global trade and tariffs,
have resulted in uncertainty regarding the global economy. The impact of U.S. tariffs on certain products was a
38
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
component of increased cost of sale during the year ended December 31, 2021. The implementation of more
restrictive trade policies, such as higher tariffs or new barriers to entry, in countries in which we manufacture or
sell large quantities of products could negatively impact our business, cash flows, results of operations and
financial condition.
We also continue to focus on controlling our costs. Historically, we have been able to mitigate the effects of
cost increases primarily by implementing cost reduction programs and, to a lesser extent, by passing along cost
increases to customers. We have also entered into set pricing and pre-buying arrangements with certain suppliers
and hedge agreements for diesel fuel and other commodities. Additionally, our focus on tight cost controls has
enabled us to effectively navigate recent challenging economic conditions. In 2021, due to the significant
increase in input costs, we have not been able to fully mitigate the impact of these increases with cost control
measures and productivity programs. We have, and will continue to, implement price increases to address cost
inflation. However, we cannot be certain that these price increases will be accepted by customers.
The identification and integration of strategic acquisitions are an important component of our overall
strategy and product category diversification. Acquisitions have added significantly to our sales and profits and
product category diversification over the last decade. This is evidenced by our 2015 acquisition of certain assets
of Varied Industries Corporation (the “Vi-cor Acquisition”), the 2016 acquisitions of Spencer Forrest, Inc., the
maker of TOPPIK (the “Toppik Acquisition”), and the ANUSOL and RECTINOL businesses from Johnson &
Johnson (the “Anusol Acquisition”), the 2017 acquisitions of VIVISCAL from Lifes2Good Holdings Limited
(the “Viviscal Acquisition”), Agro BioSciences, Inc. (the “Agro Acquisition”), and WATERPIK from Pik
Holdings, Inc. (the “Waterpik Acquisition”), the 2018 acquisition of Passport Food Safety Solutions, Inc. (the
“Passport Acquisition”), the 2019 acquisition of FLAWLESS; the 2020 acquisition of ZICAM from Consumer
Health Holdco LLC and the 2021 acquisition of THERABREATH from Dr. Harold Katz, LLC and HK-IP
International, Inc. The failure to effectively identify or integrate any acquisition or achieve expected synergies
may cause us to incur material asset write-downs. We actively seek acquisitions that fit our guidelines, and our
strong financial position provides us with flexibility to take advantage of acquisition opportunities. In addition,
our ability to quickly integrate acquisitions and leverage existing infrastructure has enabled us to establish a
strong track record in making accretive acquisitions. Since 2001, we have acquired 13 of our 14 “power brands”.
We believe we are positioned to meet the ongoing challenges described above due to our strong financial
condition, experience operating in challenging environments and continued focus on key strategic initiatives. Our
focus is to maintain competitive marketing and trade spending, manage our cost structure, continue to develop
and launch new and differentiated products, while pursuing strategic acquisitions. This focus, together with the
strength of our portfolio of premium and value brands, has enabled us to succeed in a range of economic
environments. Moreover, the generation of a significant amount of cash from operations combined with an
investment grade credit rating, provides us with the financial flexibility to pursue acquisitions, drive new product
development, make capital expenditures to support organic growth and gross margin improvements, return cash
to stockholders through dividends and share buy backs, and reduce outstanding debt. These factors position us to
continue to increase stockholder value over the long-term.
For information regarding risks and uncertainties that could materially adversely affect our business, results
of operations and financial condition and cash flows, see “Risk Factors” in Item 1A of this Annual Report.
Recent Developments
TheraBreath Acquisition
On December 24, 2021, we acquired all of the outstanding equity of Dr. Harold Katz, LLC and HK-IP
International, Inc., the owners of the THERABREATH brand of oral care products business (the “TheraBreath
39
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Acquisition”). We paid $556.0, net of cash acquired, at closing and deferred an additional cash payment of $14.0
related to certain indemnity obligations provided by the seller. The additional amount, to the extent not used in
satisfaction of such indemnity obligations, is payable in installments between two and four years from the
closing. THERABREATH’s annual net sales for the year ended December 31, 2021 were approximately $100.
The acquisition was financed by the proceeds from a $400.0 three-year term loan and an underwritten public
offering of $400.0 aggregate principal Senior Notes due on December 15, 2031 (as defined below) completed on
December 10, 2021. The THERABREATH business is managed in the Consumer Domestic and Consumer
International segments.
Dividend Increase
On January 28, 2022, the Board declared a 4% increase in the regular quarterly dividend from $0.2525 to
$0.2625 per share, equivalent to an annual dividend of $1.05 per share payable to stockholders of record as of
February 15, 2022. The increase raises the annual dividend payout from $248.0 to approximately $255.0.
Accelerated Share Repurchase Program
In December 2021, we entered into an ASR contract with a commercial bank to purchase Common
Stock. We paid $200.0 to the bank, inclusive of fees, and received an initial delivery of shares equal to $180.0, or
1.8 million shares. We used cash on hand and short-term borrowings to fund the initial purchase price. Upon the
completion of the ASR, which ended in February 2022, the bank delivered an additional 0.2 million shares to us.
The final shares delivered to us were determined by the average price per share paid by the bank during the
purchase period. All 2.0 million shares were purchased under the 2021 Share Repurchase Program.
As a result of our recent stock repurchases, there remains $729.7 of share repurchase availability under the
2021 Share Repurchase Program as of December 31, 2021.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our Consolidated Financial Statements have been prepared in accordance with accounting principles
generally accepted in the U.S. (GAAP). The preparation of these financial statements requires management to
make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and
related disclosure of contingent assets and liabilities. By their nature, these judgments are subject to uncertainty.
They are based on our historical experience, our observation of trends in industry, information provided by our
customers and information available from other outside sources, as appropriate. Our significant accounting
policies and estimates are described below.
Revenue Recognition and Promotional and Sales Return Reserves
Virtually all of our revenue represents sales of finished goods inventory and is recognized when received or
picked up by our customers. The reserves for consumer and trade promotion liabilities and sales returns are
established based on our best estimate of the amounts necessary to settle future and existing claims on products
sold as of the balance sheet date. Promotional reserves are provided for sales incentives, such as coupons to
consumers, and sales incentives provided to customers (such as slotting, cooperative advertising, incentive
discounts based on volume of sales and other arrangements made directly with customers). All such costs are
netted against sales. Slotting costs are recorded when the product is delivered to the customer. Cooperative
advertising costs are recorded when the customer places the advertisement for our products. Discounts relating to
price reduction arrangements and coupons are recorded when the related sale takes place. Costs associated with
end-aisle or other in-store displays are recorded when product that is subject to the promotion is sold. We rely on
40
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
historical experience and forecasted data to determine the required reserves. For example, we use historical
experience to project coupon redemption rates to determine reserve requirements. Based on the total face value
of Consumer Domestic coupons redeemed over the past several years, if the actual rate of redemptions were to
deviate by 0.1% from the rate for which reserves are accrued in the financial statements, a difference of
approximately $0.1 in the reserve required for coupons would result. With regard to other promotional reserves
and sales returns, we use experience-based estimates, customer and sales organization inputs and historical trend
analysis in arriving at the reserves required. If our estimates for promotional activities and sales returns reserves
were to change by 10% the impact to promotional spending and sales return accruals would be approximately
$11.3. While management believes that its promotional and sales returns reserves are reasonable and that
appropriate judgments have been made, estimated amounts could differ materially from actual future obligations.
Impairment of goodwill, trade names and other intangible assets
Carrying values of goodwill and indefinite-lived trade names are reviewed periodically for possible
impairment. Finite intangible assets are assessed when there are business triggering events. Our impairment
analysis is based on a discounted cash flow approach that requires significant judgment with respect to unit
volume, revenue and expense growth rates, and the selection of an appropriate discount rate and royalty rate.
Management uses estimates based on expected trends in making these assumptions. With respect to goodwill,
impairment occurs when the carrying value of the reporting unit exceeds the discounted present value of cash
flows for that reporting unit. For trade names and other intangible assets, an impairment charge is recorded for
the difference between the carrying value and the net present value of estimated future cash flows, which
represents the estimated fair value of the asset. Judgment is required in assessing whether assets may have
become impaired between annual valuations. Indicators such as unexpected adverse economic factors,
unanticipated technological change, distribution losses, or competitive activities and acts by governments and
courts may indicate that an asset has become impaired. The result of our annual goodwill impairment test
determined that the estimated fair value substantially exceeded the carrying values of all reporting units. In
addition, there were no goodwill impairment charges for each of the years in the three-year period ended
December 31, 2021.
Fair value for indefinite lived intangible assets was estimated based on a “relief from royalty” or “excess
earnings” discounted cash flow method, which contains numerous variables that are subject to change as business
conditions change, and therefore could impact fair values in the future. We determined that the fair value of all
intangible assets for each of the years in the three-year period ended December 31, 2021 exceeded their
respective carrying values based upon the forecasted cash flows and profitability. However, in recent years our
TROJAN business, specifically the condom category, has not grown and competition has increased resulting in a
reduction in expected future cash flows. In addition, the COVID-19 pandemic has further negatively impacted
condom sales due to social distancing. As a result, the TROJAN business has experienced sales and profit
declines that has eroded a significant portion of the excess between the fair and carrying value of the tradename,
which, if these trends continue, could potentially result in an impairment. However, the condom category began
to recover in 2021 as fewer social restrictions led to an increase in sexual activity with less shutdowns and
governmental restrictions. While management can and has implemented strategies to address the risk, significant
changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to
estimate fair values and could result in a decline in fair value that could trigger future impairment charges of
these assets.
It is possible that our conclusions regarding impairment or recoverability of goodwill or other intangible
assets could change in future periods if, for example, (i) the businesses or brands do not perform as projected,
(ii) overall economic conditions in future years vary from current assumptions (including changes in discount
rates), (iii) business conditions or strategies change from current assumptions, (iv) investors require higher rates
41
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded
companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of
revenues and EBITDA. A future impairment charge for goodwill or intangible assets could have a material effect
on our consolidated financial position or results of operations.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are
recognized to reflect the future tax consequences attributable to the differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit
carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which the differences are expected to be recovered or settled. Management
provides a valuation allowance against deferred tax assets for amounts which are not considered “more likely
than not” to be realized. We record liabilities for potential assessments in various tax jurisdictions under U.S.
GAAP guidelines. The liabilities relate to tax return positions that, although supportable by us, may be
challenged by the tax authorities and do not meet the minimum recognition threshold required under applicable
accounting guidance for the related tax benefit to be recognized in the income statement. We adjust this liability
as a result of changes in tax legislation, interpretations of laws by courts, rulings by tax authorities, changes in
estimates and the expiration of the statute of limitations. Many of the judgments involved in adjusting the
liability involve assumptions and estimates that are highly uncertain and subject to change. In this regard,
settlement of any issue, or an adverse determination in litigation, with a taxing authority could require the use of
cash and result in an increase in our annual tax rate. Conversely, favorable resolution of an issue with a taxing
authority would be recognized as a reduction to our annual tax rate.
New Accounting Pronouncements
Refer to Note 1 to the Consolidated Financial Statements included in this Annual Report for recently
adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of
December 31, 2021.
RESULTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2021, 2020 AND 2019
The discussion of results of operations at the consolidated level presented below is followed by a more
detailed discussion of results of operations by segment. This section of this Form 10-K generally discusses 2021
and 2020 results and year-to-year comparisons between 2021 and 2020. Discussions of 2019 items and
year-to-year comparisons between 2020 and 2019 that are not included in this Form 10-K can be found in
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of
our Annual Report on Form 10-K for the year ended December 31, 2020. The segment discussion also addresses
certain product line information. Our operating segments are consistent with our reportable segments.
42
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Consolidated results
2021 compared to 2020
Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross Profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross Margin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Marketing Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Percent of Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, General & Administrative Expenses . . . . . . . . . . . .
Percent of Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating Margin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share—Diluted . . . . . . . . . . . . . . . . . . . . . . . .
Net Sales
Twelve Months
Ended
December 31,
2021
$5,190.1
$2,263.5
Change vs.
Prior Year
6.0%
2.2%
43.6% -160 basis points
$ 577.7
-2.3%
11.1% -100 basis points
$ 606.7
2.3%
11.7% -40 basis points
$1,079.1
4.8%
20.8% -20 basis points
3.32
6.4%
$
Twelve Months
Ended
December 31,
2020
$4,895.8
$2,214.2
45.2%
$ 591.2
12.1%
$ 593.3
12.1%
$1,029.7
21.0%
3.12
$
Net sales for the year ended December 31, 2021 were $5,190.1, an increase of $294.3, or 6.0% compared to
2020 net sales. The components of the net sales increase are as follows:
Net Sales—Consolidated
Product volumes sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pricing/Product mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign exchange rate fluctuations / Other
Volume from acquired product lines (net of divestiture) (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net Sales increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 31,
2021
1.0%
3.3%
0.9%
0.8%
6.0%
(1) On December 24, 2021, we acquired all of the outstanding equity of Dr. Harold Katz, LLC and HK-IP
International, Inc., the owners of the THERABREATH brand of oral care products (the “TheraBreath
Acquisition”). On December 1, 2020, we acquired all of the outstanding equity of Consumer Health Holdco
LLC, the owner of the ZICAM brand and cold remedy products business (the “Zicam Acquisition”). The
results of these acquisitions are included in our results since the date of acquisition.
The volume change reflects increased product sales in the Consumer International and SPD segments,
partially offset by slightly decreased sales in the Consumer Domestic segment. Price/mix was favorable in the
Consumer Domestic and SPD segments, but was partially offset by slightly unfavorable price/mix in the
Consumer International segment.
Our gross profit for 2021 was $2,263.5, a $49.3 increase compared to 2020. Gross margin was 43.6% in
2021 compared to 45.2% in 2020, a 160 basis points (“bps”) decrease. The decrease is due to the impact of
higher manufacturing costs including labor and commodities of 400 bps, higher transportation costs of 80 bps,
and higher costs of 30 bps as a result of incremental tariffs, partially offset by favorable price/volume/mix of 200
bps, the impact of productivity programs of 130 bps and business acquisition benefits of 20 bps.
43
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Operating Costs
Marketing expenses for 2021 were $577.7, a decrease of $13.5 compared to 2020. We reduced marketing
spending, mainly in household products, as supply shortages impacted our ability to meet customer demand.
Marketing expenses as a percentage of net sales decreased 100 bps to 11.1% in 2021 as compared to 2020 due to
70 bps of leverage on higher net sales and 30 bps on lower expenses.
SG&A expenses for 2021 were $606.7, an increase of $13.4 or 2.3% compared to 2020. The increase is
primarily due to higher expenses related to the Zicam Acquisition (including amortization), asset impairment
charges of $11.3 associated with the Passport business acquired in 2018, and the prior year gain on the sale of
PERL WEISS®, partially offset by lower incentive compensation and litigation costs. SG&A as a percentage of
net sales decreased 40 bps to 11.7% in 2021 compared to 12.1% in 2020. The decrease is due to 70 bps
of leverage associated with higher sales offset by 30 bps on higher expenses. The favorable adjustment to the fair
value of the Flawless business acquisition liability, which is recognized as a reduction in expense, was $98.0 in
2021 compared to $94.0 in 2020.
Other Income and Expenses
Other expense increased nominally in 2021 as compared to 2020.
Interest expense in 2021 was $54.5, a decrease of $6.5. The decrease is primarily due to lower interest rates.
Taxation
The 2021 U.S. federal effective income tax rate was 19.8% compared to 19.3% in 2020. The increase of 50
basis points was impacted by a favorable tax settlement in 2020.
Segment results for 2021, 2020 and 2019
We operate three reportable segments: Consumer Domestic, Consumer International and SPD. These
segments are determined based on differences in the nature of products and organizational and ownership
structures. We also have a Corporate segment.
Segment
Products
Consumer Domestic
Household and personal care products
Consumer International
Primarily personal care products
SPD
Specialty chemical products
The Corporate segment income consists of equity in earnings of affiliates. As of December 31, 2021, we
held 50% ownership interests in each of Armand and ArmaKleen, respectively. Our equity in earnings of
Armand and ArmaKleen, totaling $9.4, $6.7 and $6.6 for the three years ended December 31, 2021, 2020 and
2019, respectively, are included in the Corporate segment.
Some of the subsidiaries that are included in the Consumer International segment manufacture and sell
personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer
International segment results set forth below.
44
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Segment net sales and income before income taxes for each of the three years ended December 31, 2021,
2020 and 2019 were as follows:
Consumer
Domestic
Consumer
International
SPD
Corporate(3)
Total
Net Sales(1)
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income before Income Taxes(2)
2021(4)
2020(5)
2019(6)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$3,941.9
3,767.6
3,302.6
$ 861.4
832.4
645.8
$912.2
828.2
756.3
$127.3
105.0
74.0
$336.0
300.0
298.8
$ 33.6
29.7
47.3
$0.0
0.0
0.0
$9.4
6.7
6.6
$5,190.1
4,895.8
4,357.7
$1,031.7
973.8
773.7
(1)
(2)
Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table,
were $10.8, $11.7 and $10.5 for the years ended December 31, 2021, 2020 and 2019, respectively.
In determining income before income taxes, interest expense, investment earnings and certain aspects of
other income and expense were allocated among segments based upon each segment’s relative income from
operations.
(3) Corporate segment consists of equity in earnings of affiliates from Armand and ArmaKleen in 2021, 2020
and 2019.
(4) 2021 results include a $98.0 reduction in SG&A expenses to reduce the Flawless business acquisition
liability, of which $83.2 was recorded to Consumer Domestic and $14.8 was recorded to Consumer
International.
(5) 2020 results include a $94.0 reduction of SG&A expenses to reduce the Flawless business acquisition
liability, of which $79.9 was recorded to Consumer Domestic and $14.1 was recorded to Consumer
International. During 2020, we sold our PERL WEISS toothpaste brand in Germany resulting in a reduction
in SG&A expenses of $3.0 recorded in Consumer International.
(6) 2019 results include an SG&A charge associated with selling our consumer business in Brazil of $7.6
recorded in Consumer International and a $10.0 SG&A charge to adjust the Flawless business acquisition
liability, of which $8.5 was recorded to Consumer Domestic and $1.5 was recorded to Consumer
International. These charges were partially offset by a $7.3 adjustment to the Passport business acquisition
liability and a $1.5 adjustment to the Agro business acquisition liability, both of which reduced SG&A
expenses in SPD.
Product line revenues for external customers for the years ended December 31, 2021, 2020 and 2019 were
as follows:
Household Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Personal Care Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$2,103.0
1,838.9
$2,038.5
1,729.1
$1,821.7
1,480.9
Total Consumer Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Consumer International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total SPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3,941.9
912.2
336.0
3,767.6
828.2
300.0
3,302.6
756.3
298.8
Total Consolidated Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$5,190.1
$4,895.8
$4,357.7
2021
2020
2019
Household Products include deodorizing, cleaning and laundry products. Personal Care Products include
condoms, pregnancy kits, oral care products, skin care products, hair care products and gummy dietary
supplements.
45
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Consumer Domestic
2021 compared to 2020
Consumer Domestic net sales in 2021 were $3,941.9, an increase of $174.3 or 4.6% compared to net sales of
$3,767.6 in 2020. The components of the net sales change are the following:
Net Sales—Consumer Domestic
Product volumes sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pricing/Product mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquired product lines (1)
Net Sales increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 31,
2021
(0.3%)
3.9%
1.0%
4.6%
(1)
Includes the TheraBreath and Zicam Acquisitions since the date of acquisition.
The increase in net sales for 2021 reflects the impact of the TheraBreath and Zicam Acquisitions, higher net
sales in ARM & HAMMER clumping cat litter, WATERPIK oral care products, VITAFUSION and L’IL
CRITTERS gummy vitamins, BATISTE dry shampoo, ARM & HAMMER scent booster, and OXICLEAN
powder.
In recent years our TROJAN business, specifically the condom category, had not grown and competition has
increased. Social distancing requirements due to the COVID-19 pandemic had further negatively impacted the
business. As a result, the TROJAN business had experienced stagnant sales and profits resulting in a reduction in
expected future cash flows which eroded a portion of the excess between the fair and carrying value of the
tradename. This indefinite-lived intangible asset may be susceptible to impairment risk and a continued decline
in fair value could trigger a future impairment charge of the TROJAN tradename. While management can and
has implemented strategies to address the risk, including lowering our production costs, investing in new product
ideas, and developing new creative advertising, significant changes in operating plans or adverse changes in the
future could reduce the underlying cash flows used to estimate fair value. In 2021, TROJAN experienced a
recovery in sales and profits as it is benefiting from an easing of COVID-19 social restrictions leading to an
increase in sexual activity. We expect this trend will continue into next year with the continued adoption of
vaccines, the reduction of social distancing restrictions and the benefit of management strategies to improve sales
and profitability.
Consumer Domestic income before income taxes for 2021 was $861.4, a $29.0 increase as compared to
2020. The increase is due primarily to favorable price/mix of $135.6, a $31.0 benefit from higher sales volumes,
lower marketing expenses of $18.6, lower SG&A expenses of $10.3 (including a $3.3 favorable year-over-year
fair value adjustment to the Flawless business acquisition liability), and lower interest and other expenses of
$5.8, mostly offset by unfavorable manufacturing and distribution expenses of $171.9.
46
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Consumer International
2021 compared to 2020
Consumer International net sales in 2021 were $912.2, an increase of $84.0 or 10.1% as compared to 2020.
The components of the net sales change are the following:
Net Sales—Consumer International
Product volumes sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pricing/Product mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign exchange rate fluctuations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net Sales increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
December 31,
2021
5.3%
(0.3%)
5.1%
10.1%
Excluding the impact of foreign exchange rates, higher sales were driven primarily by FEMFRESH®
feminine hygiene products, VITAFUSION and L’IL CRITTERS gummy vitamins, STERIMAR nasal spray, and
NAIR depilatories in the GMG business.
Consumer International income before income taxes was $127.3 in 2021, an increase of $22.3 compared to
2020 due to a $26.4 benefit from higher sales volumes, favorable foreign exchange rates of $8.8, lower marketing
expenses of $1.9 and lower interest expense of $0.2, offset by unfavorable manufacturing and commodity costs
of $11.4, higher SG&A costs of $2.4 (partially due to the prior year gain on the sale of PERL WEISS of $3.0),
and unfavorable price/product mix of $1.2.
Specialty Products
2021 compared to 2020
SPD net sales were $336.0 for 2021, an increase of $36.0, or 12.0% compared to 2020. The components of
the net sales change are the following:
Net Sales—SPD
December 31,
2021
Product volumes sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pricing/Product mix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.6%
7.4%
Net Sales increase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12.0%
Net sales increased due to higher volumes across all categories, higher pricing for our dairy segment
products and reduced competitive imports due to a constrained transportation market.
SPD income before income taxes was $33.6 in 2021, an increase of $3.9 compared to 2020. The increase in
income before income taxes for 2021 is due primarily to favorable price/product mix of $22.4 and a $3.8 benefit
from higher sales volumes, which were partially offset by unfavorable manufacturing costs of $17.6, higher
SG&A costs of $4.0 primarily due to asset impairments in the Passport business of $11.3, and higher marketing
expenses of $0.8.
Corporate
Corporate includes administrative costs of the production, planning and logistics functions which are
allocated to the operating segments in SG&A expenses but are elements of cost of sales in our Consolidated
Statements of Income. Such amounts were $47.1, $59.8 and $48.2 for 2021, 2020 and 2019, respectively.
47
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
Also included in corporate are the equity in earnings of affiliates from Armand and ArmaKleen, totaling
$9.4, $6.7 and $6.6 for the three years ended December 31, 2021, 2020 and 2019, respectively.
Liquidity and Capital Resources
On May 1, 2019, we amended the credit agreement (the “Credit Agreement”) that provides for our $1,000.0
unsecured revolving credit facility (the “Revolving Credit Facility”) to extend the term of the Revolving Credit
Facility from March 29, 2023 to March 29, 2024. We continue to have the ability to increase our borrowing up to
an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement.
Borrowings under the Credit Agreement are available for general corporate purposes.
As of December 31, 2021, we had $240.6 in cash and cash equivalents, and approximately $746.0 available
through the revolving facility under our Credit Agreement and our commercial paper program. To preserve our
liquidity, we invest cash primarily in government money market funds, prime money market funds, short-term
commercial paper and short-term bank deposits.
On December 22, 2021, we entered into a $400.0 unsecured term loan facility with various banks. The loan
was fully drawn at closing. Unless prepaid, the loan is due on December 22, 2024. The interest rate is LIBOR
plus an applicable margin based on our credit rating, which can range from 60 basis points (“bps”) to 125 bps.
The proceeds of the loan were used to partially fund the TheraBreath Acquisition, with the remaining proceeds
used for the repayment of commercial paper.
Additionally, we financed the TheraBreath Acquisition with a portion of the proceeds from an underwritten
public offering of $400.0 aggregate principal amount Senior Notes due 2031 (the “2031 Notes”). These Notes
bear interest at 2.3% and were issued in an underwritten transaction under an indenture with Deutsche Bank
Trust Company Americas, as trustee. Interest on the 2031 Notes is payable semi-annually, on each June 15 and
December 15. The 2031 Notes will mature on December 15, 2031, unless earlier retired or redeemed.
We financed the Waterpik Acquisition with a portion of the proceeds from an underwritten public offering
of $1,425.0 aggregate principal amount of Senior Notes completed on July 25, 2017, consisting of $300.0
aggregate principal amount of Floating Rate Senior Notes that were due in 2019 and have been fully repaid,
$300.0 aggregate principal amount of 2.45% Senior Notes due 2022, $425.0 aggregate principal amount of
3.15% Senior Notes due 2027 and $400.0 aggregate principal amount of 3.95% Senior Notes due 2047
(collectively with the 2031 Notes, the “Senior Notes”). The $300.0 Floating Rate Senior Notes, which matured
and were repaid in full with cash on hand and commercial paper on January 25, 2019, bore interest at a rate, reset
quarterly, equal to three-month LIBOR plus 0.15%.
On September 26, 2012, we issued $400.0 aggregate principal amount of 2.875% Senior Notes due 2022
(the “2022 Notes”). The 2022 Notes were issued under the second supplemental indenture, dated September 26,
2012 (the “BNY Mellon Second Supplemental Indenture”) to the indenture dated December 15, 2010 (the “BNY
Mellon Base Indenture”) between us and The Bank of New York Mellon Trust Company, N.A., as trustee. These
Notes will mature on October 1, 2022, unless earlier retired or redeemed pursuant to the terms of the BNY
Mellon Second Supplemental Indenture.
In 2021, we repaid the $300.0 term loan due May 1, 2022 that was used to partially fund the Flawless
acquisition in 2019, with proceeds from commercial paper borrowings and cash on hand.
In 2015, we initiated a Supply Chain Finance program (“SCF Program”). Under the SCF Program,
qualifying suppliers may elect to sell their receivables from us for early payment. Participating suppliers
48
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
negotiate their receivables sales arrangements directly with a third party. We are not party to those agreements
and do not have an economic interest in the supplier’s decision to sell their receivables. The SCF Program may
allow suppliers more favorable terms than they could secure on their own. The terms of our payment obligations
are not impacted by a supplier’s participation in the SCF Program. Our payment terms with suppliers are
consistent between suppliers that elect to participate in the SCF Program and those that do not participate. As a
result, the program does not have an impact to our average days outstanding.
All amounts outstanding to suppliers participating in the SCF Program are recorded within Accounts
Payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities
within our Consolidated Statements of Cash Flows.
The current economic environment presents risks that could have adverse consequences for our liquidity.
See the discussion of this and other risks under “Risk Factors” in Item 1A of this Annual Report. Although there
is uncertainty related to the impact of the COVID-19 pandemic on our future results, we believe our efficient
business model and strong balance sheet position us to manage our business through this crisis. We continue to
manage all aspects of our business including, but not limited to, monitoring the financial health of our customers,
suppliers and other third-party relationships, implementing gross margin enhancement strategies and developing
new opportunities for growth. We do not anticipate that current economic conditions will adversely affect our
ability to comply with the financial covenant in the Credit Agreement because we currently are, and anticipate
that we will continue to be, in compliance with the maximum leverage ratio requirement under the Credit
Agreement.
In December 2020, we entered into an accelerated share repurchase (“ASR”) contract with a commercial
bank to purchase Common Stock. We paid $300.0 to the bank, inclusive of fees, and received an initial delivery
of shares equal to $270.0, or 3.1 million shares. We used cash on hand and short-term borrowings to fund the
initial purchase price. Upon the completion of the ASR, which ended in February 2021, the bank delivered to us
an additional 0.4 million shares. The final shares delivered to us were determined by the average price per share
paid by the bank during the purchase period. All 3.5 million shares were purchased under our evergreen program.
In August 2021, we executed an agreement to purchase up to $200.0 of our Common Stock through
October 31, 2021. We purchased 1.6 million shares for approximately $130.0 through October, inclusive of fees,
all of which was purchased under the 2017 Share Repurchase Program.
On October 28, 2021, the Board authorized a new share repurchase program under which we may purchase
up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase
Program does not have an expiration and replaces our 2017 Share Repurchase Program. All remaining dollars
authorized for repurchase under the 2017 Share Repurchase Plan have been cancelled. The 2021 Share
Repurchase Program does not modify our evergreen share repurchase program, authorized by the Board on
January 29, 2014, under which we may repurchase, from time to time, Common Stock to reduce or eliminate
dilution associated with issuances of Common Stock under our incentive plans.
In December 2021, we executed open market purchases of 1.8 million shares for $170.3, inclusive of fees,
of which $100.0 was purchased under the evergreen share repurchase program and $70.3 was purchased under
the 2021 Share Repurchase Program. In December 2021, we also entered into an ASR contract with a
commercial bank to purchase Common Stock. We paid $200.0 to the bank, inclusive of fees, and received an
initial delivery of shares equal to $180.0, or 1.8 million shares. We used cash on hand and short-term borrowings
to fund the initial purchase price. Upon the completion of the ASR, which ended in February 2022, the bank
delivered an additional 0.2 million shares to us. The final shares delivered to us were determined by the average
price per share paid by the bank during the purchase period. All 2.0 million shares were purchased under our
2021 Share Repurchase Program.
49
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
As a result of our recent stock repurchases, there remains $729.7 of share repurchase availability under the
2021 Share Repurchase Program as of December 31, 2021.
On January 28, 2022, the Board declared a 4% increase in the regular quarterly dividend from $0.2525 to
$0.2625 per share, equivalent to an annual dividend of $1.05 per share payable to stockholders of record as of
February 15, 2022. The increase raises the annual dividend payout from $248.0 to approximately $255.0.
We anticipate that our cash from operations, together with our current borrowing capacity, will be sufficient
to fund our share repurchase programs to the extent implemented by management, pay debt and interest as it
comes due and pay dividends at the latest approved rate, and meet our capital expenditure program costs, which
are expected to be approximately $216.0 in 2022 primarily for manufacturing capacity investments in laundry,
litter and vitamins to support expected future sales growth. Cash, together with our current borrowing capacity,
may be used for acquisitions that would complement our existing product lines or geographic markets.
Cash Flow Analysis
Year Ended
December 31,
2021
December 31,
2020
December 31,
2019
Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash used in financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 993.8
$(682.0)
$(252.1)
$ 990.3
$(608.1)
$(360.1)
$ 864.5
$(553.5)
$(472.9)
2021 compared to 2020
Net Cash Provided by Operating Activities – Our primary source of liquidity is our cash flow provided by
operating activities, which is dependent on the level of net income and changes in working capital. Our net cash
provided by operating activities in 2021 increased by $3.5 to $993.8 as compared to $990.3 in 2020 as higher
cash earnings (net income adjusted for non-cash items) were mostly offset by higher working capital. The
increase in working capital is primarily related to lower obligations for incentive compensation and marketing.
We measure working capital effectiveness based on our cash conversion cycle. The following table presents our
cash conversion cycle information for the quarters ended December 31, 2021 and 2020:
Days of sales outstanding in accounts receivable (“DSO”)
. . . . . . . . . . . . . .
Days of inventory outstanding (“DIO”) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Days of accounts payable outstanding (“DPO”) . . . . . . . . . . . . . . . . . . . . . . .
Cash conversion cycle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
28
64
78
14
28
62
72
18
As of
December 31,
2021
December 31,
2020
Change
—
2
(6)
(4)
Our cash conversion cycle (defined as the sum of DSO plus DIO less DPO) at December 31, 2021, which is
calculated using a two period average method, decreased 4 days from the prior year due to an increase in DPO of
6 days due to payable term extensions partially offset by an increase in DIO of 2 days. We continue to focus on
reducing our working capital requirements.
Net Cash Used in Investing Activities – Net cash used in investing activities during 2021 was $682.0,
primarily reflecting $556.0 for the TheraBreath Acquisition and $118.8 for property, plant and equipment
50
CHURCH & DWIGHT CO., INC AND SUBSIDIARIES
(Dollars in millions, except share and per share data)
additions. Net cash used in investing activities during 2020 was $608.1, primarily reflecting $512.7 for the Zicam
Acquisition, $98.9 for property, plant and equipment additions, partially offset by cash proceeds of $7.0 from the
sale of the PERL WEISS toothpaste brand in Germany.
Net Cash Used in Financing Activities – Net cash used in financing activities during the twelve months of
2021 was $252.1, reflecting $500.0 of repurchases of our Common Stock, $247.5 of cash dividend payments and
$3.9 of financing costs, partially offset by $400.7 of net debt borrowings, and $98.7 of proceeds from stock
option exercises. Net cash used in financing activities during the twelve months of 2020 was $360.1, reflecting
$300.0 of repurchases of our Common Stock, $237.3 of cash dividend payments, and $14.5 for the Agro business
acquisition liability settlement, partially offset by $99.0 of short-term debt borrowings, net of repayments, and
$93.0 of proceeds from stock option exercises.
OTHER ITEMS
Market risk
Concentration of Risk
A group of three customers accounted for approximately 37% of consolidated net sales in 2021 and 36% in
2020 and 2019, respectively, of which a single customer, Walmart, accounted for approximately 24%, 23% and
24% in 2021, 2020 and 2019, respectively.
Interest Rate Risk
We had outstanding total debt at December 31, 2021, of $2,562.9, net of debt issuance costs, of which
approximately 75% has a fixed weighted average interest rate of 3.0% and the remaining 25% was constituted of
commercial paper issued by us that currently has a weighted average interest rate of approximately 0.30% and
the term loan due 2024 with a current rate of approximately 0.80% In 2019, we entered into interest rate swap
lock agreements to hedge the risk of changes in the interest payments attributable to changes in the benchmark
LIBOR interest rate associated with anticipated issuances of debt. The notional amount of the interest rate swap
locks is $300.0. These interest rate swap lock agreements have been designated as hedges of the changes in fair
value of the underlying debt obligation attributable to changes in interest rates and are accounted for as fair value
hedges. The fair value of the interest rate swap lock agreements is $41.6 and is reflected in the Consolidated
Balance Sheet included in this Annual Report within Accounts payable and accrued expenses as it will be settled
in 2022.
Other Market Risks
We are also subject to market risks relating to our diesel and other commodity costs, fluctuations in foreign
currency exchange rates, and changes in the market price of the Common Stock. Refer to Note 3 to the
Consolidated Financial Statements included in this Annual Report for a discussion of these market risks and the
derivatives used to manage the risks associated with changing diesel fuel and other commodity prices, foreign
exchange rates and the price of our Common Stock.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
This information appears under the heading “Market Risk” in the “Management’s Discussion and Analysis”
section. Refer to page 51 of this Annual Report.
51
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management of Church & Dwight Co., Inc. (the “Company”) is responsible for establishing and maintaining
adequate internal control over financial reporting. Internal control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A company’s
internal control over financial reporting includes those policies and procedures that pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the
company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of
financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and
directors of the company; and provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
Management evaluated the Company’s internal control over financial reporting as of December 31, 2021. In
making this assessment, management used the framework established in Internal Control-Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). As a result
of this assessment and based on the criteria in the COSO framework, management has concluded that as of
December 31, 2021, the Company’s internal control over financial reporting was effective.
The Company’s independent registered public accounting firm, Deloitte & Touche LLP, has audited the
Company’s internal control over financial reporting. Their opinions on the effectiveness of the Company’s
internal control over financial reporting and on the Company’s consolidated financial statements and financial
statement schedule appear on pages 53 and 56 of this Annual Report on Form 10-K.
/s/ Matthew T. Farrell
Matthew T. Farrell
President and Chief Executive Officer
/s/
Richard A. Dierker
Richard A. Dierker
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
February 17, 2022
52
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Church & Dwight Co., Inc.
Ewing, New Jersey
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Church & Dwight Co., Inc. and subsidiaries
(the “Company”) as of December 31, 2021 and 2020, the related consolidated statements of income,
comprehensive income, stockholders’ equity, and cash flows, for each of the three years in the period ended
December 31, 2021, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to
as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in
all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of
its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity
with the accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2021,
based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission and our report dated February 17, 2022, expressed an
unqualified opinion on the Company’s internal control over financial reporting.
Change in Accounting Principle
As discussed in Note 1 to the consolidated financial statements, effective January 1, 2019, the Company adopted
the Financial Accounting Standard Board’s new standard related to leases using the optional transition method of
adoption, which permits the Company to continue presenting all periods prior to January 1, 2019 under the
previous lease accounting guidance.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility
is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public
accounting firm registered with the PCAOB and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and
Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free
of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the
risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable
basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current-period audit of the
consolidated financial statements that were communicated or required to be communicated to the audit
53
committee and that (1) relate to accounts or disclosures that are material to the consolidated financial statements
and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical
audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole,
and we are not, by communicating the critical audit matters below, providing separate opinions on the critical
audit matters or on the accounts or disclosures to which they relate.
Tradenames and Other Intangibles, Net – Trojan—Refer to Notes 1 and 7 to the Consolidated Financial
Statements
Critical Audit Matter Description
The Company owns tradenames that are considered to have indefinite lives. These tradenames are required to be
measured periodically for impairment. In recent years the Company’s Trojan business, specifically the condom
category, has not grown and competition has increased resulting in a reduction in expected future cash flows. As
a result, the Trojan business has experienced sales and profit declines that has eroded a portion of the excess
between the fair and carrying value, which could result in an impairment of the asset if such sales and profit
declines continue. The carrying value of the Trojan tradename is $176.4 million and fair value exceeded the
carrying value by 70% as of December 31, 2021.
Management estimates the fair value of this tradename on a periodic basis. The determination of the fair value
requires management to make significant estimates and assumptions related to future performance, such as
revenue growth rates, as well as the selection of appropriate valuation assumptions such as the royalty rate and
discount rate. Changes in these assumptions could have a significant impact on the fair value of the tradename,
leading to an impairment.
Given the significant judgments made by management to estimate the tradename’s fair value, performing audit
procedures to evaluate the reasonableness of management’s estimates and assumptions related to the revenue
growth rates and the selection of the royalty rate and discount rate, involved a high degree of auditor judgment
and an increased extent of effort, including the need to involve our fair value specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the revenue growth rates and selection of the royalty rate and discount rate for the
tradename included the following, among others:
• We tested the effectiveness of controls over the account balance, including those over the revenue
growth rates and the selection of the royalty rate and discount rate.
• We evaluated management’s ability to accurately forecast revenue growth by comparing actual
performance to management’s historical forecasts.
• We evaluated the reasonableness of management’s forecasted revenue growth by comparing the
forecasts to:
– Historical performance.
–
Internal communications to management and the Board of Directors.
– Forecasted information included in analyst and industry reports for the Company and certain of its
peer companies.
• With the assistance of our fair value specialists, we evaluated the reasonableness of the royalty rate and
discount rate by:
– Testing the source information underlying the determination of the royalty rate and discount rate
and the mathematical accuracy of the calculation.
54
– Developing a range of independent estimates and comparing those to the royalty rate and discount
rate selected by management.
Acquisition – TheraBreath Tradename – Refer to Note 6 to the Consolidated Financial Statements
Critical Audit Matter Description
The Company acquired all of the outstanding equity of Dr. Harold Katz, LLC and HK-IP International, Inc., the
owner of the THERABREATH® brand and oral care products business (the “TheraBreath Acquisition”). The
Company paid $556.0, net of cash acquired, and may make an additional cash payment up to $14.0 million
related to certain indemnifications provided by the seller. The Company accounted for the TheraBreath
Acquisition under the acquisition method of accounting for business combinations. Accordingly, the purchase
price was allocated to the assets acquired and liabilities assumed based on their respective fair values, including a
tradename of $487.0 million. Management estimated the fair value of the tradename using a discounted cash flow
method. The fair value determination of the tradename required management to make significant estimates and
assumptions related to future revenue, cash flows and the selection of a discount rate.
Given that the fair value determination of the tradename requires management to make significant estimates and
assumptions related to the forecasts of future revenue and cash flows, and the selection of a discount rate,
performing audit procedures to evaluate the reasonableness of these estimates and assumptions required a high
degree of auditor judgment and an increased extent of effort, including the need to involve our fair value
specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the forecasts of future revenue and cash flows for the valuation of the tradename,
as well as the selection of the associated discount rate, included the following, among others:
• We tested the effectiveness of controls over the valuation of the tradename, including management’s
controls over forecasts of future revenue and cash flows and selection of a discount rate.
• We assessed the reasonableness of management’s forecasts of future revenue and cash flows by
comparing the projections to:
– Historical performance.
–
Internal communications to management and the Board of Directors.
– Forecasted information included in analyst and industry reports for the Company and certain of its
peer companies.
• With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate
by:
– Testing the source information underlying the determination of the discount rate and testing the
mathematical accuracy of the calculation.
– Developing a range of independent estimates and comparing those to the discount rate selected by
management.
/s/ DELOITTE & TOUCHE LLP
Parsippany, NJ
February 17, 2022
We have served as the Company’s auditor since 1968.
55
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Church & Dwight Co., Inc.
Ewing, New Jersey
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Church & Dwight Co., Inc. and subsidiaries (the
“Company”) as of December 31, 2021, based on criteria established in Internal Control — Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our
opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of
December 31, 2021, based on criteria established in Internal Control — Integrated Framework (2013) issued by
COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021,
of the Company and our report dated February 17, 2022, expressed an unqualified opinion on those consolidated
financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and
for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying
Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion
on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with
the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether effective internal control over financial
reporting was maintained in all material respects. Our audit included obtaining an understanding of internal
control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on the assessed risk, and performing such other
procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable
basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. A company’s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the
company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
56
controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
/s/ DELOITTE & TOUCHE LLP
Parsippany, NJ
February 17, 2022
57
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share data)
Year Ended December 31,
2021
2020
2019
Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$5,190.1
2,926.6
$4,895.8
2,681.6
$4,357.7
2,373.7
Gross Profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Marketing expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from Operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity in earnings of affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investment earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other income (expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income before Income Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2,263.5
577.7
606.7
1,079.1
9.4
0.0
(2.3)
(54.5)
1,031.7
204.2
2,214.2
591.2
593.3
1,029.7
6.7
0.5
(2.1)
(61.0)
973.8
187.9
1,984.0
515.0
628.8
840.2
6.6
1.6
(1.1)
(73.6)
773.7
157.8
Net Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 827.5
$ 785.9
$ 615.9
Weighted average shares outstanding—Basic . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average shares outstanding—Diluted . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share—Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share—Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash dividends per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
244.9
249.6
3.38
3.32
1.01
$
$
$
246.8
252.2
3.18
3.12
0.96
$
$
$
246.2
252.1
2.50
2.44
0.91
$
$
$
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Net Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income, net of tax:
Year Ended December 31,
2021
2020
2019
$827.5
$785.9
$615.9
Foreign exchange translation adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Defined benefit plan loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income (loss) from derivative agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(3.8)
(0.6)
13.8
10.4
0.0
(21.3)
5.7
(0.9)
(17.9)
Other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9.4
(10.9)
(13.1)
Comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$836.9
$775.0
$602.8
See Notes to Consolidated Financial Statements.
58
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except share and per share data)
December 31, December 31,
2020
Assets
Current Assets
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable, less allowances of $5.5 and $3.7 . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Current Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, Plant and Equipment, Net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity Investment in Affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade Names and Other Intangibles, Net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021
$
240.6
405.5
535.4
51.9
1,233.4
652.7
9.1
3,494.3
2,274.5
332.5
$
183.1
398.8
495.4
35.1
1,112.4
612.8
9.1
3,110.2
2,229.6
340.4
Total Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 7,996.5
$ 7,414.5
Liabilities and Stockholders’ Equity
Current Liabilities
Short-term borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Current Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term Debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred Income Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred and Other Long-term Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Business Acquisition Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued . . . . . . . .
Common Stock, $1.00 par value, Authorized 600,000,000 shares; 292,855,100 shares
issued as of December 31, 2021 and 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additional paid-in capital
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Common stock in treasury, at cost: 50,309,124 shares as of December 31, 2021 and
$
252.8
699.4
1,119.7
3.3
2,075.2
1,610.7
745.1
298.3
34.0
4,763.3
$
351.4
0.0
1,024.5
12.7
1,388.6
1,812.5
707.3
367.7
118.0
4,394.1
0.0
0.0
292.8
310.3
5,366.0
(68.2)
292.8
274.4
4,786.0
(77.6)
47,494,982 shares as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2,667.7)
(2,255.2)
Total Stockholders’ Equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3,233.2
3,020.4
Total Liabilities and Stockholders’ Equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 7,996.5
$ 7,414.5
See Notes to Consolidated Financial Statements.
59
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
(In millions)
Cash Flow From Operating Activities
Net Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in fair value of business acquisition liabilities . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity in net earnings of affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Distributions from unconsolidated affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asset impairment charge and other asset write-offs . . . . . . . . . . . . . . . . . . . . .
Gain on sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in assets and liabilities:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other operating assets and liabilities, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year Ended December 31,
2021
2020
2019
$ 827.5
$ 785.9
$ 615.9
68.4
150.7
(98.0)
20.3
(9.4)
9.4
23.7
14.9
0.0
3.6
2.4
(29.1)
(6.1)
47.5
(16.0)
(16.0)
66.2
123.5
(93.7)
25.7
(6.7)
7.4
21.5
1.9
(3.0)
2.3
(13.4)
(61.9)
(10.2)
168.0
12.2
(35.4)
63.8
112.6
1.3
5.6
(6.6)
5.3
20.8
13.8
0.0
0.1
(9.2)
(33.8)
4.9
72.8
3.4
(6.2)
Net Cash Provided By Operating Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
993.8
990.3
864.5
Cash Flow From Investing Activities
Additions to property, plant and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(118.8)
0.0
(556.0)
(7.2)
(98.9)
7.0
(512.7)
(3.5)
(73.7)
0.0
(475.0)
(4.8)
Net Cash Used In Investing Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(682.0)
(608.1)
(553.5)
Cash Flow From Financing Activities
Long-term debt borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt (repayments) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term debt (repayments), net of borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from stock options exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Payment of cash dividends . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchase of treasury stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Payment of business acquisition liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred financing and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
799.2
(300.0)
(98.5)
98.7
(247.5)
(500.0)
0.0
(4.0)
0.0
0.0
99.0
93.0
(237.3)
(300.0)
(14.5)
(0.3)
300.0
(600.0)
251.0
52.8
(224.1)
(250.0)
0.0
(2.6)
Net Cash Used In Financing Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(252.1)
(360.1)
(472.9)
Effect of exchange rate changes on cash and cash equivalents . . . . . . . . . . . . . . . . .
Net Change In Cash and Cash Equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and Cash Equivalents at Beginning of Period . . . . . . . . . . . . . . . . . . . . . . .
(2.2)
57.5
183.1
5.3
27.4
155.7
0.9
(161.0)
316.7
Cash and Cash Equivalents at End of Period . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 240.6
$ 183.1
$ 155.7
60
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW—(Continued)
(In millions)
Cash paid during the year for:
Interest (net of amounts capitalized) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 51.8
$ 58.8
$ 70.6
Income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$202.8
$162.1
$134.8
Supplemental disclosure of non-cash investing activities:
Property, plant and equipment expenditures included in Accounts Payable . . . . .
$ 10.7
$ 20.1
$ 10.4
Year Ended December 31,
2021
2020
2019
See Notes to Consolidated Financial Statements.
61
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Years Ended December 31, 2021, 2020 and 2019
(In millions)
Number of Shares
Amounts
Common
Stock
Treasury
Stock
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Stock
Total
Church &
Dwight Co.,
Inc.
Stockholders’
Equity
292.8
(46.0)
$292.8
$280.8
$3,832.6
$(53.6)
$(1,898.8)
$2,453.8
0.0
0.0
0.0
0.0
0.0
0.0
292.8
0.0
0.0
0.0
0.0
0.0
292.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
(3.6)
2.2
(47.4)
0.0
0.0
0.0
(3.1)
3.1
(47.4)
0.0
0.0
0.0
(5.7)
2.8
0.0
0.0
0.0
0.0
0.0
0.0
$292.8
0.0
0.0
0.0
0.0
0.0
$292.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
13.0
615.9
0.0
(224.1)
0.0
14.7
$295.5
0.0
0.0
$4,237.4
785.9
0.0
0.0
(30.0)
0.0
(237.3)
0.0
8.9
$274.4
0.0
0.0
$4,786.0
827.5
0.0
0.0
10.0
0.0
(247.5)
0.0
25.9
0.0
0.0
0.0
(13.1)
0.0
0.0
0.0
$(66.7)
0.0
(10.9)
0.0
0.0
0.0
$(77.6)
0.0
9.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
(250.0)
13.0
615.9
(13.1)
(224.1)
(250.0)
57.6
72.3
$(2,091.2)
0.0
$2,667.8
785.9
0.0
0.0
(270.0)
(10.9)
(237.3)
(300.0)
106.0
114.9
$(2,255.2)
0.0
$3,020.4
827.5
0.0
0.0
(510.0)
9.4
(247.5)
(500.0)
97.5
123.4
December 31, 2018 . . . . . . . . . . . . . . .
Adoption of new accounting
pronouncements (Note 1) . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . .
Other comprehensive (loss)
income . . . . . . . . . . . . . . . . . . . . . .
Cash dividends . . . . . . . . . . . . . . . . . .
Stock purchases . . . . . . . . . . . . . . . . .
Stock based compensation expense
and stock option plan
transactions . . . . . . . . . . . . . . . . . . .
December 31, 2019 . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income
(loss) . . . . . . . . . . . . . . . . . . . . . . . .
Cash dividends . . . . . . . . . . . . . . . . . .
Stock purchases . . . . . . . . . . . . . . . . .
Stock based compensation expense
and stock option plan
transactions . . . . . . . . . . . . . . . . . . .
December 31, 2020 . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income
(loss) . . . . . . . . . . . . . . . . . . . . . . . .
Cash dividends . . . . . . . . . . . . . . . . . .
Stock purchases . . . . . . . . . . . . . . . . .
Stock based compensation expense
and stock option plan
transactions . . . . . . . . . . . . . . . . . . .
December 31, 2021 . . . . . . . . . . . . . .
292.8
(50.3)
$292.8
$310.3
$5,366.0
$(68.2)
$(2,667.7)
$3,233.2
See Notes to Consolidated Financial Statements.
62
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In millions, except share and per share data)
1.
Significant Accounting Policies
Business
The Company, founded in 1846, develops, manufactures and markets a broad range of household, personal
care and specialty products focused on animal productivity, chemicals and cleaners. The Company sells its
consumer products under a variety of brands through a broad distribution platform that includes supermarkets,
mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar, pet and other specialty
stores and websites and other e-commerce channels, all of which sell the products to consumers. The Company
also sells specialty products to industrial customers, livestock producers and through distributors.
Basis of Presentation
The accompanying Consolidated Financial Statements are presented in accordance with accounting
principles generally accepted in the U.S. (“GAAP”) and include the accounts of the Company and its
majority-owned subsidiaries. For equity investments in which the Company does not control or have the ability
to exert significant influence over the investee, which generally is when the Company has less than a 20%
ownership interest, the investments are accounted for under the cost method. In circumstances where the
Company has greater than a 20% ownership interest and has the ability to exercise significant influence over, but
does not control, the investee, the investment is accounted for under the equity method. As a result, the Company
accounts for its 50% interest in its Armand Products Company (“Armand”) joint venture and its 50% interest in
The ArmaKleen Company (“ArmaKleen”) joint venture under the equity method. Armand and ArmaKleen are
specialty chemical businesses. The Company’s equity in earnings of Armand and ArmaKleen are included in the
Corporate segment, as described in Note 16.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent gains and losses at the date of the financial statements and reported amounts of revenue
and expenses during the reporting period. Management makes estimates regarding inventory valuation,
promotional and sales returns reserves, the carrying amount of goodwill and other intangible assets, the
realization of deferred tax assets, tax reserves, business acquisition liabilities, liabilities related to other
postretirement benefit obligations and other matters that affect the reported amounts and other disclosures in the
financial statements. These estimates are based on judgment and available information. Actual results could
differ materially from those estimates, and it is possible that changes in such estimates could occur in the near
term.
Revenue Recognition
Revenue is recognized when control of a promised good is transferred to a customer in an amount that
reflects the consideration that the Company expects to be entitled to in exchange for that good. This usually
occurs when finished goods are delivered to the Company’s customers or when finished goods are picked up by a
customer or a customer’s carrier.
a. Nature of Goods and Services
The Company primarily ships finished goods to its customers and operates in three segments: Consumer
Domestic, Consumer International and Specialty Products Division (“SPD”). The segments are based on
63
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
differences in the nature of products and organizational and ownership structures. The Consumer Domestic and
Consumer International segments market a variety of personal care and household products and over-the-counter
products, including but not limited to baking soda, cat litter, laundry detergent, condoms, stain removers, hair
removal, gummy dietary supplements, dry shampoo, water flossers and showerheads. The SPD segment focuses
on sales to businesses and participates in three product areas: Animal and Food Production, Specialty Chemicals
and Specialty Cleaners. The Company’s products are distinct and separately identifiable on customer contracts or
invoices, with each product sale representing a separate performance obligation.
The Company sells consumer products under a variety of brands through a broad distribution platform that
includes supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar,
pet and other specialty stores and websites and other e-commerce channels, all of which sell its products to
consumers. The Company sells its specialty products to industrial customers, livestock producers and through
distributors.
Refer to Note 17 for disaggregated revenue information with respect to each of the Company’s segments.
b. When Performance Obligations are Satisfied
For performance obligations related to the shipping and invoicing of products, control transfers at the point
in time upon which finished goods are delivered to the Company’s customers or when finished goods are picked
up by a customer or a customer’s carrier. Once a product has been delivered or picked up by the customer, the
customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The
Company considers control to have transferred upon delivery or customer receipt because the Company has an
enforceable right to payment at that time, the customer has legal title to the asset, the Company has transferred
physical possession of the asset, and the customer has significant risk and rewards of ownership of the asset.
c. Variable Consideration
The Company conducts extensive promotional activities, primarily through the use of off-list discounts,
slotting, coupons, cooperative advertising, periodic price reduction arrangements, and end-aisle and other in-store
displays. The costs of such activities are netted against sales and are recorded when the related sale takes
place. The reserves for sales returns and consumer and trade promotion liabilities are established based on the
Company’s best estimate of the amounts necessary to settle future and existing obligations for products sold as of
the balance sheet date. The Company uses historical trend experience and coupon redemption inputs in arriving
at coupon reserve requirements, and uses forecasted appropriations, customer and sales organization inputs, and
historical trend analysis in determining the reserves for other promotional activities and sales returns.
d. Practical Expedients
The Company expenses incremental direct costs of obtaining a contract (broker commissions) when the
related sale takes place. These costs are recorded in SG&A expenses in the accompanying consolidated
statements of income.
The Company accounts for shipping and handling costs as fulfillment activities which are therefore
recognized upon shipment of the goods.
The Company has applied the portfolio approach to all open contracts as they have similar characteristics
and can reasonably expect that the effects on the financial statements of applying this new guidance to the
64
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
portfolio of contracts would not differ materially from applying this guidance to the individual contracts within
the portfolio.
The Company excludes from its revenue any amounts collected from customers for sales (and similar) taxes.
Sales of Accounts Receivable
The Company entered into a factoring agreement with a financial institution to sell certain customer
receivables at discounted rates in 2015. Transactions under this agreement are accounted for as sales of accounts
receivable and are removed from the Consolidated Balance Sheet at the time of the sales transaction. As the
customers associated with the Company’s factoring program have been consistent in recent years, the sales
performance by customer has driven the amount factored each year. The Company factored an incremental
$21.2, $21.1, and $26.0 during the years ended December 31, 2021, 2020 and 2019, respectively.
Cost of Sales, Marketing and Selling, General and Administrative Expenses
Cost of sales include costs related to the manufacture of the Company’s products, including raw material,
inbound freight, direct labor (including employee compensation benefits) and indirect plant costs such as plant
supervision, receiving, inspection, maintenance labor and materials, depreciation, taxes and insurance,
purchasing, production planning, operations management, logistics, freight to customers, warehousing costs,
internal transfer freight costs and plant impairment charges.
Marketing expenses include costs for advertising (excluding the costs of cooperative advertising programs,
which are reflected in net sales), costs for coupon insertion (mainly the cost of printing and distribution),
consumer promotion costs (such as on-shelf advertisements and floor ads), public relations, package design
expense and market research costs.
Selling, general and administrative expenses (“SG&A”) expenses include, among others, costs related to
functions such as sales, corporate management, research and development, marketing administration, information
technology and legal. Such costs include salary compensation related costs (such as benefits, incentive
compensation and profit sharing), stock option costs, depreciation, travel and entertainment related expenses,
professional and other consulting fees and amortization of intangible assets.
Foreign Currency Translation
Unrealized gains and losses related to currency translation are recorded in Accumulated Other
Comprehensive Income (Loss). Gains and losses on foreign currency transactions are recorded in the
Consolidated Statements of Income.
Cash Equivalents
Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature
within three months of their original maturity date.
Inventories
Inventories are valued at the lower of cost or market (net realizable value, which reflects any costs to sell or
dispose). The Company identifies any slow moving, obsolete or excess inventory to determine whether an
65
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
adjustment is required to establish a new carrying value. The determination of whether inventory items are slow
moving, obsolete or in excess of needs requires estimates and assumptions about the future demand for the
Company’s products, technological changes, and new product introductions. Estimates as to the future demand
used in the valuation of inventory involve judgments regarding the ongoing success of the Company’s products.
The Company evaluates its inventory levels and expected usage on a periodic basis and records adjustments as
required. Adjustments to reflect inventory at net realizable value were $36.2 at December 31, 2021, and $17.0 at
December 31, 2020.
Property, Plant and Equipment
Property, Plant and Equipment (“PP&E”) are stated at cost. Depreciation is recorded using the straight-line
method over the estimated useful lives of the respective assets. Estimated useful lives for building and
improvements, machinery and equipment, and office equipment range from 9-40, 3-20 and 3-10 years,
respectively. Routine repairs and maintenance are expensed when incurred. Leasehold improvements are
depreciated over a period no longer than the respective lease term, except where a lease renewal has been
determined to be reasonably assured and failure to renew the lease results in a significant penalty to the
Company.
PP&E is reviewed annually and whenever events or changes in circumstances indicate that possible
impairment exists. The Company’s impairment review is based on an undiscounted cash flow analysis at the
lowest level at which cash flows of the long-lived assets are largely independent of other groups of Company
assets and liabilities. The analysis requires management judgment with respect to changes in technology, the
continued success of product lines, and future volume, revenue and expense growth rates. The Company
conducts annual reviews to identify idle and underutilized equipment, and reviews business plans for possible
impairment. Impairment occurs when the carrying value of the asset exceeds the future undiscounted cash flows.
When an impairment is indicated, the estimated future cash flows are then discounted to determine the estimated
fair value of the asset and an impairment charge is recorded for the difference between the carrying value and the
net present value of estimated future cash flows.
Software
The Company capitalizes certain costs of developing computer software. Amortization is recorded using the
straight-line method over the estimated useful life of the software, which is estimated to be no longer than 10
years.
Fair Value of Financial Instruments
Certain financial instruments are required to be recorded at fair value. The estimated fair values of such
financial instruments (including investment securities and other derivatives) have been determined using market
information and valuation methodologies. Changes in assumptions or estimation methods could affect the fair
value estimates. Other financial instruments, including cash equivalents and short-term debt, are recorded at cost,
which approximates fair value. Additional information regarding the Company’s risk management activities,
including derivative instruments and hedging activities, are separately disclosed. See Notes 2 and 3.
Goodwill and Other Intangible Assets
Carrying values of goodwill and indefinite-lived trade names are reviewed periodically for possible
impairment. The Company’s impairment analysis is based on a discounted cash flow approach that requires
66
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
significant judgment with respect to unit volume, revenue and expense growth rates, and the selection of an
appropriate discount rate and royalty rate. Management uses estimates based on expected trends in making these
assumptions. With respect to goodwill, impairment occurs when the carrying value of the reporting unit exceeds
the discounted present value of cash flows for that reporting unit. For trade names and other intangible assets, an
impairment charge is recorded for the difference between the carrying value and the net present value of
estimated future cash flows, which represents the estimated fair value of the asset. Judgment is required in
assessing whether assets may have become impaired between annual valuations. Indicators such as unexpected
adverse economic factors, unanticipated technological change, distribution losses, or competitive activities and
acts by governments and courts may indicate that an asset has become impaired. Intangible assets with finite
lives are amortized over their estimated useful lives, which range from 3-20 years, using the straight-line method,
and reviewed for impairment when changes in market circumstances occur.
It is possible that the Company’s conclusions regarding impairment or recoverability of goodwill or other
intangible assets could change in future periods if, for example, (i) the businesses or brands do not perform as
projected, (ii) overall economic conditions in future years vary from current assumptions (including changes in
discount rates), (iii) business conditions or strategies change from current assumptions, (iv) investors require
higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly
traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower
multiples of revenues and EBITDA.
Research and Development
The Company incurred research and development expenses in the amount of $105.2, $102.6 and $93.6 in
2021, 2020 and 2019, respectively. These expenses are included in SG&A expenses and are expensed as
incurred.
Earnings Per Share (“EPS”)
Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common
Stock”) and the weighted-average number of shares outstanding during the reported period. Diluted EPS includes
additional dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options.
The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock
outstanding to the weighted-average number of shares outstanding on a diluted basis:
Weighted average common shares outstanding— basic . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dilutive effect of stock options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
244.9
4.7
246.8
5.4
246.2
5.9
Weighted average common shares outstanding—diluted . . . . . . . . . . . . . . . . . . . . . . . . . .
249.6
252.2
252.1
Antidilutive stock options outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1.6
1.5
1.5
2021
2020
2019
Employee and Director Stock Based Compensation
The fair value of share-based compensation is determined at the grant date and the related expense is
recognized over the required employee service period in which the share-based compensation vests. The
67
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
following table presents the pre-tax expense associated with the fair value of unvested stock options and
restricted stock awards included in SG&A expenses and in cost of sales:
For the Year Ended
December 31,
2021
2020
2019
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 3.3
22.3
$ 3.6
21.0
$ 2.8
19.6
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$25.6
$24.6
$22.4
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are
recognized to reflect the future tax consequences attributable to the differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit
carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which the differences are expected to be recovered or settled. Management
provides a valuation allowance against deferred tax assets for amounts which are not considered “more likely
than not” to be realized. The Company records liabilities for potential assessments in various tax jurisdictions in
accordance with GAAP. The liabilities relate to tax return positions that, although supportable by the Company,
may be challenged by the tax authorities and do not meet the minimum recognition threshold required under
applicable accounting guidance for the related tax benefit to be recognized in the income statement. The
Company adjusts this liability as a result of changes in tax legislation, interpretations of laws by courts, rulings
by tax authorities, changes in estimates and the expiration of the statute of limitations. Many of the judgments
involved in adjusting the liability involve assumptions and estimates that are highly uncertain and subject to
change. In this regard, settlement of any issue with, or an adverse determination in litigation against, a taxing
authority could require the use of cash and result in an increase in the Company’s annual tax rate. Conversely,
favorable resolution of an issue with a taxing authority would be recognized as a reduction to the Company’s
annual tax rate.
Recently Adopted Accounting Pronouncements
In March 2020, the FASB issued new accounting guidance intended to provide temporary optional
expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease
the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate
(“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance was effective beginning
on March 12, 2020, and the Company may apply the amendments prospectively to contract modifications made
or relationships entered into or evaluated through December 31, 2022. The adoption of this guidance did not have
an impact on the Company’s consolidated financial position, results of operations or cash flows in the current
period. The Company will continue to evaluate the impacts of this guidance on future contract modifications
through December 31, 2022.
In February 2016 and July 2018, the FASB issued new lease accounting guidance, requiring lessees to
recognize right-of-use lease assets and lease liabilities on the balance sheet for those leases previously classified
as operating leases, with a term greater than a year. The new guidance also expands the required quantitative and
qualitative disclosures surrounding leases. The guidance was effective for annual and interim periods beginning
68
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
after December 15, 2018, and allowed companies to apply the requirements retrospectively, either to all prior
periods presented or through a cumulative adjustment in the year of adoption. The Company adopted the new
standard on January 1, 2019 using the optional transition method of adoption which permits the entity to continue
presenting all periods prior to January 1, 2019 under the previous lease accounting guidance. The Company has
implemented the appropriate internal controls and applications to monitor and record historical and future lease
arrangements and required disclosures.
For all existing operating leases as of December 31, 2018, the Company recorded Right of Use Assets of
approximately $55.0 and corresponding lease liabilities of approximately $57.0 with an offset to Deferred and
Other Long-term Liabilities of approximately $2.0 to eliminate deferred rent on the consolidated balance sheet.
In addition, based on the transition guidance surrounding failed sale-and-leaseback transactions, the
Company re-evaluated the lease for its corporate headquarters in Ewing, New Jersey. This lease was previously
considered a failed sale-and-leaseback transaction under Accounting Standards Codification (“ASC”) 840
because of continuing involvement. The re-evaluation resulted in a change in classification from a finance
transaction to an operating lease. The corporate headquarters building, which had a net book value of
approximately $35.0 recorded in Property, Plant and Equipment as of December 31, 2018, was derecognized on
January 1, 2019 and a Right of Use Asset of approximately $52.0 was recorded with an offset to Deferred
Income Taxes of $4.0 and Retained Earnings of $13.0. The Lease Liability pertaining to this asset of
$52.0 remained unchanged.
In total, at the adoption of the new accounting guidance there were Right of Use Assets of approximately
$107.0 and a corresponding Lease Liabilities of $109.0. This did not include an existing cease-use liability of
approximately $7.0 pertaining to one of the Company’s previous corporate offices that remained unchanged as a
result of the transition. Refer to Note 8 for the Company’s lease disclosures.
The effects of the recently adopted lease accounting standard to the Company’s consolidated balance sheet
as of January 1, 2019 is as follows:
Balance at
December 31,
2018
New Lease
Standard
Adjustment
Balance at
January 1,
2019
Property, plant and equipment, net
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred and other long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 598.2
117.4
725.1
180.9
576.4
3,832.6
$ (35.2)
107.5
13.6
41.3
4.4
13.0
$ 563.0
224.9
738.7
222.2
580.8
3,845.6
The adoption of the new lease accounting standard did not have a material impact on the Company’s results
of operations or cash flows.
Recent Accounting Pronouncements Not Yet Adopted
There have been no other accounting pronouncements issued but not yet adopted by the Company which are
expected to have a material impact on the Company’s consolidated financial position, results of operations or
cash flows.
69
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
2. Fair Value Measurements
Fair Value Hierarchy
Accounting guidance on fair value measurements and disclosures establishes a hierarchy that prioritizes the
inputs used to measure fair value (generally, assumptions that market participants would use in pricing an asset
or liability) based on the quality and reliability of the information provided by the inputs, as follows:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
Fair Values of Other Financial Instruments
The following table presents the carrying amounts and estimated fair values of the Company’s other
financial instruments at December 31, 2021 and December 31, 2020:
December 31, 2021
December 31, 2020
Input
Level
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Financial Assets:
Cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Level 1
$ 17.1
$ 17.1
$ 73.7
$ 73.7
Financial Liabilities:
Short-term borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Level 2
Term loan due May 1, 2022 . . . . . . . . . . . . . . . . . . . . . . . . . Level 2
2.45% Senior notes due August 1, 2022 . . . . . . . . . . . . . . . Level 2
2.875% Senior notes due October 1, 2022 . . . . . . . . . . . . . Level 2
Term loan due December 22, 2024 . . . . . . . . . . . . . . . . . . . Level 2
3.15% Senior notes due August 1, 2027 . . . . . . . . . . . . . . . Level 2
2.3% Senior notes due December 15, 2031 . . . . . . . . . . . . . Level 2
3.95% Senior notes due August 1, 2047 . . . . . . . . . . . . . . . Level 2
Interest Rate Swap Lock Agreement liability . . . . . . . . . . . Level 2
Business Acquisition Liabilities . . . . . . . . . . . . . . . . . . . . . Level 3
252.8
0.0
300.0
399.9
400.0
424.7
399.2
397.5
41.6
34.0
252.8
0.0
302.9
406.4
400.0
450.1
403.5
471.6
41.6
34.0
351.4
300.0
299.9
399.9
0.0
424.7
0.0
397.4
57.0
118.0
351.4
300.0
310.1
416.6
0.0
472.4
0.0
502.2
57.0
118.0
The Company recognizes transfers between input levels as of the actual date of the event. There were no
transfers between input levels during the twelve months ended December 31, 2021.
The following methods and assumptions were used to estimate the fair value of each class of financial
instruments reflected in the Consolidated Balance Sheets:
Cash Equivalents: Cash equivalents consist of highly liquid short-term investments and term bank deposits,
which mature within three months. The estimated fair value of the Company’s cash equivalents approximates
their carrying value.
Short-Term Borrowings: The carrying amounts of the Company’s unsecured lines of credit and commercial
paper issuances approximates fair value because of their short maturities and variable interest rates.
Senior Notes: The Company determines the fair value of its senior notes based on their quoted market value
or broker quotes, when possible. In the absence of observable market quotes, the notes are valued using
non-binding market consensus prices that the Company seeks to corroborate with observable market data.
70
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
Interest Rate Swap Lock Agreement: The Company entered into interest rate swap lock agreements
(“Interest Rate Swap Lock Agreements”) which are used to hedge the risk of changes in the interest payments
attributable to changes in the benchmark U.S. Dollar London Interbank Offered Rate (“LIBOR”) interest rate
associated with anticipated issuances of debt in 2022. These interest rate swap lock agreements have been
designated as cash flow hedges and have a notional amount of $300.0. The liability decreased by $15.4 during
the year ended December 31, 2021 primarily due to higher current and projected interest rates with the offset in
Accumulated Other Comprehensive Loss and Deferred Taxes. The liability was reclassified to Accounts Payable
and Accrued Expenses during the third quarter of 2021.
Business Acquisition Liabilities: The business acquisition liabilities represent the estimated fair value of
additional future contingent consideration payable for acquisitions of businesses that included contingent
consideration clauses. The fair value of business acquisition liabilities is evaluated on an ongoing basis and is
based on management estimates and entity-specific assumptions which are considered Level 3 inputs. As of
December 31, 2021, the Company had a business acquisition liability of $20.0 in connection with the Zicam
Acquisition and a $14.0 business acquisition liability in connection with the TheraBreath Acquisition (both of
which are defined in Note 6). Any amount that may be due for the Zicam business acquisition liability is payable
five years from the closing date. Any amount that may be due for the TheraBreath business acquisition liability is
payable in installments between two and four years from the closing. As of December 31, 2020, the Company
had a business acquisition liability related to the Flawless Acquisition of $98.0 and a $20.0 liability in connection
with the Zicam acquisition which is payable five years from the closing date.
The initial fair value of the Flawless business acquisition liability was $182.0. That amount was established
based on initial projections in the purchase price allocation. Since the initial fair value was established, the
Company has recorded a reduction in fair value of the entire $182.0 business acquisition liability of which $98.0
was recorded in the twelve months ended December 31, 2021, based on the revised valuation due to updated
sales forecasts. The reduction in fair value was recorded as a reduction in SG&A expense within the Consumer
Domestic and Consumer International segments. At December 31, 2021, which was the end of the earn out
period, the business acquisition liability value was $0.0. See Note 15 for further details.
The fair value measurement of the business acquisition liabilities is determined using Level 3 inputs. The
fair value is determined using the present value of the weighted probabilities of the possible payments due to
randomly changing revenue growth. These fair value measurements represent Level 3 measurements as they are
based on significant inputs not observable in the market. Significant judgment is employed in determining the
appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly,
changes in assumptions could have a material impact on the fair value of the business acquisition liabilities.
Changes in the fair value of the business acquisition liabilities are recorded in general and administrative
expenses in the accompanying consolidated statements of operations.
Other: The carrying amounts of accounts receivable, and accounts payable and accrued expenses,
approximated estimated fair values as of December 31, 2021 and 2020.
3. Derivative Instruments and Risk Management
Changes in interest rates, foreign exchange rates, the price of the Common Stock and commodity prices
expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such
as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign
exchange forward contracts. The Company does not use derivatives for trading or speculative purposes.
71
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The Company formally designates and documents qualifying instruments as hedges of underlying exposures
when it enters into derivative arrangements. Changes in the fair value of derivatives designated as hedges and
qualifying for hedge accounting are recorded in other comprehensive income and reclassified into earnings
during the period in which the hedged exposure affects earnings. The Company reviews the effectiveness of its
hedging instruments on a quarterly basis. If the Company determines that a derivative instrument is no longer
effective in offsetting changes in fair values or cash flows, it recognizes the hedge ineffectiveness in current
period earnings and discontinues hedge accounting with respect to the derivative instrument. Changes in the fair
value of derivatives not designated as hedges or those not qualifying for hedge accounting are recognized in
current period earnings. Upon termination of cash flow hedges, the Company reclassifies gains and losses from
accumulated other comprehensive income based on the timing of the underlying cash flows, unless the
termination results from the failure of the intended transaction to occur in the expected timeframe. Such untimely
transactions require immediate recognition in earnings of gains and losses previously recorded in other
comprehensive income.
During 2021 and 2020, the Company used derivative instruments to mitigate risk, some of which were
designated as hedging instruments. The tables following the discussion of the derivative instruments below
summarize the fair value of the Company’s derivative instruments and the effect of derivative instruments on the
Company’s consolidated Statement of Operations and on other comprehensive income.
Derivatives Designated as Hedging Instruments
Diesel Fuel Hedges
The Company uses independent freight carriers to deliver its products. These carriers currently charge the
Company a basic rate per mile for diesel fuel price increases. The Company has entered into hedge agreements
with counterparties to mitigate the volatility of diesel fuel prices, and not to speculate in the future price of diesel
fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined
at the time the agreements were executed and to receive a floating rate payment that is determined on a monthly
basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month
and is designed to offset any increase or decrease in fuel costs that the Company pays to it common carriers. The
agreements covered approximately 75% of the Company’s 2021 diesel fuel requirements. These diesel fuel hedge
agreements qualified for hedge accounting. Therefore, changes in the fair value of such agreements are recorded
under Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet. There are no
remaining hedges outstanding as of December 31, 2021.
Foreign Currency
The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S.
Dollar/Euro, U.S. Dollar/ Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, and U.S. Dollar/
Australian Dollar.
The Company enters into forward exchange contracts to reduce the impact of foreign exchange rate
fluctuations related to anticipated but not yet committed sales or purchases denominated in U.S. Dollar, Canadian
Dollar, Pound, Euro, Mexican Peso, Chinese Yuan, and Australian Dollar. The Company entered into forward
exchange contracts to hedge itself from the risk that, due to fluctuations in currency exchange rates, it would be
adversely affected by net cash outflows. The face value of the unexpired contracts as of December 31, 2021
totaled $222.2 in U.S. Dollars, of which $216.3 qualifies as foreign currency cash flow hedges and, therefore,
changes in the fair value of the contracts are recorded in Accumulated Other Comprehensive Income (Loss) and
reclassified to earnings when the hedged transaction affected earnings.
72
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
Interest Rate Swap Lock Agreement
The Company entered into interest rate swap lock agreements to hedge the risk of changes in the interest
payments attributable to changes in the benchmark LIBOR interest rate associated with anticipated issuances of
debt. These interest rate swap lock agreements have been designated as cash flow hedges and have a notional
amount of $300.0. The fair value of the interest rate swap lock agreements is reflected in the Consolidated
Balance Sheet within Accounts Payable and Accrued Expenses.
Commodity Hedges
The Company is subject to exposure due to changes in prices of commodities used in production. To limit
the effects of fluctuations in the future market price paid and related volatility in cash flows, the Company enters
into commodity forward swap contracts. These hedges are designated as cash flow hedges for accounting
purposes and, therefore, changes in the fair value of the contracts are recorded in Accumulated Other
Comprehensive Income (Loss) and reclassified to earnings when the hedged transaction affected earnings. The
fair value of these commodity hedge agreements is reflected in the Consolidated Balance Sheet within Other
Current Assets and Accounts Payable and Accrued Expenses.
Derivatives not Designated as Hedging Instruments
Equity Derivatives
The Company has entered into equity derivative contracts covering the Common Stock in order to minimize
its liability under its Executive Deferred Compensation Plan resulting from changes in the quoted fair values of
the Common Stock to participants who have investments under the Plan in a notional Common Stock fund. The
contracts are settled in cash. Since the equity derivatives contracts do not qualify for hedge accounting, the
Company is required to mark such contracts to market throughout the contract term and record changes in fair
value in the consolidated Statement of Operations.
The notional amount of a derivative instrument is the nominal or face amount used to calculate payments
made on that instrument. Notional amounts are presented in the following table:
Notional
Amount
Notional
Amount
December 31,
2021
December 31,
2020
Derivatives designated as hedging instruments
Foreign exchange contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest rate swap lock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diesel fuel contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Commodities contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
216.3
300.0
0.0 gallons
72.1 pounds
$
$
252.7
300.0
6.7 gallons
84.0 pounds
Derivatives not designated as hedging instruments
Foreign exchange contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
5.9
28.9
$
$
8.0
23.3
Excluding the interest rate swap lock disclosed in Note 2, the fair values and amount of gain (loss)
recognized in income and other comprehensive income associated with the derivative instruments disclosed
above do not have a material impact on the Company’s consolidated financial statements.
73
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
4.
Inventories
Inventories consist of the following:
Raw materials and supplies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Work in process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5. Property, Plant and Equipment, Net (“PP&E”)
PP&E consist of the following:
December 31,
2021
December 31,
2020
$116.2
40.0
379.2
$535.4
$112.9
33.0
349.5
$495.4
December 31,
2021
December 31,
2020
Land . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings and improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Office equipment and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Construction in progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
28.3
290.8
828.9
107.8
92.7
104.3
$
28.3
265.3
793.4
103.0
85.1
86.8
Gross PP&E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less accumulated depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,452.8
800.1
1,361.9
749.1
Net PP&E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 652.7
$ 612.8
For the Year Ended December 31,
2021
2020
2019
Depreciation expense on PP&E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$68.4
$66.2
$63.8
6. Acquisitions
On December 24, 2021, the Company acquired all of the outstanding equity of Dr. Harold Katz, LLC and
HK-IP International, Inc., the owners of the THERABREATH® brand of oral care products business (the
“TheraBreath Acquisition”). The Company paid $556.0, net of cash acquired, at closing and deferred an
additional cash payment of $14.0 related to certain indemnity obligations provided by the seller. The additional
amount, to the extent not used in satisfaction of such indemnity obligations, is payable in installments between
two and four years from the closing. THERABREATH’s annual net sales for the year ended December 31, 2021
were approximately $100. The acquisition was financed by the proceeds from a $400.0 three-year term loan and
the Company’s underwritten public offering of $400.0 aggregate principal Senior Notes due on December 15,
2031 (as defined in Note 10) completed on December 10, 2021. The THERABREATH business is managed in
the Consumer Domestic and Consumer International segments.
74
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The preliminary fair values of the net assets at acquisition are set forth as follows:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade name (indefinite lived) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Business acquisition liabilities—long-term . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 11.3
12.9
487.0
30.1
43.7
(15.0)
(14.0)
Cash purchase price (net of cash acquired) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$556.0
The trade names and other intangible assets were valued using a discounted cash flow model. The life of the
amortizable intangible assets recognized from the TheraBreath Acquisition have a useful life which ranges
from 10 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquired
business and the Company. Pro forma results are not presented because the impact of the acquisition is not
material to the Company’s consolidated financial results. The goodwill and other intangible assets associated
with the TheraBreath Acquisition are deductible for U.S. tax purposes.
On December 1, 2020, the Company acquired all of the outstanding equity of Consumer Health Holdco
LLC, the owner of the ZICAM® brand and cold remedy products business (the “Zicam Acquisition”). The
Company paid $512.7, net of cash acquired, at closing and deferred an additional cash payment of $20.0 related
to certain indemnifications provided by the seller. The deferred amount is recorded in Business Acquisition
Liabilities on the consolidated balance sheet and any amount that may be due for the business acquisition liability
is payable five years from the closing. Zicam’s annual net sales for the year ended December 31, 2020 were
approximately $107.0. The acquisition was financed by the Company with a combination of cash on hand and
short-term borrowings. The ZICAM business is managed in the Consumer Domestic segment.
The fair values of the net assets acquired are set forth as follows:
Inventory and other working capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash purchase price (net of cash acquired)
$ 40.2
0.5
367.8
93.8
152.2
(13.1)
(108.0)
(20.7)
$ 512.7
The trade names and other intangible assets were valued using a discounted cash flow model. All of the
intangible assets recognized from the Zicam Acquisition have a useful life which ranges from 10 -20 years. The
goodwill is a result of expected synergies from combined operations of the acquired business and the
Company. Pro forma results are not presented because the impact of the acquisition is not material to the
Company’s consolidated financial results. The goodwill and other intangible assets associated with the Zicam
Acquisition are not deductible for U.S. tax purposes.
75
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
On May 1, 2019, the Company closed on its previously announced acquisition of the FLAWLESS® business
(the “Flawless Acquisition”) from Ideavillage Products Corporation (“Ideavillage”). The Company paid $475.0
at closing and agreed to make an additional business acquisition liability payment based on a trailing twelve-
month net sales target ending no later than December 31, 2021. At September 30, 2021 the business acquisition
liability value was $0.0. The Company does not expect to make a payment for the Flawless business acquisition
liability. The transaction was funded with a three-year term loan and commercial paper borrowings. There was a
six-month integration transition period in which the net cash received from Ideavillage was accounted for as
other revenue as a component of net sales. The Company purchased the inventory as part of the acquisition
following the transition period, and at such time the Company became the principal party to the sales transactions
and began recording revenue on a gross basis. The FLAWLESS business is managed in the Consumer Domestic
and Consumer International segments and represents an addition to the Company’s specialty haircare portfolio
which includes BATISTE® dry shampoo, VIVISCAL hair thinning supplements, and TOPPIK® hair fibers.
The fair values of the net assets acquired are set forth as follows:
Trade name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Business acquisition liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash purchase price
$ 447.3
121.8
87.9
(182.0)
$ 475.0
As a result of the Company purchasing assets, the goodwill and other intangible assets associated with the
Flawless Acquisition are deductible for U.S. tax purposes. The trade names and other intangible assets were
valued using a discounted cash flow model. All of the intangible assets recognized from the Flawless Acquisition
have a useful life which ranges from 15—20 years. The goodwill is a result of expected synergies from combined
operations of the acquired business and the Company. Pro forma results are not presented because the impact of
the acquisition was not material to the Company’s consolidated financial results. Ideavillage continued to help
support the business through a separate transition services agreement which expired on December 31, 2021.
7. Goodwill and Other Intangibles, Net
The following table provides information related to the carrying value of all intangible assets, other than
goodwill:
December 31, 2021
December 31, 2020
Gross
Carrying
Amount
Accumulated
Amortization
Net
Amortization
Period
(Years)
Gross
Carrying
Amount
Accumulated
Amortization
Net
Amortizable intangible assets:
Trade names . . . . . . . . . . . . . . . . . $1,386.7
664.0
Customer Relationships . . . . . . . .
239.1
Patents/Formulas . . . . . . . . . . . . .
$(336.2) $1,050.5
341.6
(322.4)
139.7
(99.4)
3-20
15-20
4-20
$1,389.6
659.5
230.5
$(269.6) $1,120.0
368.3
(291.2)
145.2
(85.3)
Total . . . . . . . . . . . . . . . . . . . . . . . $2,289.8
$(758.0) $1,531.8
$2,279.6
$(646.1) $1,633.5
76
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
Indefinite lived intangible assets—Carrying value
Trade names . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,962.5
$1,476.7
December 31, December 31,
2021
2020
The increase in indefinite lived intangible assets is due to the TheraBreath Acquisition.
Intangible amortization expense amounted to $120.3 for 2021, $99.9 for 2020 and $90.4 for 2019,
respectively. The Company estimates that intangible amortization expense will be approximately $117.0 in 2022
and approximately $115.0 to $107.0 annually over the next five years.
The Company determined that the carrying value of its trade names as of December 31, 2021 and 2020, was
recoverable based upon the forecasted cash flows and profitability of the brands.
Fair value for indefinite lived intangible assets was estimated based on a “relief from royalty” or “excess
earnings” discounted cash flow method, which contains numerous variables that are subject to change as business
conditions change, and therefore could impact fair values in the future. The key assumptions used in determining
fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates. The Company
determined that the fair value of all indefinite lived intangible assets for each of the years in the three-year period
ended December 31, 2021 exceeded their respective carrying values based upon the forecasted cash flows and
profitability. The Company’s indefinite lived intangible impairment review is completed in the fourth quarter of
each year.
In recent years the Company’s TROJAN® business, specifically the condom category, has not grown and
competition has increased. Social distancing requirements due to the COVID-19 pandemic had further negatively
impacted the business. As a result, the TROJAN business had experienced stagnant sales and profits resulting in
a reduction in expected future cash flows which eroded a portion of the excess between the fair and carrying
value of the tradename. This indefinite-lived intangible asset may be susceptible to impairment risk and a
continued decline in fair value could trigger a future impairment charge of the TROJAN tradename. The carrying
value of the TROJAN tradename is $176.4 and fair value exceeded carrying value by 70% as of December 31,
2021. The key assumptions used in the projections from the Company’s October 1, 2021 impairment analysis
include discount rates of 7.0% in the U.S. and 8.5% internationally, growth assumptions based on recent trends,
and an average royalty rate of approximately 10%.
While management can and has implemented strategies to address the risk, including lowering our
production costs, investing in new product ideas, and developing new creative advertising, significant changes in
operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair
value. In 2021, TROJAN experienced a recovery in sales and profits as it is benefiting from an easing of
COVID-19 social restrictions leading to an increase in sexual activity. The Company expects this trend will
continue into next year with the continued adoption of vaccines, the reduction of social distancing restrictions
and the benefit of management strategies to improve sales and profitability.
The Company’s Passport Food Safety business has experienced sales and profit declines due to decreased
demand driven by the COVID-19 pandemic and pressures from new competitive activities resulting from the loss
of exclusivity on a key product line. In the fourth quarter of 2021, management’s review of the outlook for the
Passport business indicated an assessment of the recoverability of the long-lived assets associated with the
77
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
business was necessary. That review determined that the estimated future cash flows would not be sufficient to
recover the carrying value of the assets resulting in an impairment of the associated tradename and other
intangible assets of $11.3. The charge is recorded in selling, general and administrative expenses. The assets have
a current remaining net book value of approximately $9.5 and are being amortized over their remaining weighted
average life which has been reduced to 7 years. The Company is implementing strategies to address the decline in
profitability. However, if unsuccessful, this decline could trigger an additional future impairment charge.
During the first quarter of 2020, the Company sold its PERL WEISS® toothpaste brand in Germany with a
tradename net book value of $2.7 and corresponding goodwill of $1.3 for cash proceeds of $7.0. The $3.0 gain
associated with this transaction was recorded as a reduction of SG&A expense in the Consumer International
segment.
The changes in the carrying amount of goodwill for the years ended December 31, 2021 and 2020 are as
follows:
Consumer
Domestic
Consumer
International
Specialty
Products
Balance at December 31, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PERL WEISS divestiture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Zicam acquired goodwill
Balance at December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TheraBreath acquired goodwill
. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax related and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,707.9
0.0
151.4
$1,859.3
39.3
1.2
Balance at December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,899.8
$235.6
(1.3)
0.0
$234.3
4.4
0.0
$238.7
Total
$2,079.5
(1.3)
151.4
$2,229.6
43.7
1.2
$136.0
0.0
0.0
$136.0
0.0
0.0
$136.0
$2,274.5
The result of the Company’s annual goodwill impairment test, performed in the beginning of the second
quarter of 2021, determined that the estimated fair value substantially exceeded the carrying values of all
reporting units. The determination of fair value contains numerous variables that are subject to change as
business conditions change and therefore could impact fair value in the future. The Company has never incurred
a goodwill impairment charge.
8. Leases
The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment.
Leases with an initial term of twelve months or less are not recorded on the consolidated balance sheet. All
recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the
lease term. For leases beginning in 2019, lease components (base rental costs) are accounted for separately from
the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate,
the Company uses its estimated secured incremental borrowing rate based on the information available at
commencement date in determining the present value of lease payments.
78
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
A summary of the Company’s lease information is as follows:
Classification
December 31,
2021
December 31,
2020
Assets
Right of use assets . . . . . . . . . . . . . . . . . . . . Other Assets
Liabilities
Current lease liabilities . . . . . . . . . . . . . . . . . Accounts Payable and Accrued Expenses
Long-term lease liabilities . . . . . . . . . . . . . . Deferred and Other Long-term Liabilities
Total lease liabilities . . . . . . . . . . . . . . . . . .
Other information
Weighted-average remaining lease term
(years) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted-average discount rate . . . . . . . . . .
$159.4
$181.6
$ 24.4
146.6
$171.0
$ 25.0
168.3
$193.3
9.1
4.3%
9.7
4.3%
Statement of Income
Lease cost(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$32.7
$27.7
$24.6
Twelve Months
Ended
December 31, 2021
Twelve Months
Ended
December 31, 2020
Twelve Months
Ended
December 31, 2019
Twelve Months
Ended
December 31, 2021
Twelve Months
Ended
December 31, 2020
Other information
Leased assets obtained in exchange for new lease liabilities(2) . . . . . . . . . . . .
Cash paid for amounts included in the measurement of lease liabilities . . . . .
$ 3.5
$32.6
$50.4
$25.6
(1) Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-
term lease expense is excluded from this amount and is not material. The Company also has certain variable
leases which are not material. The noncash component of lease expense for the twelve months ended
December 31, 2021, 2020 and 2019 was $25.4, $20.1 and $17.9, respectively, is included in the amortization
caption in the condensed consolidated statement of cash flows.
(2) Leased assets obtained in exchange for new lease liabilities in 2021 primarily consisted of equipment lease
additions, partially offset by lease modification terminations. Leased assets obtained in exchange for new
lease liabilities in 2020 consisted of $32.4 of real estate lease additions and $18.0 of equipment lease
additions, net of modifications. These additions included $24.1 for an agreement between the Company and
a third-party warehouse provider for warehouse space and equipment.
79
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The Company’s minimum annual rentals including reasonably assured renewal options under lease
agreements are as follows:
2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2027 and thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating
Leases
$ 30.9
26.6
24.2
22.7
15.3
91.0
Total future minimum lease commitments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Imputed Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
210.7
(39.7)
Present value of lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$171.0
9. Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consist of the following:
Trade accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued marketing and promotion costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued wages and related benefit costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 663.8
201.6
87.7
166.6
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,119.7
$ 588.1
177.8
124.2
134.4
$1,024.5
December 31,
2021
December 31,
2020
80
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
10. Short-Term Borrowings and Long-Term Debt
Short-term borrowings and long-term debt consist of the following:
December 31,
2021
December 31,
2020
Short-term borrowings
Commercial paper issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Various debt due to international banks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 249.7
3.1
Total short-term borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 252.8
Long-term debt
Term loan due May 1, 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.45% Senior notes due August 1, 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.875% Senior notes due October 1, 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Term loan due December 22, 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.15% Senior notes due August 1, 2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.3% Senior notes due December 15, 2031 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.95% Senior notes due August 1, 2047 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt issuance costs, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
0.0
300.0
0.0
400.0
(0.1)
400.0
425.0
(0.3)
400.0
(0.8)
400.0
(2.5)
(11.2)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total long-term debt
Less: current maturities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2,310.1
(699.4)
$ 349.0
2.4
$ 351.4
$ 300.0
300.0
(0.1)
400.0
(0.1)
0.0
425.0
(0.3)
0.0
0.0
400.0
(2.6)
(9.4)
1,812.5
0.0
Net long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,610.7
$1,812.5
Revolving Credit Facility
On May 1, 2019, the Company amended its $1,000.0 unsecured revolving credit facility (the “Credit
Agreement”) to extend the term of the Credit Agreement from March 29, 2023 to March 29, 2024. Under the
Credit Agreement, the Company has the ability to increase its borrowing up to an additional $600.0, subject to
lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit
Agreement are available for general corporate purposes and are used to support the Company’s
$1,000.0 commercial paper program. In March 2020, the Company drew down a total amount of $825.0 under
the Revolving Credit Facility. The Company initiated borrowings under the Revolving Credit Facility as a
precautionary measure to increase its cash position and preserve financial flexibility in light of uncertainty in the
global markets resulting from the COVID-19 pandemic. The full $825.0 was repaid in May 2020.
Interest on the Company’s borrowings under the Credit Agreement will accrue at a per annum rate equal to
the sum of (x) either (at the Company’s option) (i) the adjusted LIBOR rate (generally, the LIBOR rate for an
interest period selected by the Company and adjusted for statutory reserves) or (ii) the Base Rate (generally equal
to the highest of (a) the Federal Funds Rate plus 0.50%, (b) Bank of America’s “prime rate” and (c) the adjusted
LIBOR rate for an interest period of one-month plus 1.00%), in any case not less than zero, plus (y) the
applicable margin. The applicable margin is determined based upon the corporate credit rating of the Company
81
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
and ranges from 0.875% to 1.500% per annum, in the case of any borrowing bearing interest by reference to the
adjusted LIBOR rate, and 0% to 0.50%, in the case of any borrowing bearing interest by reference to the Base
Rate. In addition, the Company will bear certain customary fees, including a commitment fee, determined based
upon the corporate credit rating of the Company and ranging from 0.070% to 0.175% per annum on the
aggregate unused commitments under the Credit Agreement, and additional issuance fees and participation fees
in respect of any letters of credit issued under the Credit Agreement.
The Credit Agreement contains customary affirmative and negative covenants, including without limitation,
restrictions on the indebtedness, liens, investments, asset dispositions, fundamental changes, changes in the
nature of the business conducted, affiliate transactions, burdensome agreements and use of proceeds.
Under the Credit Agreement, the Company is required to maintain its leverage ratio, defined as the ratio of
its Consolidated Funded Indebtedness (as defined in the Credit Agreement) to EBITDA, at a level no greater than
3.75 to 1.00 (or, to the extent the Company or any Subsidiary has consummated a material acquisition, (i) at a
level no greater than 4.25:1.00 for the 12 month period commencing on the date the Company or any Subsidiary
consummates the first material acquisition after the closing date and (ii) at a level no greater than 4.25:1.00 for
the 12 month period commencing on the date the Company or any Subsidiary consummates any additional
material acquisition, provided that the Company has maintained a leverage ratio of 3.75:1.00 or less during each
of the immediately preceding four consecutive fiscal quarters before the date of such additional material
acquisition).
The Credit Agreement also contains customary events of default, including failure to make certain payments
under the Credit Agreement when due, breach of covenants, materially incorrect representations and warranties,
default on other material indebtedness, events of bankruptcy, material adverse judgments, certain events relating
to pension plans, the failure of any of the loan documents to remain in full force and effect and the occurrence of
any change in control with respect to the Company.
December 22, 2024 Term Loan
On December 22, 2021, the Company entered into a $400.0 unsecured term loan facility (the “Term Loan
Facility”) with various banks. The loan was fully drawn at closing. Unless prepaid, the loan is due
on December 22, 2024. The interest rate is LIBOR plus an applicable margin based on the Company’s credit
rating, which can range from 60 basis points (“bps”) to 125 bps. The proceeds of the loan were used to partially
fund the TheraBreath Acquisition, with the remaining proceeds used for the repayment of commercial paper.
The Term Loan Facility contains customary affirmative and negative covenants, including without
limitation, restrictions on the indebtedness, liens, investments, asset dispositions, fundamental changes, changes
in the nature of the business conducted, affiliate transactions, burdensome agreements and use of proceeds.
Under the Term Loan Facility, the Company is required to maintain its leverage ratio, defined as the ratio of
its Consolidated Funded Indebtedness (as defined in the Term Loan Facility) to Consolidated EBITDA, at a level
no greater than 3.75 to 1.00 (or, to the extent the Company or any Subsidiary has consummated a material
acquisition, (i) at a level no greater than 4.25:1.00 for the 12 month period commencing on the date the Company
or any Subsidiary consummates the Acquisition (as defined in the Term Loan Facility) and (ii) at a level no
greater than 4.25:1.00 for the 12 month period commencing on the date the Company or any Subsidiary
consummates any material acquisition, provided that the Company has maintained a leverage ratio of 3:75:1.00
or less during each of the immediately preceding four consecutive fiscal quarters before the date of such material
acquisition).
82
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The Term Loan Facility also contains customary events of default, including failure to make certain
payments under the Term Loan Facility when due, breach of covenants, materially incorrect representations and
warranties, default on other material indebtedness, events of bankruptcy, material adverse judgments, certain
events relating to pension plans, the failure of any of the loan documents to remain in full force and effect and the
occurrence of any change in control with respect to the Company.
2.3% Senior Notes
The Company financed the TheraBreath Acquisition with a portion of the proceeds from an underwritten
public offering of $400.0 aggregate principal amount Senior Notes due 2031 (the “2031 Notes”). These Notes
bear interest at 2.3% and were issued in an underwritten offering under an indenture with Deutsche Bank Trust
Company Americas, as trustee. Interest on the 2031 Notes is payable semi-annually, on each June 15 and
December 15. The 2031 Notes will mature on December 15, 2031, unless earlier retired or redeemed.
$1.425M Senior Notes
The Company financed the Waterpik Acquisition with a portion of the proceeds from an underwritten public
offering of $1,425.0 aggregate principal amount of Senior Notes completed on July 25, 2017, consisting of
$300.0 aggregate principal amount of Floating Rate Senior Notes that were due in 2019 and fully repaid, $300.0
aggregate principal amount of 2.45% Senior Notes due 2022, $425.0 aggregate principal amount of 3.15% Senior
Notes due 2027 and $400.0 aggregate principal amount of 3.95% Senior Notes due 2047 (collectively with the
2031 Notes, the “Senior Notes”). The $300.0 Floating Rate Senior Notes which matured and were repaid in full
on January 25, 2019, bore interest at a rate, reset quarterly, equal to three-month U.S. Dollar LIBOR plus 0.15%.
The remaining proceeds of the offering of the Senior Notes were used to pay down in its entirety and terminate
the Company’s $200.0 term loan borrowed in the second quarter of 2017 and to repay a portion of the
Company’s outstanding commercial paper borrowings.
2.875% Senior Notes
On September 26, 2012, the Company issued $400.0 aggregate principal amount of 2.875% Senior Notes
due 2022 (the “2022 Notes”). These Notes were issued under the second supplemental indenture dated
September 26, 2012 (the “BNY Mellon Second Supplemental Indenture”) to the indenture dated December 15,
2010 (the “BNY Mellon Base Indenture”) between the Company and The Bank of New York Mellon Trust
Company, N.A. (“BNY Mellon”), as trustee. Interest on the 2022 Notes is payable semi-annually, on each
April 1 and October 1. The 2022 Notes will mature on October 1, 2022, unless earlier retired or redeemed.
May 1, 2022 Term Loan
On May 1, 2019, the Company entered into a $300.0 unsecured term loan credit facility with various banks,
the proceeds of which were used to partially fund the Flawless Acquisition. The interest rate was LIBOR plus an
applicable margin based on the Company’s credit rating, which can range from 60 basis points (“bps”)
to 125 bps. In June 2021, the Company repaid $100.0 principal of the $300.0 term loan due May 1, 2022, with
the remaining $200.0 principal repaid in early July 2021. The term loan was repaid with proceeds from
commercial paper borrowings and cash on hand.
Commercial Paper
The Company has an agreement with four banks to establish a commercial paper program (the “Program”).
Under the Program, the Company may issue notes from time to time up to an aggregate principal amount
83
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
outstanding at any given time of $1,000.0. The maturities of the notes will vary but may not exceed 397 days.
The notes will be sold under customary terms in the commercial paper market and will be issued at a discount to
par or, alternatively, will be sold at par and will bear varying interest rates based on a fixed or floating rate basis.
The interest rates will vary based on market conditions and the ratings assigned to the notes by the rating
agencies designated in the agreement at the time of issuance. Subject to market conditions, the Company intends
to utilize the Program as its primary short-term borrowing facility and does not intend to sell unsecured
commercial paper notes in excess of the available amount under the revolving credit agreement. If, for any
reason, the Company is unable to access the commercial paper market, the revolving credit facility would be
utilized to meet the Company’s short-term liquidity needs. The Company had $249.7 of commercial paper
outstanding as of December 31, 2021 with a weighted-average interest rate of approximately 0.30% and had
$349.0 of commercial paper outstanding as of December 31, 2020 with a weighted-average interest rate of
approximately 0.26%. As of December 31, 2021, the Company had approximately $746.0 available through the
revolving facility under the Credit Agreement and commercial paper program.
Interest Rate Swap Lock Agreement
The Company entered into interest rate swap lock agreements to hedge the risk of changes in the interest
payments attributable to changes in the benchmark LIBOR interest rate associated with anticipated issuances of
debt. These interest rate swap lock agreements have been designated as cash flow hedges and have a notional
amount of $300.0. The fair value of these interest rate swap lock agreements is reflected in the Consolidated
Balance Sheet within Accounts Payable and Accrued Expenses.
11. Income Taxes
The components of income before taxes are as follows:
Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 958.6
73.1
$921.6
52.2
$726.7
47.0
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$1,031.7
$973.8
$773.7
2021
2020
2019
The following table summarizes the provision for U.S. federal, state and foreign income taxes:
Current:
U.S. federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$130.6
34.1
19.2
$114.2
32.1
15.9
$117.2
24.9
10.1
2021
2020
2019
Deferred:
U.S. federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
183.9
162.2
152.2
16.5
4.5
(0.7)
20.3
22.9
4.2
(1.4)
25.7
3.6
(0.5)
2.5
5.6
Total provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$204.2
$187.9
$157.8
84
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
Deferred tax assets (liabilities) consist of the following at December 31:
Deferred tax assets:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension, postretirement and postemployment benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax credit carryforwards/other tax attributes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International operating loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total gross deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax liabilities:
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trade names and other intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment
2021
2020
$
8.6
52.0
6.1
23.3
2.9
8.2
10.3
$
6.8
48.6
6.3
19.9
17.9
8.7
14.2
111.4
(13.1)
98.3
122.4
(22.6)
99.8
(270.2)
(508.5)
(55.5)
(226.9)
(520.4)
(56.1)
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(834.2)
(803.4)
Net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$(735.9) $(703.6)
Long term net deferred tax asset
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long term net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9.2
(745.1)
3.7
(707.3)
Net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$(735.9) $(703.6)
The difference between tax expense and the tax that would result from the application of the federal
statutory rate is as follows:
Statutory rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax that would result from use of the federal statutory rate . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State and local income tax, net of federal effect
Varying tax rates of foreign affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation Allowances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Options Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Worthless Stock Deduction—Investment in Brazil . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Reserve for Uncertain Tax Position—Investment in Brazil
. . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021
2020
2019
21% 21%
21%
$216.6
30.5
2.6
(8.5)
(29.0)
0.0
0.0
(8.0)
$204.5
28.7
2.8
2.9
(29.4)
0.0
(10.6)
(11.0)
$162.4
19.3
1.8
0.9
(16.1)
(12.0)
12.0
(10.5)
Recorded tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$204.2
$187.9
$157.8
Effective tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19.8% 19.3% 20.4%
At December 31, 2021, certain foreign subsidiaries of the Company had net operating loss carryforwards of
approximately $25.1. The net operating loss carryforwards are not subject to expiration.
85
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The Company believes that it is more likely than not that the benefit from these net operating loss
carryforwards will not be realized. In recognition of this risk, the Company has provided a valuation allowance of
$8.1 and $8.7 at December 31, 2021 and 2020, respectively, on the deferred tax asset relating to these net
operating loss carryforwards.
The Company also believes that it is more likely than not that the benefit from certain additional deferred
tax assets of a foreign subsidiary will not be realized. In recognition of this risk, the Company maintains a
valuation allowance of $0.9 and $1.3 at December 31, 2021 and 2020, respectively, on these deferred tax assets.
As of December 31, 2020 the Company maintained a valuation allowance of $12.6 relating to certain
foreign tax credit carryforwards which were determined not more likely than not to be realized. During 2021, the
Company determined that it was able to utilize approximately $8.5 in foreign tax credits in 2018, 2019, and 2020,
resulting in a reduction in the valuation allowance, and a corresponding tax benefit. Accordingly, the Company
filed amended returns with the IRS claiming refunds for 2018 and 2019, totaling $6.5, and utilized $2.0 of
foreign tax credits in 2020. The Company determined that it is not more likely than not that the remaining benefit
from certain foreign tax credit carryforwards will be realized. In recognition of this risk, the Company
maintained a valuation allowance of $4.1 at December 31, 2021, on the deferred tax asset relating to these
foreign tax credit carryforwards. The Company does not have any undistributed earnings of foreign subsidiaries
that are considered to be indefinitely reinvested outside of the U.S.
The Company has recorded liabilities in connection with uncertain tax positions, which, although
supportable by the Company, may be challenged by tax authorities. Under applicable accounting guidance, these
tax positions do not meet the minimum threshold required for the related tax benefit to be recognized in the
income statement.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
Unrecognized tax benefits at January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross increases—tax positions in current period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross increases—tax positions in prior period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross decreases—tax positions in prior period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Decreases due to settlements and payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lapse of statute of limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2021
2020
2019
$ 7.3
0.3
0.8
0.0
0.0
(3.7)
$ 18.9
0.0
1.6
(11.8)
(1.4)
0.0
$ 4.7
13.2
1.4
0.0
0.0
(0.4)
Unrecognized tax benefits at December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 4.7
$ 7.3
$18.9
During 2019 the Company ceased conducting business in Brazil and recorded a $12.0 reserve for an
uncertain tax position relating to a worthless stock deduction for its investment in Brazil. The Company
requested a ruling from the IRS in connection with the worthless stock deduction. During 2020 the Company
reached a settlement with the IRS for $1.4 relating to the worthless stock deduction and released the related $12.0
reserve, which resulted in a $10.6 income tax benefit.
Included in the balance of unrecognized tax benefits at December 31, 2021, December 31, 2020 and
December 31, 2019 are $4.1, $6.2 and $18.0, respectively, of tax benefits that, if recognized, would affect the
effective tax rate. Also included in the balance of unrecognized tax benefits at December 31, 2021, December 31,
2020 and December 31, 2019 are $0.6, $1.1 and $0.9, respectively, of tax benefits that, if recognized, would
result in adjustments to deferred taxes.
86
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The Company is subject to U.S. federal income tax as well as income tax in multiple state and international
jurisdictions. The Company’s U.S. federal income tax returns are closed for tax years through 2017. The
Company is currently under audit by several state taxing authorities for the years 2016 through 2017. It is
reasonably possible that a decrease of approximately $0.7 in the unrecognized tax benefits may occur within the
next twelve months related to the settlement of these audits or the lapse of applicable statutes of limitations.
The Company’s policy for recording interest associated with income tax examinations is to record interest
as a component of Income before Income Taxes. During the twelve months ended December 31, 2021,
December 31, 2020, and December 31, 2019, the Company recognized interest expense associated with uncertain
tax positions of approximately $0.5, $0.4 and $0.4, respectively. As of December 31, 2021, December 31, 2020,
and December 31, 2019 the Company had accrued interest expense related to unrecognized tax benefits of $0.5,
$1.0 and $0.6, respectively.
12. Stock Based Compensation Plans and Other Benefit Plans
The Company has non-qualified options outstanding under the Company’s Amended and Restated Omnibus
Equity Plan. Under the Amended and Restated Omnibus Equity Plan, the Company may grant stock options and
other stock-based awards to employees and directors. The Company has previously sponsored the 1983 Stock
Option Plan and the Stock Award Plan, under which the company granted stock options to key management
employees, and the Stock Option Plan for Directors, under which the Company granted stock options to
non-employee directors. Following approval of the original Omnibus Equity Plan by stockholders in 2008, no
further grants were permitted under any of the other equity compensation plans. Stock options outstanding under
the plans are issued at market value on the date of grant (with the exception of options granted to former
WATERPIK employees as part of the Waterpik Acquisition), vest on the third anniversary of the date of grant
and must be exercised within 10 years of the date of grant. No stock options are currently outstanding under the
1983 Stock Option Plan, the Stock Award Plan, or the Stock Option Plan for Directors.
If, upon termination of a participant’s employment (other than a termination for cause), a participant is at
least 55 years old, has at least five years of service, and the sum of the participant’s age and years of service is at
least 65, the participant may exercise any stock options granted between 2007 through 2017 within a period of
three years from the date of termination or, if earlier, the date such stock options otherwise would have expired,
subject to specified conditions. Starting with stock options granted in 2018, a terminated employee who meets
the above conditions may exercise any stock options within a period of ten years from the date of termination or,
if earlier, the date such stock options otherwise would have expired, subject to specified conditions. Issuances of
Common Stock to satisfy employee stock option exercises currently are made from treasury stock.
Stock option transactions for the year ended December 31, 2021 were as follows:
Outstanding as of December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cancelled . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options
12.7
1.5
(2.8)
(0.1)
Outstanding as of December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . .
11.3
Weighted
Average
Exercise
Price
$50.72
84.71
35.48
75.48
$58.83
Exercisable as of December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . .
6.7
$44.80
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
6.1
4.3
$493.3
$380.5
87
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The following table summarizes information relating to options outstanding and exercisable as of
December 31, 2021:
Range of
Exercise Prices
$20.01 - $30.00
$30.01 - $40.00
$40.01 - $50.00
$50.01 - $60.00
$60.01 - $70.00
$70.01 - $80.00
$80.01 - $90.00
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
Options Outstanding
Options Exercisable
Outstanding
as of
12/31/2021
Weighted
Average
Remaining
Contractual Life
Weighted
Average
Exercise
Price
Exercisable
as of
12/31/2021
Weighted
Average
Exercise
Price
0.2
1.3
2.4
2.7
0.1
3.1
1.5
11.3
0.5
2.2
3.9
6.0
6.9
8.0
9.5
6.1
$26.98
$33.93
$44.07
$51.98
$65.52
$75.36
$84.70
$58.83
0.2
1.3
2.4
2.7
0.1
0.0
0.0
6.7
$26.98
$33.93
$44.07
$51.98
$65.52
$ —
$ —
$44.80
The table above represents the Company’s estimate of stock options fully vested and expected to vest.
Expected forfeitures are not material and, therefore, are not reflected in the table above.
The following table provides information regarding the intrinsic value of stock options exercised and stock
compensation expense related to stock option awards:
Intrinsic Value of Stock Options Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock Compensation Expense Related to Stock Option Awards . . . . . . . . . . . . . . . . . .
Issued Stock Options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted Average Fair Value of Stock Options issued (per share)
. . . . . . . . . . . . . . .
Fair Value of Stock Options Issued . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$157.3
$ 23.3
1.5
$17.32
$ 26.6
$159.8
$ 21.1
1.9
$12.85
$ 24.5
$ 93.1
$ 20.3
1.5
$14.90
$ 22.1
2021
2020
2019
The following table provides a summary of the assumptions used in the valuation of issued stock options:
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected life in years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividend yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1.3% 0.5% 2.0%
7.2
7.3
20.7%19.9% 17.2%
1.2% 1.3% 1.2%
7.3
2021
2020
2019
The fair value of stock options is based upon the Black Scholes option pricing model. The Company
determined the stock options’ lives based on historical exercise behavior and their expected volatility and
dividend yield based on the historical changes in stock price and dividend payments. The risk-free interest rate is
based on the yield of an applicable term Treasury instrument.
As of December 31, 2021, there was a fair value of $19.0 related to unamortized stock option compensation
expense, which is expected to be recognized over the next three years. The Company’s Consolidated Statements
of Cash Flow reflect an add back to Net Cash Provided by Operating Activities of $23.7, $21.5 and $20.8 in
2021, 2020 and 2019, respectively, for non-cash compensation expense, primarily stock option expense.
88
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
In January 2021, the Company issued cash-settled stock units under the Amended and Restated Omnibus
Equity Plan to all employees at the level of vice president and below. These restricted stock units are scheduled
to vest and be settled on the third anniversary of the date of grant.
In May 2018, the Company issued cash-settled stock units under the Amended and Restated Omnibus
Equity Plan to all employees at the level of vice president and below. These restricted stock units were scheduled
to vest and be settled on the third anniversary of the date of grant. In December 2020, the Company accelerated
the grant to vest in December 2020.
As a result of the issued cash-settled stock units, the Company recorded stock compensation expense of
$1.9, $3.1 and $1.5 in 2021, 2020 and 2019, respectively. The liability was approximately $1.9 as of
December 31, 2021, and there was no liability as of December 31, 2020.
Other Benefit Plans
Deferred Compensation Plans
The Company maintains a non-qualified deferred compensation plan under which certain members of
management are eligible to defer a maximum of 85% of their regular compensation (i.e., salary) and, in general,
up to 85% of their incentive bonus. The amounts deferred under this plan are credited with earnings or losses
based upon changes in values of notional investments selected by the plan participant. The investment options
available include notional investments in various stock, bond and money market funds as well as the Company’s
Common Stock. Each plan participant is fully vested in the amounts the participant defers. The plan permits the
Company to make profit sharing contributions that cannot otherwise be contributed to the qualified savings and
profit sharing plan due to limitations established by the Internal Revenue Service. These contributions vest under
the same vesting schedule applicable to the qualified plan.
The liability to plan participants for contributions designated for notional investment in Common Stock is
based on the quoted fair value of the Common Stock plus any dividends credited. The Company uses cash-settled
hedging instruments to minimize the cost related to the volatility of Common Stock. At December 31, 2021 and
2020, the amount of the Company’s liability under the deferred compensation plan is included in Current and
Deferred and Other Long-term Liabilities and was $131.9 and $116.9, respectively and the funded balances
recorded in Other Assets amounted to $107.3 and $101.4, respectively. The amounts charged to earnings,
including the effect of the hedges, totaled expense of $2.2 in 2021, expense of $2.1 in 2020 and income of $1.0 in
2019, respectively.
Non-employee members of the Company’s Board are eligible to defer up to 100% of their directors’
compensation into a similar plan; however, the only option for investment is Common Stock. Members of the
Board are fully vested in their account balance. As of December 31, 2021, there were approximately 149,000
shares of Common Stock from shares held as Treasury Stock in a rabbi trust to protect the interest of the
directors’ deferred compensation plan participants in the event of a change of control.
13. Share Repurchases
On November 1, 2017, the Board authorized a share repurchase program, under which the Company may
repurchase up to $500.0 in shares of Common Stock (the “2017 Share Repurchase Program”).
In December 2020, the Company entered into an accelerated share repurchase (“ASR”) contract with a
commercial bank to purchase Common Stock. The Company paid $300.0 to the bank, inclusive of fees, and
89
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
received an initial delivery of shares equal to $270.0, or 3.1 million shares. The Company used cash on hand and
short-term borrowings to fund the initial purchase price. Upon the completion of the ASR, which ended in
February 2021, the bank delivered an additional 0.4 million shares to the Company. The final shares delivered to
the Company were determined by the average price per share paid by the bank during the purchase period. All
3.5 million shares were purchased under the Company’s evergreen program.
In August 2021, the Company executed an agreement to purchase up to $200.0 of its Common Stock
through October 31, 2021. The Company purchased 1.6 million shares for approximately $130.0 through
October, inclusive of fees, all of which was purchased under the 2017 Share Repurchase Program.
On October 28, 2021, the Board authorized a new share repurchase program, under which the Company
may repurchase up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021
Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program. All
remaining dollars authorized for repurchase under the 2017 Share Repurchase Plan have been cancelled. The
2021 Share Repurchase Program did not modify the Company’s evergreen share repurchase program, authorized
by the Board on January 29, 2014, under which the Company may repurchase, from time to time, Common Stock
to reduce or eliminate dilution associated with issuances of Common Stock under its incentive plans.
In December 2021, the Company executed open market purchases of 1.8 million shares for $170.3, inclusive
of fees, of which $100.0 was purchased under the evergreen share repurchase program and $70.3 was purchased
under the 2021 Share Repurchase Program. In December 2021, the Company also entered into an accelerated
share repurchase contract with a commercial bank to purchase Common Stock. The Company paid $200.0 to the
bank, inclusive of fees, and received an initial delivery of shares equal to $180.0, or 1.8 million shares. The
Company used cash on hand and short-term borrowings to fund the initial purchase price. Upon the completion
of the ASR, which ended in February 2022, the bank delivered an additional 0.2 million shares to the Company.
The final shares delivered to the Company were determined by the average price per share paid by the bank
during the purchase period. All 2.0 million shares were purchased under the 2021 Share Repurchase Program.
As a result of the Company’s recent stock repurchases, there remains $729.7 of share repurchase availability
under the 2021 Share Repurchase Program as of December 31, 2021.
14. Accumulated Other Comprehensive Income (Loss)
Comprehensive income is defined as net income and other changes in stockholders’ equity from transactions
and other events from sources other than stockholders.
90
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The components of changes in accumulated other comprehensive income (“AOCI”) are as follows:
Foreign
Currency
Adjustments
Defined
Benefit
Plans
Derivative
Agreements
Accumulated
Other
Comprehensive
Income (Loss)
Balance December 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(42.5)
3.8
Other comprehensive income before reclassifications . . . . . . . . . . .
1.9
Amounts reclassified to consolidated statement of income(a) . . . . . .
0.0
Tax benefit (expense) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 0.9
(1.3)
0.0
0.4
$(12.0)
(30.2)
6.1
6.2
Other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . .
5.7
(0.9)
(17.9)
Balance December 31, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(36.8)
10.4
Other comprehensive income (loss) before reclassifications . . . . . .
0.0
Amounts reclassified to consolidated statement of income(a) . . . . . .
0.0
Tax benefit (expense) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . .
10.4
Balance December 31, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(26.4)
(3.8)
Other comprehensive income (loss) before reclassifications . . . . . .
0.0
Amounts reclassified to consolidated statement of income(a) . . . . . .
0.0
Tax benefit (expense) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . .
(3.8)
$ 0.0
0.0
0.0
0.0
0.0
$ 0.0
(0.8)
0.0
0.2
(0.6)
$(29.9)
(34.8)
5.8
7.7
(21.3)
$(51.2)
26.7
(8.2)
(4.7)
13.8
$(53.6)
(27.7)
8.0
6.6
(13.1)
$(66.7)
(24.4)
5.8
7.7
(10.9)
$(77.6)
22.1
(8.2)
(4.5)
9.4
Balance December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $(30.2)
$(0.6)
$(37.4)
$(68.2)
(a) Amounts reclassified to cost of sales, selling, general and administrative expenses, or interest expense.
15. Commitments, Contingencies and Guarantees
Commitments
a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based
mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the
partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the
partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw
materials at the prevailing market price. The Company is not engaged in any other material transactions with the
partnership or the partner supplier.
b. As of December 31, 2021, the Company had commitments of approximately $362.6. These commitments
include the purchase of raw materials, packaging supplies and services from its vendors at market prices to
enable the Company to respond quickly to changes in customer orders or requirements, as well as costs
associated with licensing and promotion agreements.
c. As of December 31, 2021, the Company had various guarantees and letters of credit totaling $4.7.
d. In connection with the Company’s acquisition of Agro BioSciences, Inc. on January 17, 2017, the
Company was obligated to pay an additional amount of up to $25.0 based on sales performance in 2019. The
91
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
initial fair value of this business acquisition liability was $17.8, which was established in the purchase price
allocation. In December 2019, the liability was lowered to $14.2 based on 2019 sales. The reduction was
recorded in SG&A in the SPD segment. In April 2020, a payment of $14.5 was paid to settle the liability.
In connection with the Passport Acquisition, the Company was obligated to pay an additional amount of up
to $25.0 based on sales performance through 2020. The initial fair value of this business acquisition liability was
$7.3, which was established in the purchase price allocation. During the second quarter of 2019, the Company
recorded a reduction in fair value of the entire $7.3 Passport business acquisition liability based on the revised
valuation due to updated sales forecasts. The reduction was recorded in SG&A in the SPD segment. The business
acquisition liability was reassessed at each balance sheet date leading up to December 31, 2020 with no
additional changes to the fair value.
In connection with the Flawless Acquisition, the Company was obligated to pay an additional amount of up
to $425.0 based on sales performance through 2021. The initial fair value of this business acquisition liability
was $182.0. That amount was established in the purchase price allocation. During the years ended December 31,
2021 and 2020, the Company decreased the fair value of the business acquisition liability by $98.0 and by $94.0,
respectively, based on updated sales forecasts. As a result of these adjustments, the fair value of this business
acquisition liability was $0.0 as of December 31, 2021, which was the end of the earn-out period. The changes in
fair value were recorded within the Consumer Domestic and Consumer International segments.
In connection with the Zicam Acquisition, the Company deferred an additional cash payment of $20.0
related to certain indemnifications provided by the seller. The additional amount is payable five years from the
closing.
In connection with the TheraBreath Acquisition, the Company deferred an additional cash payment of $14.0
related to certain indemnity obligations provided by the seller. The additional amount, to the extent not used in
satisfaction of such indemnity obligations, is payable in installments between two and four years from the
closing.
Legal proceedings
e. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company
entered into select guarantees and indemnifications of performance with respect to the fulfillment of the
Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify
the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties
surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.
Representations and warranties that survive the closing date generally survive for periods up to five years or the
expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally
limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select
provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements
for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities,
if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations
and cash flows.
f. In addition to the matters described above, from time to time in the ordinary course of its business the
Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or
other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions,
92
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety
and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and
their outcomes, and any related damages, may not be reasonably predictable or estimable. Any such
proceedings could result in a material adverse outcome negatively impacting the Company’s business, financial
condition, results of operations or cash flows.
16. Related Party Transactions
The following summarizes the balances and transactions between the Company and each of Armand and
ArmaKleen, in which the Company holds a 50% ownership interest:
Armand
Year Ended
December 31,
ArmaKleen
Year Ended
December 31,
2021
2020
2019
2021
2020
2019
Purchases by Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales by Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Outstanding Accounts Receivable . . . . . . . . . . . . . . . . . . . . . . . . . . .
Outstanding Accounts Payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . .
Administration & Management Oversight Services(1)
$12.9
$ 0.0
$ 1.0
$ 1.2
$ 2.2
$14.2
$ 0.0
$ 0.7
$ 1.4
$ 2.1
$14.3
$ 0.0
$ 0.6
$ 1.6
$ 2.7
$0.0
$1.2
$0.9
$0.0
$2.1
$0.0
$1.1
$0.5
$0.0
$2.2
$0.0
$1.1
$0.8
$0.0
$2.1
(1) Billed by Company and recorded as a reduction of SG&A expenses.
17. Segments
Segment Information
The Company operates three reportable segments: Consumer Domestic, Consumer International and
Specialty Products Division. These segments are determined based on differences in the nature of products and
organizational and ownership structures. The Company also has a Corporate segment.
Segment revenues are derived from the sale of the following products:
Segment
Consumer Domestic
Consumer International
SPD
Products
Household and personal care products
Primarily personal care products
Specialty chemical products
The Corporate segment income consists of equity in earnings of affiliates. As of December 31, 2021, the
Company held 50% ownership interests in each of Armand and ArmaKleen, respectively. The Company’s equity
in earnings of Armand and ArmaKleen, totaling $9.4, $6.7, and $6.6 for the three years ending December 31,
2021, 2020 and 2019, respectively, are included in the Corporate segment.
Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal
care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International
segment results set forth in the table below.
93
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
The following table presents selected financial information relating to the Company’s segments for each of
the three years in the period ended December 31, 2021:
Net sales
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Marketing Expenses
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, General and Administrative Expenses
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from Operations
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity in Earnings of Affiliates
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income Before Income Taxes
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Identifiable Assets
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capital Expenditures
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation & Amortization
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(1) Corporate reflects the following:
Consumer
Domestic
Consumer
International
SPD
Corporate(1) As Reported
$3,941.9
3,767.6
3,302.6
$ 912.2
828.2
756.3
$336.0
300.0
298.8
$
0.0
0.0
0.0
1,795.8
1,801.1
1,575.2
442.1
460.6
398.0
445.3
455.6
470.1
908.4
884.9
707.1
0.0
0.0
0.0
861.4
832.4
645.8
402.1
368.8
346.1
131.1
126.9
112.9
135.7
128.7
151.7
135.3
113.2
81.5
0.0
0.0
0.0
127.3
105.0
74.0
6,354.5
5,819.8
5,099.1
1,192.9
1,144.5
1,110.0
100.3
81.8
53.9
170.0
142.8
131.9
8.4
7.1
9.4
31.1
29.6
27.1
112.7
104.1
110.9
4.5
3.7
4.1
72.8
68.8
55.2
35.4
31.6
51.6
0.0
0.0
0.0
33.6
29.7
47.3
332.7
339.7
340.4
10.1
10.0
10.4
15.4
14.5
14.1
(47.1)
(59.8)
(48.2)
0.0
0.0
0.0
(47.1)
(59.8)
(48.2)
0.0
0.0
0.0
9.4
6.7
6.6
9.4
6.7
6.6
116.4
110.5
107.9
0.0
0.0
0.0
2.6
2.8
3.3
$5,190.1
4,895.8
4,357.7
2,263.5
2,214.2
1,984.0
577.7
591.2
515.0
606.7
593.3
628.8
1,079.1
1,029.7
840.2
9.4
6.7
6.6
1,031.7
973.8
773.7
7,996.5
7,414.5
6,657.4
118.8
98.9
73.7
219.1
189.7
176.4
(A) The administrative costs of the production planning and logistics functions are included in segment
Selling, General and Administrative expenses but are elements of Cost of Sales in the Company’s
Consolidated Statements of Income. Such amounts were $47.1, $59.8, and $48.2 for 2021, 2020 and
2019, respectively.
94
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(In millions, except share and per share data)
(B) Equity in earnings (loss) of affiliates from Armand and ArmaKleen for the year ended December 31,
2021, 2020 and 2019.
(C) Corporate assets include deferred compensation investments and the Company’s investment in
unconsolidated affiliates.
Other than the differences noted in the footnote above, the accounting policies followed by each of the
segments, including intersegment transactions, are substantially consistent with the accounting policies described
in Note 1.
Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table
above, were $10.8, $11.7 and $10.5 for the twelve months ended December 31, 2021, December 31, 2020 and
December 31, 2019, respectively.
Product line revenues from external customers for each of the three years ended December 31, 2021,
December 31, 2020 and December 31, 2019 were as follows:
Household Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Personal Care Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$2,103.0
1,838.9
$2,038.5
1,729.1
$1,821.7
1,480.9
Total Consumer Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total Consumer International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total SPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3,941.9
912.2
336.0
3,767.6
828.2
300.0
3,302.6
756.3
298.8
Total Consolidated Net Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$5,190.1
$4,895.8
$4,357.7
2021
2020
2019
Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include
condoms, pregnancy kits, oral care products, skin care products, hair care products and gummy dietary
supplements.
Geographic Information
Approximately 82%, 83% and 82% of the net sales reported in the accompanying consolidated financial
statements in 2021, 2020 and 2019, respectively, were to customers in the U.S. Approximately 96%, 96% and
95% of long-lived assets were located in the U.S. at December 31, 2021, 2020 and 2019, respectively. Other than
the U.S., no one country accounts for more than 5% of consolidated net sales and 5% of total assets.
Customers
A group of three customers accounted for approximately 37% of consolidated net sales in 2021 and 36% in
2020 and 2019, respectively, of which a single customer (Walmart Inc. and its affiliates) accounted for
approximately 24%, 23% and 24% in 2021, 2020 and 2019, respectively.
95
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
Not applicable.
ITEM 9A. CONTROLS AND PROCEDURES
a) Evaluation of Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief
Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in
Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at
the end of the period covered by this Annual Report. Based on that evaluation, the Chief Executive Officer and
Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the
period covered by this Annual Report are effective to provide reasonable assurance that the information required
to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized
and reported within the time periods specified in the Commission’s rules and forms, and (ii) accumulated and
communicated to the Company’s management, including the Chief Executive Officer and Chief Financial
Officer, as appropriate to allow timely decisions regarding the disclosure.
b) Management’s Report on Internal Control Over Financial Reporting
The Company’s management’s report on internal control over financial reporting is set forth in Item 8 of
this Annual Report and is incorporated by reference herein. The Company’s independent registered public
accounting firm has issued an audit report on the effectiveness of the Company’s internal control over financial
reporting, which is set forth in Item 8 of this Annual Report.
c) Change in Internal Control over Financial Reporting
No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and
15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
Not applicable.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS
Not applicable.
96
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information required by this item is incorporated by reference to the information under the captions
“Election of Directors,” “Information about the Company’s Executive Officers,” “Corporate Governance and
Other Board Matters – Code of Conduct,” and “Corporate Governance and Other Board Matters– Board of
Directors Meetings and Committees – Audit Committee,” in the Company’s definitive proxy statement, which
will be filed with the Commission not later than 120 days after the close of the fiscal year covered by this Annual
Report.
ITEM 11. EXECUTIVE COMPENSATION
Information required by this item is incorporated by reference to the information under the captions
“Compensation Discussion and Analysis,” “2021 Summary Compensation Table,” “2021 Grants of Plan Based
Awards,” “2021 Outstanding Equity Awards at Fiscal Year-End,” “2021 Option Exercises and Stock Vested,”
“2021 Nonqualified Deferred Compensation,” “Potential Payments Upon Termination or Change in Control” and
“Compensation & Human Capital Committee Report” in the Company’s definitive proxy statement, which will
be filed with the Commission not later than 120 days after the close of the fiscal year covered by this Annual
Report.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
Information required by this item is incorporated by reference to the information under the captions
“Securities Authorized for Issuance under Equity Compensation Plans” and “Securities Ownership of Certain
Beneficial Owners and Management” in the Company’s definitive proxy statement, which will be filed with the
Commission not later than 120 days after the close of the fiscal year covered by this Annual Report.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
Information required by this item is incorporated by reference to the information under the caption
“Corporate Governance and other Board Matters – Board of Directors Independence” in the Company’s
definitive proxy statement, which will be filed with the Commission not later than 120 days after the close of the
fiscal year covered by this Annual Report.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Information required by this in relation to our principal accountant, Deloitte & Touche LLP (PCAOB ID
No. 34) item is incorporated by reference to the information under the caption “Fees Paid to Independent
Registered Public Accounting Firm” in the Company’s definitive proxy statement, which will be filed with the
Commission not later than 120 days after the close of the fiscal year covered by this Annual Report.
97
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
PART IV
(a) 1. Financial Statements and Schedule
The following Consolidated Financial Statements are included in Item 8 of this Form 10-K:
Consolidated Statements of Income for each of the three years in the period ended December 31,
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Balance Sheets as of December 31, 2021 and 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Cash Flow for each of the three years in the period ended December 31,
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended
December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule II — Valuation and Qualifying Accounts for each of the three years in the period ended
58
59
60
62
63
December 31, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
104
(a) 3. Exhibits
Unless otherwise noted, the file number for all the Company’s filings with the Securities and Exchange
Commission referenced below is 1-10585.
(3.1)
(3.2)
(3.3)
(4.1)
(4.2)
(4.3)
(4.4)
(4.5)
Amended and Restated Certificate of Incorporation of the Company, incorporated by reference to
Exhibit 3.1 to the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2020.
Amendment to the Company’s Amended and Restated Certificate of Incorporation, incorporated
by reference to Exhibit 3.1 to the Company’s current report on Form 8-K filed on April 30, 2021.
By-laws of the Company, amended and restated as of May 1, 2020, incorporated by reference to
Exhibit 3.2 to the Company’s current report on Form 8-K filed on May 1, 2020.
Indenture, dated as of December 15, 2010, between Church & Dwight Co., Inc. and The Bank
of New York Mellon Trust Company, N.A., as trustee, relating to the 2.875% Notes due 2022,
incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K filed on
December 15, 2010.
Second Supplemental Indenture, dated as of September 26, 2012, between Church & Dwight
Co., Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the
2.875% Notes due 2022, incorporated by reference to Exhibit 4.2 to the Company’s current
report on Form 8-K filed on September 26, 2012.
Indenture, dated as of December 9, 2014, between Church & Dwight Co., Inc. and Wells Fargo
Bank, National Association, as trustee, incorporated by reference to Exhibit 4.1 to the
Company’s current report on Form 8-K filed on December 9, 2014.
Second Supplemental Indenture, dated as of July 25, 2017, between Church & Dwight Co., Inc.
and Wells Fargo Bank, National Association, as trustee, relating to the Notes, incorporated by
reference to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed on July 25, 2017.
Indenture, dated as of December 10, 2021, between Church and Dwight Co., Inc. and Deutsche
Bank Trust Company Americas, as trustee, relating to the Notes, incorporated by reference to
Exhibit 4.1 to the Company’s current report on Form 8-K filed on December 10, 2021.
98
(4.6)
(4.7)
(10.1)
(10.1.1)
(10.2)
(10.2.1)
(10.3)
* (10.4)
* (10.4.1)
* (10.4.2)
* (10.5)
* (10.6)
First Supplemental Indenture, dated as of December 10, 2021, between Church & Dwight Co.,
Inc. and Deutsche Bank Trust Company Americas, as trustee, relating to the Notes, incorporated
by reference to Exhibit 4.2 to the Company’s current report on Form 8-K filed on December 10,
2021.
Description of Registrant’s Securities, incorporated by reference to Exhibit 4.5 to the Company’s
annual report on Form 10-K for the year ended December 31, 2019.
Credit Agreement, dated as of May 1, 2019, among Church & Dwight Co., Inc., the lenders party
thereto from time to time, Bank of America, N.A., as administrative agent and a lender, Wells
Fargo Bank, National Association and SunTrust Bank, as syndication agents and Bank of
Montreal, as documentation agent, incorporated by reference to Exhibit 10.2 to the Company’s
current report on Form 8-K filed on May 7, 2019.
First Amendment to the Credit Agreement, dated as of May 1, 2019, among Church & Dwight
Co., Inc., the initial lenders named therein, Bank of America, N.A., as lead administrative
agent, swing line lender, and L/C issuer, Wells Fargo Bank, National Association, as
co-administrative agent, syndication agent and swing line lender, SunTrust Bank, as syndication
agent and swing line lender, Bank of Montreal, Deutsche Bank Securities Inc., HSBC Bank
USA, National Association, The Bank of Nova Scotia and The Bank of Tokyo-Mitsubishi UFJ,
LTD., as documentation agents, the other lenders party thereto and Merrill Lynch, Pierce,
Fenner & Smith Incorporated, SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities,
LLC, as joint lead arrangers and joint bookrunners, incorporated by reference to Exhibit 10.1 to
the Company’s current report on Form 8-K filed on May 7, 2019.
Form of Commercial Paper Dealer Agreement, dated February 23, 2017, by and between
Church & Dwight Co., Inc. and Dealer, incorporated by reference to Exhibit 10.2 to the
Company’s annual report on Form 10-K for the year ended December 31, 2016.
Form of Amended and Restated Commercial Paper Dealer Agreement, dated February 23,
2017, by and between Church & Dwight Co., Inc. and Dealer, incorporated by reference to
Exhibit 10.3 to the Company’s annual report on Form 10-K for the year ended December 31,
2016.
Stock Purchase Agreement, dated as of July 17, 2017, among Church & Dwight Co., Inc., PIK
Holdings, Inc., the Representative and the stockholders party thereto, incorporated by reference
to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed on July 17, 2017.
Church & Dwight Co., Inc. Executive Deferred Compensation Plan, effective as of June 1,
1997, incorporated by reference to Exhibit 10(f) to the Company’s annual report on Form 10-K
for the year ended December 31, 1997.
Amendment to the Church & Dwight Co., Inc. Executive Deferred Compensation Plan,
effective January 1, 2007, incorporated by reference to Exhibit 10.4.1 to the Company’s annual
report on Form 10-K for the year ended December 31, 2011.
Amendment to the Church & Dwight Co., Inc. Executive Deferred Compensation Plan,
effective February 1, 2012, incorporated by reference to Exhibit 10.4.2 to the Company’s
annual report on Form 10-K for the year ended December 31, 2011.
Church & Dwight Co., Inc. Executive Deferred Compensation Plan II, amended and restated as
of January 1, 2012, incorporated by reference to Exhibit 10.5 to the Company’s annual report
on Form 10-K for the year ended December 31, 2011.
Deferred Compensation Plan for Directors effective as of May 1, 2008, incorporated by
reference to Exhibit 10.5 to the Company’s quarterly report on Form 10-Q for the quarter ended
March 28, 2008.
99
* (10.7)
* (10.8)
* (10.9)
* (10.10)
* (10.11)
Amended and Restated Compensation Plan for Directors, effective January 1, 2015, incorporated
by reference to Exhibit 10.7 to the Company’s annual report on Form 10-K for the year ended
December 31, 2015.
Amended and Restated Compensation Plan for Directors, dated November 1, 2017, incorporated
by reference to Exhibit 10.9.2 to the Company’s annual report on Form 10-K for the year ended
December 31, 2017.
The Stock Option Plan for Directors, effective as of January 1, 1991, incorporated by reference to
Exhibit 10(j) to the Company’s annual report on Form 10-K for the year ended December 31,
2005.
The Church & Dwight Co., Inc. Stock Award Plan as amended, incorporated by reference to
Exhibit 10 to the Company’s quarterly report on Form 10-Q for the quarter ended June 29,
2007.
Church & Dwight Co., Inc., Amended and Restated Omnibus Equity Compensation Plan,
incorporated by reference to Exhibit A to the Company’s Proxy Statement for its 2013 Annual
Meeting of Stockholders, filed on March 21, 2013.
* (10.11.1)
First Amendment to Church & Dwight Co., Inc. Amended and Restated Omnibus Equity
Compensation Plan, incorporated by reference to Exhibit 10.1 to the Company’s quarterly
report on Form 10-Q for the quarter ended October 31, 2019.
* (10.12)
* (10.13)
Form of Award Agreement for Directors Under the Church & Dwight Co., Inc., Amended and
Restated Omnibus Equity Compensation Plan, incorporated by reference to Exhibit 10.12.1 to
the Company’s annual report on Form 10-K for the year ended December 31, 2018.
Form of Award Agreement for CEO and EVPs Under the Church & Dwight Co., Inc., Amended
and Restated Omnibus Equity Compensation Plan, incorporated by reference to Exhibit 10.2 to
the Company’s quarterly report on Form 10-Q for the quarter ended October 31, 2019.
• * (10.13.1)
Form of Award Agreement for CEO and EVPs Under the Church & Dwight Co., Inc., Amended
and Restated Omnibus Equity Compensation Plan.
* (10.14)
Form of Award Agreement for Employees Under the Church & Dwight Co., Inc., Amended and
Restated Omnibus Equity Compensation Plan, incorporated by reference to Exhibit 10.12.2 to
the Company’s annual report on Form 10-K for the year ended December 31, 2018.
• * (10.14.1)
Form of Award Agreement for Employees Under the Church & Dwight Co., Inc., Amended and
Restated Omnibus Equity Compensation Plan.
* (10.15)
* (10.16)
* (10.17)
* (10.18)
Church & Dwight Co., Inc. Third Amended and Restated Annual Incentive Plan, incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
December 6, 2018.
Employment Agreement, dated October 31, 2011, by and between the Company and Patrick de
Maynadier, incorporated by reference to Exhibit 10.18 to the Company’s annual report on Form
10-K for the year ended December 31, 2011.
Employment Agreement, dated August 23, 2006, by and between the Company and Matthew T.
Farrell, incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form
10-Q for the quarter ended September 29, 2006.
Amended and Restated Change in Control and Severance Agreement, entered into by and
between the Company and Matthew T. Farrell, incorporated by reference to Exhibit 10.1 to the
Company’s current report on Form 8-K filed on February 2, 2016.
100
* (10.19)
* (10.20)
* (10.21)
(10.22)
(21)
(23)
(31.1)
(31.2)
(32.1)
(32.2)
•
•
•
•
•
•
•
•
Form of Amended and Restated Change in Control and Severance Agreement entered into by and
between the Company and each of the senior executive officers (other than Matthew T. Farrell),
incorporated by reference to Exhibit 10.2 to the Company’s current report on Form 8-K filed on
February 2, 2016.
Transition Separation Agreement, dated September 28, 2021, by and between the Company and
Britta Bomhard.
Employment Agreement, dated September 4, 2021, by and between the Company and Barry
Bruno.
Lease Agreement (Build to Suit), dated July 20, 2011, between Church & Dwight Co., Inc. and
CD 95 L.L.C., incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on
Form 10-Q for the quarter ended September 30, 2011.
List of the Company’s subsidiaries.
Consent of Independent Registered Public Accounting Firm.
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) under
the Securities Exchange Act.
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) under
the Securities Exchange Act.
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under
the Exchange Act and 18 U.S.C. Section 1350.
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under
the Exchange Act and 18 U.S.C. Section 1350.
(101.INS)
Inline XBRL Instance Document—the instance document does not appear in the Interactive
Data File because its XBRL tags are embedded within the Inline XBRL document.
(101.SCH) Inline XBRL Taxonomy Extension Schema Document.
(101.CAL) Inline XBRL Taxonomy Extension Calculation Linkbase Document.
(101.DEF) Inline XBRL Taxonomy Extension Definition Linkbase Document.
(101.LAB) Inline XBRL Taxonomy Extension Label Linkbase Document.
(101.PRE) Inline XBRL Taxonomy Extension Presentation Linkbase Document.
(104)
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
•
*
Indicates documents filed herewith.
Constitutes management contract or compensatory plan or arrangement required to be filed as an exhibit to
this Annual Report.
ITEM 16. FORM 10-K SUMMARY
None.
101
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant
has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized, on
February 17, 2022.
CHURCH & DWIGHT CO., INC.
By:
/s/ Matthew T. Farrell
MATTHEW T. FARRELL
PRESIDENT AND CHIEF EXECUTIVE OFFICER
102
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below
by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
/s/ Matthew T. Farrell
Matthew T. Farrell
/s/
Bradlen S. Cashaw
Bradlen S. Cashaw
/s/
/s/
James R. Craigie
James R. Craigie
Bradley C. Irwin
Bradley C. Irwin
/s/
Penry W. Price
Penry W. Price
/s/
Susan G. Saideman
Susan G. Saideman
Chairman, President and Chief
Executive Officer, Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
/s/
Ravichandra K. Saligram
Ravichandra K. Saligram
Director
February 17, 2022
/s/
Robert K. Shearer
Robert K. Shearer
/s/
Janet S. Vergis
Janet S. Vergis
/s/
Arthur B. Winkleblack
Arthur B. Winkleblack
/s/
Laurie J. Yoler
Laurie J. Yoler
/s/ Richard A. Dierker
Richard A. Dierker
Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
Director
February 17, 2022
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer)
February 17, 2022
/s/
Joseph J. Longo
Joseph J. Longo
Vice President and Controller
(Principal Accounting Officer)
February 17, 2022
103
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
SCHEDULE II—Valuation and Qualifying Accounts
For each of the three years in the period ended December 31, 2021
(Dollars in millions)
Additions
Deductions
Beginning
Balance
Charged to
Expenses
Acquired
Amounts
Written Off
Foreign
Exchange
Ending
Balance
Allowance for Doubtful Accounts
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for Cash Discounts
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales Returns and Allowances
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 3.7
2.4
3.1
$ 6.0
5.1
5.0
$24.5
13.0
12.1
$
0.6
1.4
0.4
$ 98.4
96.0
86.9
$129.4
110.9
97.2
$1.9
0.0
0.0
$0.0
0.4
0.0
$0.0
0.4
0.0
$
(0.7)
(0.1)
(1.1)
$ (98.5)
(95.5)
(86.8)
$(121.5)
(99.8)
(96.4)
$0.0
0.0
0.0
$0.0
0.0
0.0
$0.0
0.0
0.1
$ 5.5
3.7
2.4
$ 5.9
6.0
5.1
$32.4
24.5
13.0
104
I, Matthew T. Farrell, certify that:
CERTIFICATIONS
EXHIBIT 31.1
1.
I have reviewed this annual report on Form 10-K of Church & Dwight Co., Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of any material fact or omit
to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this report based on our evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that
occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in
the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant’s auditors and the audit committee of
registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control
over financial reporting which are reasonably likely to adversely affect the registrant’s ability to
record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant’s internal control over financial reporting.
Date: February 17, 2022
/s/ Matthew T. Farrell
Matthew T. Farrell
President and Chief Executive Officer
I, Richard A. Dierker, certify that:
CERTIFICATIONS
EXHIBIT 31.2
1.
I have reviewed this annual report on Form 10-K of Church & Dwight Co., Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of any material fact or omit
to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this report based on our evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that
occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in
the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant’s auditors and the audit committee of
registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control
over financial reporting which are reasonably likely to adversely affect the registrant’s ability to
record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant’s internal control over financial reporting.
Date: February 17, 2022
/s/ Richard A. Dierker
Richard A. Dierker
Executive Vice President and Chief Financial Officer
CERTIFICATION PURSUANT TO
RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT AND
18 U.S.C. SECTION 1350
EXHIBIT 32.1
I, Matthew T. Farrell, President and Chief Executive Officer of Church & Dwight Co., Inc. (the
“Company”), hereby certify that, based on my knowledge:
1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2. The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
By: /s/ Matthew T. Farrell
Matthew T. Farrell
President and Chief Executive Officer
Dated: February 17, 2022
CERTIFICATION PURSUANT TO
RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT AND
18 U.S.C. SECTION 1350
EXHIBIT 32.2
I, Richard A. Dierker, Executive Vice President and Chief Financial Officer of Church & Dwight Co., Inc.
(the “Company”), hereby certify that, based on my knowledge:
1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2. The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.
By: /s/ Richard A. Dierker
Richard A. Dierker
Executive Vice President and Chief Financial Officer
Dated: February 17, 2022
Dividend Reinvestment Plan
Computershare Trust Company, N.A.
administers a dividend reinvestment and
stock purchase plan for our Stockholders.
For details, contact:
Dividend Reinvestment Plan
Church & Dwight Co., Inc.
Computershare Trust Company, N.A.
250 Royall Street, Canton, MA 02021
866.299.4219
The virtual annual meeting of
stockholders will be held at:
12:00 P.M. Thursday, April 28, 2022
New York Stock
Exchange Certification
Our Chief Executive Officer has provided
the required annual certification to the
New York Stock Exchange.
Stockholder Inquiries
Communications concerning
stockholder records, stock transfer,
changes of ownership, account
consolidations, dividends and
change of address should be
directed to:
Church & Dwight Co., Inc.
Computershare Inc.
Stockholder Relations
866.299.4219
Stockholder correspondence
should be mailed to:
Church & Dwight Co., Inc.
Computershare
P.O. BOX 30170
College Station, TX 77842-3170
Overnight correspondence
should be sent to:
Church & Dwight Co., Inc.
Computershare
211 Quality Circle, Suite 210
College Station, TX 77845
www.computershare.com/investor
Investor Information
Corporate Headquarters
Church & Dwight Co., Inc.
Princeton South Corporate Park
500 Charles Ewing Blvd.,
Ewing, New Jersey 08628
609.806.1200
Corporate Website:
www.churchdwight.com
Independent Registered
Public Accounting Firm
Deloitte & Touche LLP
100 Kimball Drive
Parsippany, NJ 07054
Transfer Agent and Registrar
Computershare Inc.
250 Royall Street
Canton, MA 02021
866.299.4219
Stock Listing
Church & Dwight Co., Inc. shares are
listed on the New York Stock Exchange.
The symbol is CHD.
10-K Report
Stockholders may obtain a copy of
the Company’s Annual Report on
Form 10-K for the year ended 12/31/21
filed with the Securities and Exchange
Commission by writing to the Secretary
at Corporate Headquarters.
Cautionary Note On Forward-Looking Information:
This Annual Report contains forward-looking statements which are based on current assumptions that are subject to risks and uncertainties
that may cause actual results to differ materially from the forward-looking statements, including the risks and uncertainties discussed on pages
14-31 of this Annual Report. The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as
a result of new information, future events or otherwise, except as required by law.
®Church & Dwight Co., Inc. 2022
CHURCH & DWIGHT CO., INC.
—
Princeton South Corporate Center
500 Charles Ewing Boulevard
Ewing, NJ 08628
www.churchdwight.com
C
H
U
R
C
H
&
D
W
I
G
H
T
C
O
.
,
I
N
C
.
—
A
N
N
U
A
L
R
E
P
O
R
T
2
0
2
1